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Abstract 
 
MARCELO S. BEHAR: Dynamic regulation and information transfer in intracellular-
signaling pathways 
(Under the direction of Timothy Elston) 
 
Cells contain myriads of specialized sensors that allow them to react to changes in the 
environment by activating pathways comprised by layers of signaling proteins. Cell 
survival requires these pathways to reliably propagate signals containing qualitative and 
quantitative information about their environment. They achieve this by modulating the 
enzymatic activity of signaling proteins. In this work we analyze some of these regulatory 
mechanisms, with emphasis on those that can be used to encode and decode quantitative 
information. In particular, we demonstrate that cells have the tools to encode quantitative 
information as signal-duration, and that by regulating pathways dynamics in a concerted 
way, they can ensure signal specificity in the presence of shared components without the 
need for cross-inhibition or scaffold proteins. A strategy termed kinetic insulation is 
introduced, which routes signals according to their temporal profile. We show that such a 
system can be built with regulatory motifs commonly observed in signaling pathways. 
We also present experimental evidence indicating that duration encoding is being used in 
the yeast pheromone response pathway. Computational modeling is used to analyze 
possible encoding mechanisms and key experiments are proposed that can distinguish 
among them. Finally, the importance of studying signals as dynamic events is discussed.   
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Chapter 1 
 
Basic concepts and review of the field 
1.1 Overview 
Cells are able to adapt and thrive in changing environments thanks to complex bio-
chemical signaling networks. These systems take environmental information gathered by 
receptors at the membrane, and through the activation of multiple levels of signaling 
proteins, they transfer it to the cellular actors that will produce the adequate response. In 
many cases, the signaling proteins are unevenly distributed inside the cell and external 
challenges often result in complex, but well-organized spatiotemporal activity patterns. 
Malfunctions in a signaling pathway or one of its components often result in disease or 
death. Knowledge of the design principles underlying these systems and the regulatory 
mechanisms controlling the flow of information, would not only deepen our 
understanding of biological systems, but also provide valuable tools to those developing 
therapies to treat disease.  
Understanding intra-cellular signaling pathways as whole entities constitutes a 
formidable biophysical problem and is the main subject of this work. This chapter 
introduces some notions from the fields of cellular and molecular biology as well as 
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biochemical and biophysical concepts necessary to understand the results presented later. 
Readers from a biology background can skip this introduction. The second part of this 
chapter provides a brief review of the field and some selected previous results are 
presented. Chapters 2 to 4 contain the bulk the results. The broad significance of the 
findings is considered in Chapter 5, in which we also speculate about their potential 
generalization and suggest future directions for this research.  
1.2  Biological background 
This section is intended as brief introduction to the biological background relevant 
to this work. For a more complete treatment of these subjects the reader is referred to the 
books by Alberts et al. (1), or Goemperts et al. (2).  
The ability to react to changes in the environment is a key aspect shared by the 
majority of living cells. In early development, stem cells specialize in part because of 
morphogenic cues present in the environment. Simple organisms are capable of 
exquisitely sensing gradients and move towards regions with high levels of nutrients or 
away from adverse environments. Cells in different parts of multicellular organisms 
communicate with each other by releasing chemical messengers that can be sensed only 
by specific kinds of target cells. Hormones, neurotransmitters, cytokines, and other 
chemical messengers mediate the control of virtually every body function in mammals. 
To stay alive, cells must detect these messages and process the information so the 
adequate action is taken. Extensive networks of signaling pathways have evolved over 
time just to do this. These pathways usually start with the activation of a sensor protein, 
called receptor (in pathways devised to react to chemical cues), and involve the activation 
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of multiple signaling proteins organized to respond in a cascade-like fashion. Activation 
occurs when an upstream event modifies a target protein, endowing it with new 
enzymatic activity (or repressing a constitutive one), which in turns allows it to 
chemically modify a downstream substrate and so on. The activation of a signaling 
pathway can result in an increased or decreased expression (upregulation and 
downregulation) of groups of genes, a change in the permeability of the cell, the release 
of different effectors from internal storage, or the redistribution of proteins, lipids and 
other components of the cell, just to name a few possibilities. The sum of these processes 
ultimately drives the appropriate physiological responses such as morphological changes, 
cell division or differentiation, neurotransmitter release, etc.  
To date, a large number of signaling pathways and components have been 
identified, and their study has revealed a number of common themes. Interestingly, 
similar designs have been observed in systems meant to operate in response to different 
cues or even in systems belonging to different species. This suggests that modularity may 
be a key feature of signaling pathways, and therefore the lessons learned from the study 
of a particular system can probably be extrapolated to other cases. For this reason and 
since it is impractical to describe the many known pathways, the rest of this section 
introduces only the elements that will be explicitly used later in this work with references 
to review articles when appropriate.   
The term G Protein Couple Receptor (GPCR) is used to describe a large family of 
mostly membrane bound proteins (3, 4). Proteins in this group, also known has 7TM (7 
Trans Membrane) receptors, are characterized by a common architecture consisting of 
seven trans-membrane helical segments. GPCR’s are widespread; more than 800 have 
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been identified in the human genome so far and more than 5% of the nematode C. 
Elegans genes encode them. These proteins usually act as sensors at the head of signaling 
cascades, becoming active when exposed to an agonist or ligand. Many receptors are 
capable of detecting chemical compounds with exquisite sensitivity and specificity. For 
example, the senses of smell and taste are initiated by odorants or flavonoids binding to 
GPCR’s. In multicellular organisms, cells depend on these receptors to measure blood 
concentration of hormones such as epinephrine (adrenaline) or other molecules such as 
glucose or nucleosides, and regulate organs function accordingly. Cells in the nervous 
system use GPCRs to detect some of the neurotransmitters (such as dopamine) that allow 
them to communicate with each other. Specialized GPCR’s are coupled to photosensitive 
compounds that undergo conformational changes when activated by light. These 
receptors are the basis of vision. In yeasts, GPCR’s are responsible for detecting the 
pheromone that induces these organisms to mate. The activation of most of the proteins 
that fall in this class is reversible, although there are groups of GPCR’s that are activated 
in an irreversible way when part of their extracellular domain is cleaved by an agonist. 
GPCR activity usually results from a conformational change induced (or stabilized) by 
the presence of the agonist. This change may expose intracellular catalytic or binding 
domains that are not accessible in the inactive state. Signaling by active GPCR’s can be 
terminated by the release of the agonist or the relaxation of the photosensitive species. 
GPCR activity can also be modulated by cytosolic species (residing in the cytosol) that 
bind to the receptor and prevent the activation of their intracellular targets (arrestins) or 
chemically modify it with the same result (GRK proteins). In some cases, receptor 
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activity is regulated by proteins that tag them for internalization (removal from the cell 
surface) often followed by degradation.  
The primary targets of most G Protein Coupled Receptors are hetero-trimeric G 
Proteins (5, 6). These are usually the first layer of signaling proteins targeted by active 
receptors. Hetero-trimeric G proteins are complexes formed by the non-covalent 
association of three proteins, referred to as the α, β, and γ subunits. The α subunit has the 
ability to bind GDP and GTP (Guanidyl di/triphosphate). It also has hydrolytic activity, 
which allows it to remove a phosphate group from a GTP molecule and transform it into 
GDP. In the inactive state, the β and γ subunits are bound together to a GDP bound Gα. 
Active receptors induce Gα to exchange GDP for GTP. This change destabilizes the 
complex, prompting it to dissociate into a Gβγ complex and GTP-bound Gα. In most 
systems, the subsequent response is mediated by the action of the GTP-Gα moiety, which 
depending on the family, can activate or inhibit the action of other proteins such as 
adenyl cyclases, phospholipases, and ion channels. The Gβγ complex remains attached to 
the membrane, and it is usually thought to act as a regulator of Gα activity. As a matter of 
fact, constitutive pathway activity (that is, ligand-independent activity) is often observed 
in cells in which the stoichiometric balance between the subunits has been altered. In 
some cases, however, as in the yeast pheromone response pathway, it is the Gβγ complex 
that activates signaling. G protein signals are terminated as Gα converts GTP back into 
GDP thus allowing the hetero-trimeric complex to re-form. A family of GTP-ase proteins 
called Regulators of G Protein Signaling (RGS) can accelerate this process. In addition to 
hetero-trimeric G proteins, other GTP-ases exist and are commonly encountered in 
signaling networks, often playing mayor regulatory roles. Because these proteins do not 
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explicitly participate in the specific pathways considered in the next sections, they will 
not be discussed here. Interested readers should consult the references mentioned above. 
Another group of important signaling molecules are the Mitogen Activated Protein 
Kinases (MAPKs) and their upstream effectors (MAPKK and MAPKKK) (7, 8). Upon 
phosphorylation, MAPKKK, MAPKK, and MAPK proteins gain kinase activity and 
become competent to phosphorylate their substrates. These proteins constitute the core of 
many signaling pathways, operating in cascades in which a MAPKKK phosphorylates 
and activates a downstream MAPKK, which in turns phosphorylates and activates a 
MAPK. MAPKKK and MAPKK proteins are usually very specific, with each being able 
to efficiently phosphorylate a very limited set of substrates, often only one. The souerce 
of this specificity are docking motifs that permit a MAPKKK to efficiently bind only to 
its target MAPKK. MAP kinases on the other hand can phosphorylate a variety of 
downstream targets, including transcription factors proteins that interact with the DNA 
processing machinery to induce or repress gene expression. The MAPK family is just one 
of the many protein groups with kinase activity. In fact, phosphorylation is one of the 
main mechanisms used by cells to regulate protein activity. There are many known 
MAPK proteins. The human genome encodes for at least 30 (including MAPKK and 
MAPKKK proteins). They are all part of networks that allow cells to relay information 
about a plethora of different stimuli. How specificity is maintained in these networks, that 
is, how different stimuli manage to elicit specific responses, is a matter of intense study 
and is the motivation for Chapter 3. 
Phosphorylation is a reversible process, at least in principle. Phosphatases are a 
group of enzymes that can remove the phosphate groups from phosphorylated residues 
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(9). Tyrosine phosphatases are specific for that kind of amino acid residue. Threonine-
serine phosphatases can dephosphorylate threonine and serine residues. Dual specificity 
phosphatases dephosphorylate threonine, serine and tyrosine residues. Comparatively less 
is known about phosphatases and how their activity is regulated than about kinases. There 
are many examples of transient kinase phosphorylation in response to a signal, which 
indicates that at least some phosphatases must be constitutively active or quickly 
activated. Phosphatases often localize to specific parts of the cell. For example, 
phosphatases Ptp2 and Ptp3 are nuclear and cytosolic proteins respectively. Phosphatases 
can be promiscuous and operate on a number of substrates, or can be specific to a 
particular protein or protein family.    
Signaling pathways target a number of systems inside cells, such as ion channels, 
ATP producing proteins, DNA binding proteins, etc. These systems then elicit the 
response necessary to cope with the conditions that triggered the signal. In many cases, 
the response includes the upregulation or downregulation of specific genes or group of 
genes. Signaling pathways affect gene expression by activating transcription factors, 
repressors, or other proteins that modify the interaction between the DNA encoding the 
gene and the machinery in charge of reading it. Pathways also can affect protein levels by 
modifying messenger RNA, either stabilizing it or making it more labile. Ultimately, it is 
the combination of these processes that causes the phenotypic response.  
Many signaling pathways have been discovered during the past four decades, yet 
characterization of most of them is still in its infancy. Thanks to advances in light 
microscopy and genetic manipulation this is changing rapidly. There is currently great 
interest in the study of the organization and function of the signaling and information 
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processing systems operating inside the cell. The pharmacological potential of such 
understanding is huge. Mastering the design principles behind signaling networks 
associated with a given disease would have immediate repercussion on the way the 
disease is treated and provide a valuable guide for developing novel therapies. This is a 
complex task that requires the combination of a variety of technologies, skills, and 
perspectives in order to be successfully tackled. Biophysical modeling is one of these 
tools. Because it is extensively used in this work, the next section describes some of the 
approaches common in this field as well as some selected results. 
1.3 Modeling intracellular processes 
 Computational modeling is an established component of the biophysical sciences. 
Early applications include the analysis of pattern formation driven by reaction-
convection-diffusion systems and the use of the theory of dynamical systems to the study 
of problems from ecology (10). Modeling at the organism and cellular level is routinely 
used today in a number of applications (11, 12), ranging from neurophysiology (the study 
of neural activity and neurotransmitters), to pharmacokinetics (the study of drug 
distribution and elimination in the body). Many of these applications use a high level of 
abstraction to describe the system under consideration. For example, neuroscientists often 
model neurons as electrical circuits in which the cellular components play the role of 
capacitors, resistors, and batteries (12).  The advent of modern molecular and cellular 
biology experimental techniques, such as the invention of monoclonal antibodies and 
fluorescent protein markers during the past decades, has provided the ability to observe 
intracellular processes in great detail. These new tools prompted renewed efforts to 
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model these processes at lower levels of abstraction. However, this wealth of new 
information brings new levels of complexity that can easily overwhelm anyone trying to 
understand the underlying mechanisms driving cellular behavior. Determining the key 
players and interactions in any given system has become a central problem for biologists 
and biophysicists. Computational modeling is slowly becoming the tool of choice to 
integrate, analyze, and ultimately make sense of the vast amount of new data coming 
daily from the labs.  
Perhaps the most notable success story in the field of computational biophysics is 
the elucidation of the processes governing cell cycle regulation. The pieces of the puzzle, 
that is, the genes involved, were discovered in the 90’s, but it was not until the efforts by 
John Tyson and James Ferrell that the whole picture emerged. These researchers used a 
combination of computational an experimental work to show that the regulation of the 
cell cycle occurs as a result of a combination of bistable switches (13-18). These 
discoveries led to a number of studies about the properties of this regulatory network 
architecture (19, 20), and spurred a search for multi-stable systems underlying other 
biological processes. This case exemplifies how knowledge of the components and 
interactions cannot, on its own, produce understanding of how the system actually works. 
It took diligent modeling efforts to reveal inconsistencies in the experimental data, point 
to knowledge voids (hence focusing experiments), and to ultimately put the pieces 
together and provide a system level picture of cell cycle regulation.  
The success behind the elucidation of the logic driving cell cycle regulation is 
mostly due to the module-based approach taken. The researchers built a complete model 
from smaller subunits that performed a specific function and could be characterized 
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almost independently. This approach not only made this large system manageable, but 
also allowed for the experimental validation of the individual modules. In most cases, 
however, it is not evident what the modules are or even if the system can be decomposed 
this way. A number of statistical-based methods, such as principal component analysis 
(PCA) have been used in these cases and their popularity is gaining momentum (21-23). 
The caveat is that these methods usually require a significant amount of quantitative 
experimental data of the type that is commonplace for genetic expression but rarely 
available for signaling pathways. These methods are very promising, and it is easy to 
predict that they will become widespread as high throughput techniques find their way 
into the signaling field. 
Computational biophysics does more than just integrate data and provide a 
systems level picture of the system under consideration. Mathematical and computational 
approaches have been used to try to understand why cells are wired the way they are. The 
search for underlying principles guiding the design of genetic networks, that is the 
complex set of interactions between the genes in an organism, has been going on for 
some time. The availability of complete genomes, allowed researchers pursuing this area 
to look for the patterns and motifs that are commonly used by nature to regulate the 
expression of different genetic programs with amazing results. Some researchers are 
approaching this fascinating problem from a synthetic perspective, trying to build 
artificial genetic networks, hoping to gain insight by facing the same design challenges 
faced by nature (24). In contrast, the search for the design principles behind signaling 
networks has advanced more slowly. This is in part because of the lack of suitable 
experimental tools compared with the ones available to study genetics, but also because 
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much less is known about how signals are regulated and therefore there is little base to 
draw general conclusions. 
Even with this limitation, a number of studies from have shed light on many of 
the questions posed by signaling systems. For example, it has been shown kinases tend to 
affect the downstream signal amplitude, whereas phosphatases affect both amplitude and 
signal duration (25) and that amplification often is at odds with propagation speed (26). 
Others have shown how signaling networks may use component sequestration or cross-
inhibition to prevent signal leakage (cross-talk) to parallel pathways (27-29).  Counter-
intuitive effects such as back-propagation in feedback loops (30), oscillations and 
bistability in simple biochemical systems has been studied (31-34). Considerable 
modeling efforts have been devoted to understand how signaling networks cope with 
noise and stochastic variation in their components (35-37). Many of these studies apply 
some variation of Metabolic Control Analysis, a branch of control theory developed 
specifically to study biochemical and metabolic networks (38). Its methods are more 
adequate to study steady state properties and perform local sensitivity analyses in the 
region of the parameter space around the steady state. However, some efforts have been 
made towards extending the formalism to time dependent problems (39, 40).   
Despite experimental limitations several groups have produced detailed models of 
important signaling networks, some more successful than others. Some notable examples 
are the modeling of the networks targeted by Epidermal Growth Factors (EGF) (41-43). 
A beautiful combination of experimental and computational work on the dynamics of 
ERK signaling was published by Sasagawa et. al. (44). Other examples include studies on 
the dynamics of the G-protein regulation (45) as well as osmoadaptation (46-48) in yeast, 
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Her signaling regulation (49), and pathways involved in the inflammatory response in 
mammals (50, 51) just to name a few. The computational part of most of these examples 
usually involves simulating protein interactions and transport effects using ordinary 
differential equations or partial differential equations, depending on whether the system 
can be analyzed as a well stirred reactor or if the spatial distributions of the components 
plays an important role and thus must be taken into account. Stochastic simulations are 
also often used, especially for systems containing small number of molecules per cell.  
Despite the insight these efforts provided about the particular system under study, 
it could be argued that little has come out in the form of principles that could be 
generalized to other systems. This is in part because in many cases, the experimental data 
available for any given pathway is insufficient to properly constrain the models, and 
therefore a number of architectures are compatible with the observations. In other cases, 
the modelers try to capture the whole complexity of the system all at once, and the results 
are as difficult to interpret and analyze as the real cell. The success stories (e.g. cell cycle 
regulation) demonstrate that the most promising path to understand a signaling network is 
by deconstructing it into –ideally- simple modules that can be analyzed independently 
and then assembled to produce the whole. This is the guiding philosophy of this work.  
The following pages analyze a number of aspects important for the understanding of 
signaling networks. Key to what follows is the understanding that signaling is not about 
steady states but rather is a dynamic process that is better understood in terms of transient 
dynamics. The backbone of this work is based on the experimentally observed ability of 
cells to measure and reliably propagate information about the extra-cellular environment 
to the effectors that ultimately produce the adequate phenotypic response. It is often the 
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case that signaling pathways not only relay qualitative information (e.g. the presence or 
absence of a stimulus), but also quantitative information about the stimulus strength. In 
order to do so, this information has to be encoded and transferred across the network 
without interfering with other pathways. The fact that many signaling pathways share 
components makes this a delicate task and raises a number of questions regarding how 
cells manage to maintain signal specificity. In this work we demonstrate that dynamic 
modulation of pathway activity can play a fundamental role in ensuring that information 
is properly transferred down a pathway. Chapter 2 studies the different encoding 
strategies available for living cells to transfer quantitative information. The focus is not in 
a particular metric or measurement of pathway bandwidth (a very interesting problem on 
its own), but in the general properties of different encoding schemas as well as their 
relative advantages and drawbacks. A large portion of the chapter is devoted to adaptive 
systems, that is, systems that upon stimulation produce a signal and then return to pre-
stimulation levels even in the presence of a sustained stimulus. These systems are 
pervasive in signaling networks and as we show, have the potential to endow pathways 
with very flexible signal modulation capabilities. A particular encoding strategy, duration 
encoding, is analyzed in more detail in the second part of the chapter. Evidence will be 
presented in Chapter 4, supporting the case for duration encoding as an information 
transfer vehicle used in a real yeast pathway. Chapter 3 demonstrates how the dynamic 
control of a signaling pathway activity can be used to route signals through branching 
points avoiding cross-talk between pathways sharing components. This novel strategy 
does not requires cross-inhibition or scaffold proteins to achieve specificity. Finally, in 
Chapter 4, we show how these concepts can be applied to gain a systems level 
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understanding of signaling in yeast. Given that many of the components of the signaling 
pathways described in that chapter are well preserved across species, it is plausible that 
the insight obtained from studying this system can be extrapolated to higher organisms, 
providing insight into the general design principles that underlie signaling networks. 
Chapter 2 
 
Information transfer in signaling pathways 
2.1 Quantitative information transfer 
2.1.1 Overview 
Many substances such as hormones, cytokines, nucleosides, and a variety of 
drugs, affect cellular behavior by binding to membrane receptors and triggering a cascade 
of intracellular signals. These signals are processed by different parts of the cellular 
machinery, eventually leading to very specific responses. In many cases, the magnitude 
or nature of the response must be commensurate to the intensity of the external stimulus, 
forcing the cell to be aware of its environment in both qualitative and quantitative terms. 
This quantitative knowledge may come in the form of thresholds separating distinct 
response regimes, or involve a full graded scale with responses proportional to the 
stimulus strength. For example, the yeast Saccharomyces cerevisiae behaves differently 
when exposed to different concentrations of mating pheromone. At low concentrations, 
cells do not appear to respond and continue to grow and divide normally. At intermediate 
concentrations, cells undergo a transition to a filamentous-like growth pattern (52, 53). 
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Finally, at high concentrations, cells undergo growth arrest and the bona fide mating 
response with its characteristic morphological change is observed (Figure 2-1) (54). This 
behavior indicates that the signaling pathways involved are capable of  “measuring” and 
relaying information about the presence of at least three concentration levels of mating 
pheromone. In fact, gene induction studies have demonstrated that this pathway is 
capable of relaying quantitative information in a fully graded fashion as shown in Figure 
2-1. The curve shows a graded increase of the amount of reporter gene product expressed 
under the control of the mating specific gene FUS1 promoter in response to different 
concentrations of pheromone as measured by the standard beta-galactosidase assay (55). 
Further examples of fully graded responses can be observed in the action of a variety of 
agonists on their specific Seven Trans-membrane Receptors (7TM) and other systems. 
 
 
Figure 2-1 Yeast response to pheromone. A) Cells exposed to a gradient of mating pheromone in a 
microfludics chamber. Vegetative growth, pseudo-filamentous growth, and the mating response can bee 
seen from left to right. (Picture by S. Nayak - UCSD) B) Receptor occupancy (blue, data from (56)) and 
FUS1 gene induction (green) measured by the Lac Z assay (data from (45)). 
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There are two general strategies cells can use to generate stimulus intensity-
dependent responses. One is for the cell to continuously monitor the effect of the 
response and use this information for regulatory purposes. For example, in some species, 
hyper-osmotic conditions cause mechanical stresses to accumulate in the cell wall, which 
if left unchecked can result in damage (57). These cells can alleviate the stress by 
producing compatible osmolytes to restore the osmotic balance. The amount of osmolyte 
necessary to restore balance depends on the magnitude of the osmotic stress. In principle, 
to cope with this situation, a cell only needs to monitor the presence of wall stress and 
keep producing osmolytes until it is eliminated. In this case a signaling pathway that 
indicates the presence or absence of stress in the cell wall in a binary manner suffices to 
produce a response that is stimulus strength-dependent. In control systems jargon, this is 
a biological example of a closed loop system. For this strategy to be viable, the effect of 
the response has to be dependent on the stimulus intensity. In this example, the effect of a 
given amount of osmolyte on the wall stress depends on the osmotic imbalance. 
However, this is not always the case and cells also use open loop mechanisms. In these 
cases, membrane receptors or other entities measure the magnitude of a stimulus, 
information that is subsequently encoded and relayed to the appropriate cellular 
machinery eliciting a pre-programmed response. Of course, nothing prevents a closed 
loop system to take advantage of quantitative stimulus intensity information as well, and 
in fact this dual approach is observed in one of the branches of the hyper-osmotic shock 
response in yeast (47). In general, quantitative information transfer does not necessarily 
have to be part of a homeostatic control system. Cells respond to many stimuli, most 
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notably hormones or other biochemical messengers, in preprogrammed ways that in 
many cases are dose dependent. The yeast pheromone response described above is a clear 
example. The gene expression data of Figure 2-1 indicates that the receptor and the 
signaling pathway behave in a graded fashion, and therefore are capable of producing an 
internal representation of the concentration of pheromone. This information is decoded 
and binned in three dose regimens that correspond with the three distinct physiological 
responses observed in the experiments.  
The ability to encode and relay quantitative information about a stimulus is the 
topic of this chapter. More precisely, this chapter focuses on the strategies available to a 
cell for encoding, relaying, and decoding quantitative information about stimulus 
intensities, regardless of whether the information is used in a closed loop control system 
or to elicit a pre-programmed response, genetic or otherwise. This particular issue is part 
of the more general area dealing with the dynamic control of intracellular signaling, and 
therefore, considerable attention is devoted to the mechanisms of signal adaptation and 
modulation. In Chapter 3 we demonstrate that the dynamics in a given pathway can play 
a significant role helping cells to avoid crosstalk between pathways with shared 
components. Dynamic control and information encoding in some of the yeast signaling 
pathways is the subject of Chapter 4. 
2.2 Encoding strategies 
2.2.1 Linear pathways and amplitude encoding 
The previous section introduced the concept of quantitative information transfer 
in general terms, but a more explicit definition is: A system is capable of performing 
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quantitative information transfer if, in response to stimuli of different intensity, it 
produces distinct internal representations that can, in principle, be interpreted by 
downstream effectors. In other words, a signaling pathway has to enable its downstream 
effectors to discriminate between stimuli of different strength. This property can apply to 
a pathway as a whole, or just to a section of it, although where a pathway begins and 
where it ends is often context-dependent. Accordingly, the concept of stimulus is used 
here in a broad way, meaning the input to a given pathway stage. Inputs include external 
cues, but could also refer to intracellular elements operating upstream of the section of 
interest.  
The diagram in Figure 2-2 represents a simple linear signaling network with a 
membrane bound receptor at its head. Ligand binding confers the receptor with 
enzymatic activity and allows it to activate the enzymatic activity of a second 
downstream signaling protein. The active second signaling protein then activates the next 
component and so on. A prevalent example is a Mitogen Activated Protein Kinase 
cascade, in which each stage acts as a kinase able to phosphorylate the species 
immediately downstream of it. At the bottom of the pathway, the activation of a 
transcription factor triggers a genetic response, represented here by the enhanced 
expression of gene Z. The input for this pathway is the concentration or dose of a ligand, 
such as mating pheromone, which binds to the receptor. The output at each stage is the 
fraction of active signaling enzyme relative to its total concentration. The physiological, 
or cellular response in this example is the expression level of the hypothetical gene Z. 
The terms input, output, and physiological response will be used consistently throughout 
this text to refer to the concepts just described. 
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Figure 2-2 A linear pathway. Upon ligand binding, a receptor becomes active and catalyzes a chemical 
reaction that leads to the activation of a signaling component A. Active A in turns activates B, which in 
turns activate C. At the end of the pathway, the expression of gene Z is modified. 
 
A stimulus with a level that remains constant for a time-scale that is long 
compared with the signaling time scales, is referred to as a sustained stimulus. When the 
stimulus appears quickly relative to the kinetic of the signaling events, a sustained 
stimulus can be accurately represented as a square step. When exposed to a square-step  
stimulus, a simple linear pathway such as the one depicted in Figure 2-2 can only relay 
quantitative information by encoding it in the enzymatic activity levels (from now on 
activity level) at each stage in the cascade. This is so, because under sustained stimulation 
and in the absence of other regulatory mechanisms, the activation reactions making up 
the pathway (phosphorylation, hydrolysis, etc.) will reach their steady state levels and 
operate at them for the remainder of the signaling event. Therefore, the stimulus dose 
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must be accurately represented by the steady state properties of the system, starting with 
the fraction of occupied receptors and followed by the enzymes activity levels as the 
signal propagates downstream. This mode of operation is termed amplitude encoding. 
This strategy is described in Figure 2-3. 
 
 
Figure 2-3 Response curves in a linear pathway. The curves show the steady state activity levels 
normalized to their maximum realizable value. The horizontal axes correspond the range of activity levels 
achievable by the component immediately upstream. Curves for A and B show a graded response, whereas 
the curve for C illustrates a sharper, switch-like input-output relation. 
 
The figure depicts the dose-response curves for the activation level at each stage 
versus the activity level of the species immediately upstream. For simplicity, activation 
level (e.g. percent phosphorylation) is equated here with the level of enzymatic activity 
(e.g. kinase activity). It must be stressed that this applies only to concentrations and not at 
the single molecule level, that is the higher the concentration of modified (e.g. 
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phosphorylated) enzymes, the higher its enzymatic activity in the solution, but each 
individual molecule is either active or inactive. The dose response curves of Figure 2-3 
can be used to follow the resulting signal when the system is stimulated with a square-
step profile of ligand. This system will also be used to introduce the mathematical 
framework used to describe some of the relevant biochemical processes that appear 
throughout this work. The first curve corresponds to the receptor occupancy and comes 
from considering the simple reaction system: 
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where R and L represent the receptor and the ligand respectively. When there is no 
synthesis and degradation of receptor, the total amount of R + RL can be considered 
constant and the evolution of the RL complex can be described in terms of mass action 
kinetics by (2.2). 
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This equation is also valid in the common case when the production and 
degradation processes occur at a much slower time scale compared to the signaling time-
scale. Under these conditions the number of receptors is conserved and therefore [R] can 
be substituted in (2.2) by RTOTAL – [RL], RTOTAL being the total number of receptors on 
the cell membrane. The occupied receptor fraction at steady state (2.3) is obtained in a 
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straightforward manner by solving (2.2) for [RL]/RTOTAL with the time derivative (left 
hand side) set to zero. The ratio k2/k1 between the rate constants defines the equilibrium 
dissociation constant (Kd) for the specific ligand-receptor pair. This parameter will be 
used frequently in subsequent sections as a measure of the receptor affinity for the ligand.  
The dose-response curves for the signaling components downstream of the 
receptor usually arise from the combined action of activating and deactivating enzymes. 
A typical system featuring an activation-deactivation cycle may look like the one 
depicted in Figure 2-3 for enzyme B, which can be described using Michaelis-Menten 
kinetics by the following equation (2.4). 
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The above equation assumes that B is conserved (that is no production or 
degradation occurs within the signaling time-scale). The constants k1M and k2M are the 
Michaelis constants of the enzymatic reaction, and their values determine the sigmoidal 
character of the steady-state dose-response curves. For small values of these constants, 
solving (2.4) for the active B fraction vs. the concentration of the upstream activator [A*] 
yields curves with sharp transitions like the ones depicted for C* in Figure 2-3. In 
contrast large values of Michaelis constants produce more graded responses like the ones 
depicted for species A* and B*. Following pharmacological nomenclature, the point 
corresponding to 50% activation is referred to as the EC50 value for the particular stage in 
the pathway. 
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The presence of reverse reactions is crucial for effective quantitative information 
transfer. Usually, enzymes present in the intra-cellular media can reverse the chemical 
modifications performed by the upstream species and lead to deactivation of the 
enzymatic activity. For example, phosphorylation caused by the action of an upstream 
kinase can be reversed by a phosphatase. The reverse reaction in (2.4), is catalyzed by a 
negative regulator P, which is constitutively present and active (i.e. independently of the 
presence of the stimulus). The equilibrium between a stimulus dependent forward 
reaction and a stimulus-independent backward reaction (or vice versa1) is what allows the 
steady state level for the activated fraction ([B*]/BTOTAL) in this architecture to be dose-
dependent. An irreversible transformation leads to the saturation of the active species for 
any stimulus concentration, hence precluding any quantitative information transfer2.  
A system of equations of the form given in (2.4) can be used to describe how 
information travels along a simple linear cascade. The signal propagates when the active 
form of the signaling enzyme immediately upstream (A*, for example) catalyzes the 
forward reaction converting its downstream substrate into its active form (B to B*). 
When the response curves of all the pathway stages are well matched, as for A and B in 
Figure 2-3, the result is amplitude encoding. Often times, however, some stages saturate 
before others and amplification may occur, usually accompanied by a reduction in the 
range of stimuli-intensity suitable for quantitative encoding. 
                                                
1 If both, forward and backward reactions are promoted by the stimulus, the result is no longer a simple 
linear cascade but a feed-forward architecture. These systems are capable of producing complex dynamics 
and are discussed later in relation to adaptive systems. 
 
2 This statement is strictly true for a linear pathway designed to respond to long-lived stimuli. In the 
presence of non-linear regulatory elements or for transient stimuli, irreversible modifications no longer 
hinder quantitative information transfer (see section 2.3). 
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2.2.2 Dynamic range and sensitivity 
Three key properties that quantitatively characterize signaling pathways are: 
sensitivity, dynamic range, and robustness. A number of studies address sensitivity 
aspects (58-60) of signaling pathways, and some authors suggest that amplification of 
weak stimuli (increase of sensitivity) could be the main reason for the multi-tier 
architecture typically observed in these systems (61). Similarly, pathway robustness in 
terms of coping with parameter fluctuations and noise filtering has been widely analyzed 
(35, 37, 62). However, even though dynamic range is closely related to sensitivity, 
relatively little attention has been devoted to it (63). 
The dynamic range for an intra-cellular signaling pathway can be defined as the 
range of stimulus intensities the pathway can detect, encode, and propagate in a form that 
is suitable for decoding by downstream components. While this definition is useful to 
characterize particular systems, it is less suited to study the more general case because it 
ties the intrinsic encoding capabilities of the pathway to the limitations of a particular set 
of downstream effectors. Therefore, for the purpose of this work, the dynamic range of a 
given pathway stage will be defined as the range of stimulus (or upstream activity) 
concentration that produces more than 1% and less than 99% of the maximum attainable 
activation at that stage.  This operational definition is justified at the high end because it 
is unlikely that downstream effectors can distinguish between 99% and 99.9% activity of 
the upstream signaling enzyme. In some cases, high sensitivity of the downstream 
substrate to the presence of enzymatic activity, may justify the extension of the 
operational definition to lower input levels. However, the same sensitivity may cause the 
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downstream activity to saturate at low concentrations, causing the whole response curve 
to shift to the left and the dynamic range to remain constant. 
In a simple linear pathway subject to a square-step stimulus, the dynamic range is 
initially determined by the properties of the receptor/sensor and its enzymatic activity. 
The range of ligand concentration a receptor can measure can be estimated from (2.3). A 
quick calculation reveals that a ligand concentration of 99 times Kd corresponds to 99% 
receptor occupancy, while a concentration of 10-2 Kd results in 1% occupancy3.  These 
are arbitrary limits, since in principle there is nothing preventing graded signaling to 
occur for receptor occupancy fractions below 1% or above the 99% occupancy level. 
Effectors immediately downstream of receptors such as G proteins, can be exquisitely 
sensitive to receptor activity and have the potential to stretch an initial four or five-decade 
dynamic range further to the left. On the other hand, due to the non-linearity of the 
receptor occupancy curves, systems are usually unable to discriminate receptor 
occupancy at high ligand concentrations, and in the absence of other regulatory 
mechanisms (discussed later) the receptor curve is an insurmountable barrier, preventing 
dose dependent signaling for ligand concentrations an order of magnitude above the Kd 
value. 
The dynamic range of a pathway as a whole depends on the dynamic ranges of its 
component stages. To maximize the dynamic range in a linear pathway in the absence of 
feedback regulation, the response curves of the components must be properly matched. 
That is, the response curve of a given component must produce graded responses for the 
                                                
3 This scale is non-linear, but linearity is not a requirement for effective quantitative information transfer. 
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achievable output of the component immediately upstream, just like the example depicted 
in Figure 2-3.  
 
 
Figure 2-4 Amplification. As the steady state response curve at different levels shift to lower agonist 
concentrations, the signal is amplified. The curves are normalized to their maximum achievable value. 
Amplification does not compare the strength of the signals at different levels in the cascade, but the agonist 
concentrations sufficient to induce 50% of maximum activity. 
 
When the response curves of the different tiers are not well matched, there are a 
number of scenarios that can cause the EC50 concentration of the physiological response 
to shift to the left respect to the receptor Kd.  Depending on the particulars, the dynamic 
range of the pathway may reflect that which is set by the receptor affinity, except for a 
displacement to lower ligand concentrations. This effect is termed amplification (Figure 
2-4). It is important to stress that amplification in this context does not necessarily mean 
that successive stages generate more potent responses4, but that the maximal observed 
response (or the EC50) is reached at lower ligand concentrations as one moves down the 
pathway. A corollary of this observation is that amplification necessitates that the activity 
of at least one stage in the pathway, if not the physiological response itself, saturates 
before the receptor does.  In other cases, mismatched curves can also result in a narrowed 
dynamic range.  
                                                
4 The absolute magnitude of each stage output is meaningful only in terms of the input-output properties of 
the stage immediately downstream. Hence the use of normalized response curves. 
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Figure 2-5 depicts three examples (columns) of response curves for each tier of 
the hypothetical pathway of Figure 2-3, illustrating different aspects of amplification. The 
first three rows in each column show the individual steady state response curves of the 
signaling species AP, BP, CP respectively (see Figure 2-3) as function of varying 
concentrations of their activators (occupied receptor, AP, BP, respectively).  The first 
column shows a typical amplification case, in which each tier saturates at a low 
concentration of their respective upstream activators. For example, A reaches near 
maximal activity for a receptor occupancy fraction of 50%, active B saturates for an AP 
concentration of 0.5 (arbitrary units), and so on. The lower two rows depict the activity of 
each tier as a function of the ligand concentration when the individual response curves 
are combined together with the receptor occupancy curve (black) to form a pathway. The 
fourth row indicates absolute values, whereas the fifth row shows the activity levels at the 
different tiers normalized to their respective observed maxima. The parameters used to 
generate the figure are listed in the Appendix. Amplification is clearly visible in the first 
column. Notice that the actual dynamic range remains unchanged, but it is just shifted to 
lower concentrations. The center column illustrates the opposite case, in which none of 
the individual response curves saturate for the achievable concentrations of the active 
upstream components, and therefore the dynamic range of the combined response is 
limited by the receptor. In this example, the response curves do not allow species A, B, or 
C to reach total activation because in each case there is not enough upstream activator, 
causing the different levels of activity observed in the fourth row. This information 
disappears when the curves are normalized respect to the maximum observed effect (fifth 
row). Interestingly, technical constraints usually prevent absolute concentration values to 
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be determined, and therefore experimental results often consist on only normalized 
combined curves. Finally, the third column depicts the hybrid case in which an 
intermediate component saturates at a low concentration of the upstream activator. 
Amplification in this case happens downstream of the saturated component (BP).  
 
Figure 2-5 Three scenarios for a linear pathway. The top three curves are the individual steady-state 
responses for A (red), B (green) and C (blue) (Figure 2-3) as a function of their upstream activator levels. 
The combined responses as a function of ligand (L) concentration are depicted in the fourth and fifth 
(normalized) rows with the receptor occupancy curve in black. Right) Successive tiers saturating quickly 
lead to amplification. Center) Weak responses result in low activity levels for C. Because no component is 
fully activated, amplification is not observed. Left) The presence of one intermediate component with a 
narrow dynamic range results in amplification.  
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Figure 2-6 Effect of activation thresholds on a linear pathway. The rows are similar to the ones in 
Figure 2-5. Right) An intermediate component with an activation threshold and a narrow dynamic range 
limits the dynamic range of the whole pathway and changes the profile of the response curve. Center) A 
saturated upstream component produces amplification. Notice that C can be maximally activated. Left) The 
combination of switch-like responses produce systems with increasingly narrow dynamic range. 
 
The cases illustrated in Figure 2-5 are all based on graded response curves (large 
Michaelis constants), and therefore the dynamic range of the overall pathway is 
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preserved, although shifted in some instances. Figure 2-6 illustrates the effect of 
components with sigmoidal response curves. The first column illustrates a dynamic range 
reduction due to an intermediate stage with a narrow dynamic range. The second column 
depicts a case in which an amplified signal stimulates a stage with a switch-like response 
curve, causing a reduction of the dynamic range and the displacement of the response to 
the left of the receptor Kd value. The third column illustrates a common phenomenon, in 
which the subsequent action of species with relatively graded response curves produce a 
pathway with a sharp switch-like response. 
The examples above consider just a very small subset off all potential cases. It 
should be evident however, that maximization of the dynamic range a signaling pathway 
can respond to in a quantitative way sets potentially demanding requirements on the cell. 
However, it is important to keep in mind that maximizing the dynamic range does not 
need to be a design goal for every signaling pathway. In fact, the ubiquitous observation 
of amplification suggests that pathways often evolve to amplify low intensity signals 
rather than to allow quantitative responses to wide ranges of stimuli intensity. It is 
tempting to speculate that the need for amplification and a wide dynamic range may have 
driven the evolution of more complex signaling architectures. It should be also evident 
that the receptor occupancy curve sets an upper limit over which quantitative information 
transfer, and by extension, dose-dependent responses cannot occur in a simple linear 
pathway. However, this need not be the case in more complex networks containing non-
linear regulatory elements. As demonstrated in the next section, the presence of these 
regulatory elements allows for alternative encodings that endow signaling pathways with 
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more flexible ways of transferring quantitative information without necessarily 
sacrificing dynamic range. 
2.2.3 Alternative codes 
 
The previous sections introduced the notion of amplitude encoding, which is the 
only viable route to transfer quantitative information in an ideal simple linear pathway. In 
reality, pathways are seldom linear and a plethora of regulated modules have been 
identified that involve feed-forward and feedback architectures. These non-linear 
regulatory elements are pervasive in real-life signaling networks. Even seemingly linear 
pathways are often made of regulated modules. Examples abound and include feedback 
or feed-forward activation/deactivation of the enzymatic activity of a signaling molecule 
(64-66), alterations in protein trafficking that may lead to degradation or sequestration 
(67-70), alteration of protein and messenger RNA stability (71), just to name a few. One 
thing all these mechanism have in common is that they can lead to rich dynamics, even in 
response to sustained stimulus. While a simple linear pathway can only use the steady 
state activity levels to represent stimuli intensity, these more complex networks can take 
advantage of the dynamics and use them as a vehicle for information transfer. 
There are two main strategies for dynamics-based encoding cells can follow. The 
first is frequency encoding, in which the intensity of the stimulus regulates the frequency 
of oscillations in the activity of a signaling pathway. Biochemical oscillations have been 
documented for a number of systems including those behind circadian cycles (72), cell 
cycle regulation (20), hormone release (73), etc. We do not have to go further from our 
own hearts to appreciate the importance of cyclic behavior in biological systems. 
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However, the presence of oscillations in signaling pathways has been observed in just a 
few cases and the physiological relevance of these findings is still controversial (74). 
Perhaps the best-studied cases are calcium signaling (75, 76) and the NF-kB module 
mediating inflammatory responses in mammalian cells5 (51). It must be stressed that the 
study of signaling dynamics is still in its infancy. In particular, the investigation of 
oscillations in signaling pathways has been hampered by the fact that until very recently, 
most of the experimental work in this field was routinely performed integrating data from 
populations of cells, making oscillations at the individual level very hard to detect. 
Despite the experimental limitations, the possibility of oscillations and the information-
transfer properties of frequency encoding have been studied from a theoretical standpoint 
and the reader is referred to (33, 34, 77) for a more extended review.  
The second strategy for dynamics-based encoding is duration encoding, in which 
the intensity of the stimulus is codified in the duration of the signal rather than its 
amplitude. Duration encoding necessitates a downstream module with a decoder capable 
of interpreting the signal and producing the appropriate response based on its duration. 
Despite being conceptually simpler, duration encoding has not received the same 
attention as frequency encoding, and examples of this alternative have not been clearly 
documented until now. Experimental evidence for duration encoding in the yeast’s 
mating pathway is presented in Chapter 4. There is also evidence of duration encoding 
playing a role in the yeast’s osmotic response pathway as well (46). Signal duration, on 
the other hand has long been suggested to be an important parameter determining signal 
                                                
5 The oscillations the NF-kB module are damped oscillations occurring after the system has been 
stimulated with a square-step. The phenomenon is similar to the ringing observed in an under-damped 
oscillator. The physiological relevance of the oscillations in this system are the subject of considerable 
debate. 
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specificity. For example, in an often-cited review (78) the author shows that the duration 
of the active MAP kinase ERK activity underlies the cellular decision between 
differentiating or dividing when PC12 cells are exposed to Nerve Growth Factor (NGF) 
or Epidermal Growth Factor (EGF) respectively. In this case, the two stimuli (NGF and 
EGF) activate the same pathway, one in a transient manner whereas the other produces a 
more sustained response. The work of Marshall et. al. provides evidence supporting 
signal duration being a key determinant of the physiological response. This example does 
not show stimulus intensity being encoded as signal duration (although it is conceivable 
that both agonists activate upstream components with different efficiency), but explicitly 
demonstrates that signals of different duration can elicit specific genetic programs. A 
similar idea was introduced in order to explain signal specificity in yeast (79), however, 
the evidence supporting the case is incomplete.  
The two strategies presented above share a number of qualities, in particular the 
need for regulatory mechanisms capable of modulating the propagating signals to encode 
and decode them. It turns out that the necessary steps can be achieved through simple 
architectures consisting of biochemical regulatory motifs commonly observed in living 
cells. In many instances, just the proper combination of reaction kinetics can produce 
significant changes, like for example converting a square-step stimulus into a slowly 
rising signal. These regulatory mechanisms are the subject of the next section, with 
particular emphasis on adaptive systems that produce a transient output in response to a 
sustained input. In section 2.4, the theoretical aspects of duration encoding and the 
mechanisms that underlie this strategy are further analyzed. Chapter 3 considers the 
challenges involved in maintaining signal specificity in signaling pathways that share 
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components and shows how dynamic regulation provides cells with flexible strategies for 
eliminating cross talk. 
2.3 Adaptive systems 
2.3.1 Adaptation in biological systems 
Adaptation is a phenomenon commonly observed at all levels in biology, and 
signaling networks are no exception. At the molecular level, adaptation has been shown 
to play important roles in a number of systems. The best studied is perhaps the 
chemotropic response in the bacteria E. coli (80), in which a chemo-attractant receptor is 
dynamically modified by signaling components. The modifications (methylation) 
modulate the receptor activity, allowing the organism to adapt to the background level of 
chemo-attractant over a wide range of concentrations. A more familiar example comes 
from adaptation to a new smell after being exposed to it for a while. The sense of smell is 
mediated by membrane receptors and signaling pathways similar to those in yeast.  
The defining property of an adaptive system is the ability of converting a 
sustained input into a transient output. A system is perfectly adapting if the output returns 
precisely to pre-stimulation levels. Adaptation is not always perfect and many systems 
show partial adaptation. Depending of the context, partial adaptation may be 
indistinguishable from perfect adaptation. Furthermore, some adapting architectures are 
well suited to produce oscillations. The ability to produce transient responses of variable 
duration or oscillations, make these systems prime candidates to function as encoders in 
signaling pathways. In this section we study the properties of these versatile mechanisms 
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with special emphasis on those based on negative feedback. Their suitability for duration 
encoding is considered in the next section. 
 
2.3.2 Three ways to adaptation 
Broadly speaking, there are three approaches to adaptation: integral control, feed-
forward motifs, and negative feedback loops (Figure 2-7). Integral control uses the time 
integral of the difference between the response and its pre-stimulus level to regulate 
signaling, and it may rely on feed-forward or feedback regulation, although this is not 
strictly necessary. This control mechanism has been discussed extensively in the 
literature in the context of bacterial chemotaxis (81-84). Systems containing feed-forward 
motifs, in which two stimulus-dependent pathways converge on a common signaling 
component, also produce adaptation when the parallel pathways have opposing effects on 
the common component. This concerted action of a positive and a negative regulator is a 
required feature necessary for adaptation. Feed-forward motifs have received 
considerable attention in the literature and underlie the regulation of many genetic 
networks as well as signaling systems (44, 84-86). Negative feedback loops, the focus of 
this section, are pervasive in signaling systems, and many models of pathway regulation 
based on negative feedback have been proposed (64, 87-89). In these systems, adaptation 
is achieved when a signaling species initiates a feedback loop that negatively regulates its 
own activity either directly, or indirectly by targeting an upstream pathway component. 
Here, regulation occurs as a result of the propagated signal (output), whereas in feed-
forward architectures, regulation is mediated by upstream components (input) 
independently of the pathway’s output. As a result, in feedback-based systems the 
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strength of upstream pathway inhibition is determined by the magnitude of the 
downstream response. For this reason, feedback is usually the method of choice for 
engineered systems in which control is exercised as a function of how the actual 
measured output compares to the desired target value. Unlike engineered systems, in 
which overshoots are often undesirable, intracellular adapting systems, especially those 
occurring in signaling pathways, critically depend on them. In order to propagate 
information, the activities of the signaling proteins have to increase and remain 
sufficiently high long enough to activate their downstream targets. For this to happen, 
usually the negative regulator has to operate at a slower time scale than the positive one. 
Positive regulation can occur through chemical activation, translocation, or 
elimination of an inhibitor. Negative regulation in signaling cascades can assume many 
forms including deactivation (65), desensitization (47, 64), sequestration of an upstream 
species (70), spatial re-localization (90, 91), or stimulus-dependent degradation of a 
pathway component (92). Both integral control and feed-forward motifs are capable of 
strict perfect adaptation while negative feedback-based systems in general are not.  
 
Figure 2-7 Adapting systems. A) This architecture can be modeled as an integral control system, B) 
Feedback based, and C) Feed-forward based adaptive architectures. 
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The regulatory processes mentioned above merit some clarification. In the context 
of this work, we define deactivation as a process by which a species is transformed (often 
aided by an enzyme) from its active to its original inactive form (e.g. a phosphorylated 
kinase being dephosphorylated by a phosphatase), such that it can be activated again if 
the stimulus is still present. Desensitization involves the conversion of a species (by 
formation or break down of a complex, (de)oligomerization, biochemical 
transformations, etc.) into a form incompetent for signal propagation. When the 
desensitized species can be transformed back to a competent state and this process is 
relatively fast, desensitization may in practice behave like a multi-step deactivation 
process. Sequestration involves the removal of a species from the signaling pool by 
complex formation or spatial re-localization. For our purposes it can be considered a form 
of desensitization.  
Adaptation in biological systems can occur over a wide range of temporal scales. 
In the cellular context, it can involve upregulation and downregulation of genes as well as 
chemical activation or deactivation of enzymes. Adaptation at the genetic level is usually 
a slow process because it requires the production of new proteins, a process that can take 
hours (albeit it is much faster in simple prokaryotes). Short-term adaptation in signaling 
pathways is more often mediated by the second kind of processes involving fast 
modulation of the signaling species activity through chemical modifications. Because of 
this reason, the analysis that follows is focused on short-term adaptation. This does not 
mean that changes in protein number are not considered.  As a matter of fact, preferential 
degradation of the modified form of a signaling protein can occur quite fast and underlies 
adaptation in a number of systems (51). Changes in protein numbers can also occur from 
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regulation at the RNA level (71), which introduces the possibility of a signal-dependent 
enhanced protein production occurring on time-scales comparable to the ones typically 
associated to chemical modifications. 
Adaptive systems can be characterized in terms of their ability to produce strong 
transient responses, their ability to adapt to sustained stimulus, their ability to remain 
responsive to changes in the environment after stimulation, and the recovery time needed 
before becoming competent to respond to new rounds of stimulation. To evaluate the 
potential of these systems to act as encoders or decoders of intracellular signals, it is of 
fundamental importance to understand the dose-response characteristics of both, their 
steady states and kinetic properties. These properties are analyzed in the following 
subsections for a variety of feedback and feed-forward adaptive modules, and general 
observations about adaptation are presented. 
2.3.3 Negative-feedback and feed-forward based systems 
2.3.3.1 Overview 
Negative feedback and feed-forward adaptive systems share a number of 
properties, chief among them is the requirement for the coordinated action of positive and 
negative regulation in a stimulus-dependent fashion. The main difference is that while 
adaptation in feedback-based systems is driven by the output, feed-forward systems rely 
on a pre-programmed approach. In many cases however, this difference affects very little 
of the general properties of otherwise similar systems. Our observations indicate that the 
adaptation mechanism (deactivation, desensitization, degradation, etc.) and the stage in 
the pathway that is targeted place constraints on the system’s ability to signal and adapt 
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and are the main determinants of the system performance. To understand the advantages 
and disadvantages of these mechanisms, we analyze several simple negative feedback 
architectures; three based on feedback deactivation, Models I, II and III, and two that rely 
on desensitization or stimulus-dependent degradation, Models IVA-B. For the most part, 
the following results apply to feed-forward systems as well, although some differences 
occur and are pointed out in the text. The parameter values used to generate the figures in 
this and subsequent chapters are listed in the Appendix. 
2.3.3.2 Feedback-mediated self-deactivation 
In Model I the signaling component directly activates its own negative regulator 
(Figure 2-8). This mechanism is inspired by experimental evidence showing that the 
activity of some phosphatases can be increased upon phosphorylation by their substrate 
kinase (88). This feature suggests a scenario in which the stimulus leads to 
phosphorylation and activation of a kinase. In turn, the kinase regulates its activity level 
by phosphorylating and activating its own phosphatase. Note that rather than increasing 
the rate of deactivation of a pathway component, it is possible that the negative feedback 
decreases rate at which the component is activated. We investigated this scenario as well 
and found no significant differences between the two mechanisms. For the sake of clarity, 
in what follows the signaling species K will be referred to as the kinase and the negative 
regulator X will be referred to as a the phosphatase. However, the same mechanism can 
be generalized to other reversible modifications such as hydrolysis, methylation, etc. The 
signal in this model is carried by the activity of K*, which can activate some unspecified 
downstream substrate, and therefore the adaptive output considered is the concentration 
of K*. 
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Figure 2-8 Model I. Feedback deactivation. Kinase KK promotes species K phosphorylation and 
activates it. Active K activates its own phosphatase X, which in turns promotes the backwards 
dephosphorylation reaction 
 
In its simplest form Model I, can be written in terms of two variables, [K*] and [X*], the 
concentrations of the phosphorylated forms of the kinase and phosphatase, respectively. 
The model is described by the equations (2.5) and (2.6). 
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In the equations above, the total concentration of each species has been 
normalized to unity and is assumed constant. Under these conditions, this model consists 
of only two variables and its behavior can be understood by considering the phase plane 
with axes [K*] and [X*] (Figure 2-9). Information about the adaptation performance as 
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well as the dynamics of the system can be obtained from the nullclines, defined by the 
conditions d[K*]/dt = 0 and d[X*]/dt = 0.  
 
 
Figure 2-9 Phase space for a feedback deactivation-based system. Point A corresponds to the initial 
state with a basal stimulation level. When the stimulus increases, the K nullcline shifts to the right, and if 
the kinetics of K activation are considerable faster than those of X, the system jumps to point B. Point C 
corresponds to the steady state after adaptation. (With permission from the Biophysical Journal) 
 
Figure 2-9 depicts these curves for two stimulus levels. The K* nullcline can be 
interpreted as the signal-response curve for the activated kinase concentration for a given 
stimulus s, and as a function of the active phosphatase concentration. Similarly, the X* 
nullcline can be thought of as a dose-response curve for the active phosphatase 
concentration as a function of the active kinase concentration. Because the stimulus s 
does not explicitly appear in (2.6), the X* nullcline is stimulus-independent. The 
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intersection of the nullclines represents the steady state of the system. In the absence of a 
stimulus (or under basal conditions), the steady state corresponds to point A in Figure 
2-9. When the stimulus is present, the K* nullcline shifts to the right and the new steady 
state becomes point C. With the proper choice of parameters, the new steady state value 
of K* is very similar to its pre-stimulus level, and the system will be adaptive. This 
depends on the X* nullcline remaining close to the horizontal axis, which requires K* to 
be a strong activating agent for X (more on this later).  
The conditions necessary for the system to produce strong transient responses can 
be also understood in terms of the structure of the nullclines and the trajectories available 
for the system to move from point A to C (the steady states before and after stimulus 
exposure). Upon exposure, the most immediate effect of the stimulus is to promote the 
activation of the kinase. Clearly if the phosphatase responds very rapidly to changes in 
the activity level of K, then the system evolves over the X nullcline until it reaches the 
new steady state. Because the X nullcline is monotonous, and good adaptation requires it 
to be relatively flat, the concentration of K* will not increase significantly above basal 
levels during the process. This is a desirable outcome for a homeostatic control system, 
but it is not suitable for signal propagation. In contrast, when the activation kinetics of X 
are slow compared to those of K, stimulation causes the concentration of K* to rapidly 
jump to its quasi-equilibrium value (point B). The increased kinase activity slowly 
activates X, and the system evolves towards point C closely following the post-
stimulation K* nullcline. In this regime, as the system evolves, the concentration of K* 
remains in quasi-equilibrium respect the instant concentration of X*. In between these 
two limit cases (fast and slow X’s activation kinetics), the behavior of the system will 
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resemble one or the other depending on how far it operates from quasi-equilibrium. For 
the case in which the kinetics of the reactions are comparable, the resulting output may 
consist in damped oscillations around the final steady state.  
The ability to generate strong transient outputs but still adapt close to pre-
stimulation levels, makes the quasi-equilibrium regime with slow negative regulation the 
most effective one for signaling. The quasi-equilibrium condition has the added bonus of 
allowing the system to be analyzed in terms of dynamically regulated steady state 
response curves.  
Figure 2-10 shows the steady-state response curve of K as a function of the 
upstream stimulus level in the absence and presence of the negative regulator X. The 
leftmost curve corresponds to the case in which X has been deleted. The curve to the 
right corresponds to the case in which X is maximally activated. It is evident from the 
figure that the effect of the negative regulator is to shift to the dose-response curve to 
higher active stimulus levels. The quasi-equilibrium condition allows us to think of the 
effect of stimulation as a gradual displacement of the response curve to the right. 
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Figure 2-10 Feedback deactivation response. A) Steady state response curve in the absence (right) and 
presence of maximally activated X (left). B) Time curse for K (black) and X (gray) in response to a square 
step stimulus. C) Trajectory in the phase space. D) The four operational regimes (see text). E) Typical 
responses on each regime. F) Peak (right) and adaptation amplitude (left) as a function of the stimulus 
strength. G) Signal duration (period between half maxima) as a function of stimulus strength.  
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In general, there is a repertoire of four operational stimulus dose regions available 
to this system. These are summarized in Figure 2-10D and E. Figure 2-10D again shows 
the steady state response curves in the absence (left) and presence (right) of the negative 
regulator. In this figure, the graph has been stretched for illustrative purposes. The four 
shaded regions shown on this graph correspond to the different operational dose regimes. 
The first regime corresponds to low stimulus concentrations. In this regime, stimuli of 
different strength result in transient peaks of increasing amplitude but roughly the same 
duration (Figure 2-10E, left panel). For each stimulus, the peak amplitude can be 
approximately determined by the dose-response curve in the absence of negative 
regulation. Increased upstream K activity increases the rate at which X is activated, and 
hence only a relatively weak dependence of the signal duration on the stimulus dose is 
observed. Regime II arises when the stimulus strength is sufficient to saturate K activity. 
In this regime, stimulus dose is transformed into output signal duration (Figure 2-10E, 
center panel). In Regime III, the stimulus level is high enough so that the negative 
regulator is no longer able to counteract the induced activation rate of K, even when X is 
maximally activated. In this regime the system begins to lose its ability to adapt (Figure 
2-10E, right panel). If the stimulus level increases even further, the system operates in 
Regime IV and adaptation no longer occurs. In this regime, a sustained input produces a 
sustained output. Therefore, this pathway architecture is capable of acting as a switch; at 
low stimulus dose the response is transient, whereas at high levels the response becomes 
sustained. Physiological conditions and kinetic properties of signaling pathways may 
constrain some systems to operate in a subset of the theoretically possible regimes.  
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Figure 2-10F shows the measured peak activity (black) and adaptation level 
(gray) of K* for the parameters of the example, clearly illustrating the different regimes. 
Figure 2-10G shows the duration of the signal, defined as the distance between half 
maxima, as a function of the stimulus strength. The figure shows the typical response 
trends with signals duration becoming shorter at very low dose, then remaining relatively 
constant in region I. When adaptation becomes very poor (regions III and IV), the signal 
becomes sustained and signal duration as defined above is no longer meaningful. 
The ability of the architecture to function on changing environments is strongly 
affected by the recovery time after the stimulus disappears and its signaling potential 
while already under stimulation. The recovery time for this model is intrinsically linked 
to the adaptation time. When the stimulus disappears, K* quickly return to basal levels 
but because of its slow kinetics, it takes a considerable time for X* activity to subside. In 
the best-case scenario, recovery can happen within the same time scale as adaptation. 
However, the constraints set by the requirements of good adaptation and strong signaling 
often necessitate the rate of X* deactivation to be significantly slower than that of its 
activation. This may result in long recovery times compared with the adaptation time-
scale, potentially by orders of magnitude. Additionally, the potency of the negative 
feedback needed to produce adaptation means that signaling is strongly inhibited during 
most of the recovery phase while X* levels are still high, thereby generating a refractory 
period in which the system is not able to respond to a new challenge. When the system is 
exposed to a step-like stimulus, the response depends on the frequency of the 
concentration increases. If the period between stimulus increases is longer than or on the 
order of the adaptation time, the response consist on well defined signals of comparable 
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amplitude which is what we would expect based on the phase diagram (Figure 2-9). 
Increasing the dose generates adapting signals until the stimulus reaches the level that 
saturates the downstream negative regulator X. After that point, the signal fails to adapt 
and remains active until the stimulus disappears. The amplitude of the successive signals 
depends on the dose region (e.g. low dose regime with dose dependent amplitude or high 
dose regime with dose-independent amplitude), the size of the dose increases, as well as 
on the shape of the nullclines in Figure 2-9. As a result, the generated peak train can have 
increasing, constant, or decreasing amplitude, but in general strong signaling is possible 
after adaptation (Figure 2-11A). If the period between increases is short, the system starts 
to see the increases as a single stimulus and produces a single peak with an amplitude 
usually lower than the signal it would have generated had the stimulus been applied all at 
once (Figure 2-11B). This has important implications, because a bad choice of activation 
and adaptation time scales could render this mechanism blind to slow increasing stimulus 
(Figure 2-11C). This property will be exploited when considering the dynamic control of 
specificity in pathways with shared components. 
 
Figure 2-11 Response to multiple excitations. A) Model 2 response (clack) to multi-step stimulus (gray). 
B) Multi-step stimulus with time between steps on the adaptation time scale (gray). Signal that would result 
from a single square-step stimulus of the final amplitude (dashed). C) Accommodation. Stimulus grows in 
small increases (gray). Signal that would result from a single square-step stimulus of the final amplitude 
(dashed). (With permission from the Biophysical Journal) 
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The analysis above can be applied also to feed-forward based systems with two 
potentially significant caveats. Depending on the specific kinetic parameters, the post-
adaptation steady state in feedback architectures contains a residual concentration of 
active K necessary to maintain the steady state of active X. As a result, feedback based 
systems usually settle in such a way that the steady state response curve after adaptation 
rests with its threshold just above the stimulus concentration (Figure 2-10) and therefore 
these systems do not show strict perfect adaptation. Furthermore, if the separation of 
time-scales between positive and negative regulation is weak, these systems will produce 
damped oscillations. Feed-forward based systems do not share this property. Since X is 
activated by the stimulus independently of the output, negative regulation can grow much 
larger than what is strictly needed for turning K activity off. Also, because the upstream 
species activity is sustained, there is no need to maintain residual K* activity, and strict 
perfect adaptation is possible.   
2.3.3.3 Feedback-mediated deactivation of a positive regulator 
A second strategy for producing adaptation through negative feedback is for the 
signaling component to deactivate an upstream element. The simplest architecture, albeit 
the least biologically realistic, is one in which the signaling molecule K is directly 
responsible for deactivating the pathway component KK located directly upstream 
(Figure 2-12). 
As we show, this strategy usually results in poor adaptation. Its study however, 
highlights the specific benefits of more complex systems as well as the limitations of a 
feedback mechanism in which the same molecule that transmits the signal also directly 
inhibits pathway activity. A potentially more biological realistic scenario is one in which 
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the feedback effect of K is to decrease the rate at which KK is activated. Similar to Model 
I, this scenario does not produce qualitatively different results from the case of feedback 
deactivation.  
 
Figure 2-12 Model II: Direct deactivation of an upstream component. 
 
The simplest version of this model is very similar to the one studied in the 
previous section with the difference being that in this case the species K both propagates 
the signal and deactivates an upstream species KK* (the stimulus). Because of this 
reason, the analysis of this model will follow closely the one carried out in the previous 
section.  Model II can be described in mathematical terms by the following equations: 
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Figure 2-13 Phase space for direct deactivation of an upstreasm component. Point A corresponds to 
the initial state for basal stimulation. When the stimulus increases, KK nullcline moves up. Kf the kinetics 
of K activation are considerable faster than those of K, the system jumps to point B and then adapts to point 
C. (With permission from the Biophysical Journal) 
 
Like in the previous cases, the concentrations of the species have been normalized 
to unity and are considered constant. The kinetic constants have been renormalized 
appropriately. Also, species KK, is deactivated by a constitutive regulator (P) in addition 
to the signal dependent effect of K*. 
Figure 2-13 shows the phase plane for this model. The signaling species K* is on 
the vertical axis and the horizontal axis corresponds to the activating upstream kinase 
KK*. Analysis of the nullclines seems to indicate that adaptation could be possible if the 
K* nullcline (labeled as d[K*]/dt = 0) is sufficiently switch-like as a function of [KK*]. 
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However, further analysis shows that under these conditions, the system cannot fulfill the 
requirement of generating a significant response. To understand why, it is useful to 
consider the two limiting cases in which the kinetics of K are fast or slow compared to 
those of KK. When KK activation kinetics are fast, the stimulus causes KK* to rapidly 
rise from its basal level (A in Figure 2-13) to its quasi-steady state level (B) located on 
the post stimulus [KK*] nullcline. Next, K becomes activated causing the KK* level to 
decrease along the [KK*]-nullcline until it reaches the new steady state C. This scenario 
produces a monotonic increase in K* and no transient signaling occurs at this stage in the 
cascade. In a second limiting case in which the kinetics of K are fast compared to those of 
KK, the system evolves along the [K*] nullcline towards point C. Again, the increase in 
K* is monotonic in time. For the two limiting cases just described, the system is not 
capable of both adapting, and producing a significant response. In the intermediate 
regime, where the kinetics of K and KK are comparable the system is capable of showing 
some degree of transient signaling. With the right choice of parameters, the system can 
“overshoot” the equilibrium point C producing a transient increase in the [K*] level. 
However, this strategy has serious limitations. First, in the presence of the stimulus, the 
steady state K* concentration (C in Figure 2-13) has to be significantly higher than the 
basal level, thereby precluding significant adaptation.  Second, this set up is very prone to 
oscillations. An analysis in terms of response curves is of little use in this case, in part 
because the quasi-equilibrium regime does not result in initial signaling and posterior 
adaptation. Figure 2-14A shows the peak response amplitude (Gray) and the steady-state 
level of K* after adaptation (black) as a function of the stimulus strength. 
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Figure 2-14 Dose response for Model II. A) Peak (gray) and adaptation (black) amplitudes as a function 
of the stimulus dose. B) Typical time courses for K* in response to different stimulus concentration. (With 
permission from the Biophysical Journal) 
 
The time-dependent response for various doses is shown in Figure 2-14B. These 
figures clearly show how adaptation quickly disappears and the response turns into a 
small transient overshoot.  In this model, response duration is not a relevant quantity 
because the response does not return to below its half maximum.  The principal 
advantage of this system is its very fast recovery time after the stimulus has been 
removed.  This is due to the fact that K* is responsible for both propagating the signal 
and deactivating KK*, making activation and recovery times similar.   
The difference between the behavior of Model I and Model II may appear 
puzzling, especially after realizing that both share essentially the same architecture. As a 
matter of fact, Model II is a “rotated version” of Model I, in which the negative regulator 
(X* in Model I, K* in Model II) is also the signal carrier. The key difference between the 
models is that in Model I, negative feedback occurs through an intermediate step, 
whereas in Model II the kinase deactivates its upstream activator directly. This difference 
is crucial because adaptation requires a sustained feedback that responds on a time-scale 
that is slower than that of activation. Model I can produce a transient response because 
 62 
the activation of the signaling species K occurs faster than the negative feedback time-
scale determined by the kinetics of the phosphatase. However, in Model II, activation of 
the signaling species K and the onset of the negative feedback are the same process and 
therefore occur on the same timescale. Based on these observations, we find that 
intermediate steps that separate the activation time-scale from that of feedback 
deactivation are a necessary feature for systems in which adaptation occurs as a result of 
deactivating a pathway component. Such intermediate steps allow for a strong negative 
feedback capable of returning the pathway output to near basal levels, while at the same 
time providing a time delay that enables a large transient response. A strong feedback is 
incompatible with fast kinetics because it prevents the development of the initial transient 
response. To further explore this observation, the next section considers more complex 
variants of Model II that include intermediate steps. 
2.3.3.4 Effect of intermediate steps 
To better understand the dynamics of feedback deactivation it is useful to consider 
two extensions of Model II. The first case (Model IIIA, Figure 2-15A) represents a 
scenario in which the signaling species K inhibits an upstream activator KK through 
activation of a negative regulator. This can be thought of as a terminal kinase K 
activating a phosphatase X, which in turns dephosphorylates the kinase KK directly 
upstream of K. In the second scenario (Model III B, Figure 2-15B), the signaling species 
K deactivates a pathway component two levels upstream. Even though the direct 
interaction assumed in this model is unlikely to appear in real signaling systems, the 
analysis of this case reveals the specific effects of the incorporation of multiple regulation 
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levels and targeting a component further upstream. Model IIIA and IIIB can be described 
by equations (2.9)-(2.11) and (2.12)-(2.14) respectively. 
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As in the previous cases, the total concentrations have been normalized to unity and are 
assumed constant. 
 
Figure 2-15 Intermediate steps. A) Model IIA. Indirect deactivation of an upstream component. B) Model 
IIIB. Intermediate step between the source and target of the negative feedback.  
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Model IIIA is almost equivalent to Model I, except that the negative regulator X 
now acts on an upstream component rather than on the terminal signaling species K. 
Therefore, it is not surprising that the model is capable of near perfect adaptation and 
possesses dynamics and dose-response relationships very similar to Model I (not shown). 
In addition, the same analysis in terms of dynamically regulated response curves apply 
here. Figure 2-16 depicts the response produced by the system in the presence of various 
stimulus levels. As with Model I we can see that good adaptation is possible over a range 
of doses, but at some point the system looses the ability to adapt and a persistent response 
ensues. The square-pulse nature of the responses in this example is due the sharp 
response curve corresponding to the parameter values selected. This choice also 
highlights the decrease in response duration occurring at low stimulus levels. A key 
feature of this model is the relatively slow kinetics of the intermediate species X. This 
feature decouples the activation and feedback time scales allowing a sufficiently strong 
feedback for adaptation to a wide range of doses while at the same time producing a 
strong transient response. This model can also bee seen as a variant of Model II in which 
a separate negative regulator mediates the deactivation of the upstream feedback target. 
The fact that this system adapts and signals well is testament to the importance of time-
scale separation between the activating reaction and the action of the negative feedback. 
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Figure 2-16 Model IIIA. Typical responses for different stimulus concentrations. (With permission from 
the Biophysical Journal) 
 
 
Figure 2-17 Model IIIB. A) Peak (gray) and adaptation (black) amplitudes as function of the stimulus 
dose. B) Time course for K* for different stimulus (square-step) doses. Insert: KKK* (black) and KK* 
(gray) dynamics for the same stimuli. (With permission from the Biophysical Journal) 
 
Model IIIB (Figure 2-15B) resembles Model II in that the signaling species is 
directly responsible for feedback deactivation causing both timescales to be intrinsically 
linked. The key difference is that Model II now incorporates an additional step between 
the target of the negative feedback and the signaling species responsible for it. Because 
the time-scale of the negative regulator coincides with the activation of the messenger K, 
we could naively expect the system to show poor adaptation, much like Model II. While 
this is true, as the experiments represented in Figure 2-17 show, the inclusion of the 
intermediate step allows the systems to function much better because the feedback no 
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longer prevents the initial buildup of active K that constitutes the propagating signal.  
This is not an effect of the particular choice of parameters, but a more general property of 
these systems. Figure 2-17A shows the dose dependence of the response amplitude 
(Gray) and steady-state level (Black) when the intermediate species KK was adjusted to 
react slower than the upstream component KKK. Figure 2-17B shows responses 
produced at different doses as well as the [KK*] and [KKK*] responses (inset). The 
steady state level after adaptation is roughly similar to that of Model II. However, the 
presence of a slower intermediate step dramatically increases the amplitude of the 
transient response, especially at lower doses (compare with Figure 2-14). The slow 
deactivation kinetics of KK produces a delay between feedback-deactivation of KKK* 
and its downstream effect on K*. It is important to notice that the negative feedback starts 
acting as soon as K* levels rise and quickly deactivates the upstream element KKK, 
causing different components of the pathway to adapt on different times scales. This 
effect is a purely transient phenomenon, and as such cannot overcome the poor adaptation 
(a steady state property) observed with this model because the steady state level of K* 
has to be sufficient to deactivate KKK* in the face of the continuous presence of the 
stimulus.  
It is interesting to contrast Models III A and B. In Model IIIA, the slow 
intermediate species delays the effects of the negative feedback while in Model IIIB what 
is delayed is the time at which the effect of the feedback reaches downstream 
components. As expected, adding additional levels to the pathway makes it easier to 
generate oscillatory responses that may be undesirable in actual signaling networks. As a 
matter of fact, the combination of negative feedback loops and delays is a classic recipe 
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for oscillations (31, 33). In all our examples, the strength or the slow time scale of the 
feedback mechanisms precluded any significant oscillations. However, low amplitude 
ringing (very over-damped oscillations) was observed in some cases.   
As expected, Model IIIA’s response duration and recovery time are very similar 
to Model I. On the other hand, Model IIIB inherits Model II’s fast recovery time. The 
only slow component in this model is the intermediate element KK, which by the time 
adaptation is reached, has already come back to near basal levels. Therefore, this 
mechanism provides a very fast adapting system, albeit one that produces good signaling 
and adaptation only at low dose levels.  
2.3.3.5 Degradation and desensitization-based mechanisms 
 
The reason adaptation is lost at high dose levels in the case of feedback 
deactivation (Models I-III) is because the species acted upon by the feedback 
immediately becomes available for reactivation. At high stimulus levels, the negative 
feedback (which is limited by the output) may not be strong enough to counteract this 
effect. Additionally, the dual role played by species K, both as a signaling molecule and 
negative regulator, requires it to be a very effective deactivator to counteract a persistent 
stimulus, but not so strong that it prevents transient signaling altogether. Feed-forward 
based systems can partially cope with this problem because the negative regulation is 
detached from the output (adaptive) signal. However, these architectures still must juggle 
the positive and negative regulation timing and strengths carefully in order to produce 
potent transients and good adaptation.  
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An alternative approach to adaptation is to use desensitization or degradation 
rather than deactivation as the feedback mechanism. In this scenario, the desensitized (or 
degraded) component is removed (transiently or permanently) from the signaling pool, 
thereby relaxing the need for a strong sustained feedback. This mechanism plays a role in 
Raf-1 regulation (64) and the yeast pheromone response (92) among others. 
Desensitization and degradation based systems display behavior markedly different from 
feedback deactivation. To illustrate these differences, we focus on the two models 
depicted in Figure 2-18. 
 
Figure 2-18 Degradation and desenzitization-based adaptive systems. A) Model IVA. Preferential 
degradation of the active form of species KK. B) Model IVB. Desensitization of species KK. 
 
In Model IVA (Figure 2-18A) feedback regulation targets an upstream component 
of the pathway for degradation, thereby permanently removing it from the signaling pool. 
A possible scenario is one in which a kinase K feedback-phosphorylates the upstream 
kinase KK making it a target for ubiquitination and degradation. Because this mechanism 
relies on protein degradation, it is necessary to include protein synthesis in the model to 
maintain a finite concentration of KK. Model IVB (Figure 2-18B) involves a feedback 
mechanism in which the active form (K*) of the upstream signaling component is 
transformed to a desensitized form (K-) incompetent for signaling. This transformation is 
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reversible with the desensitized component eventually reentering the signaling pool. If 
the rate at which desensitization is reversed becomes very small, we recover model 
Model IVA. If on the other hand the recovery rate is fast compared with the signaling 
time scale, model II is recovered. In theory there are two scenarios for how the 
desensitized element is reintroduced into the signaling pool. In the first case, removing 
desensitization causes the protein to reenter the active state. In the second scenario the 
desensitized component must pass back through the inactive state before it can become 
active again. We recently proposed this mechanism to describe a branch of the osmotic 
response in the yeast (47). Under normal conditions, the Sho1 osmosensor exists as an 
oligomer (KK) that, when exposed to osmotic stress, initiates a signaling cascade that 
results in the phosphorylation of the kinase Hog1. Phopsho-Hog1 then feedback-
phosphorylates Sho1 causing the oligomer to dissociate and signaling to stop. The Sho1 
monomers (KK-) must then be unphosphorylated before regenerating the signaling-
competent oligomers (KK). The models are described by equations (2.15)-(2.17) and 
(2.17)-(2.20) (Model IVA and B respectively). In these equations, the concentration of 
the messenger species K is normalized to unity and its concentration assumed constant. 
The amount of upstream kinase KK is variable and depends on the regulation of its 
degradation. Protein degradation involves enzymatic steps, and, therefore should also 
follow some form of saturable kinetics. In this work, these steps are modeled using 
Michaelis-Menten kinetics just to account for this fact. 
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 Models IVA and B work in a similar fashion producing good adaptation 
regardless of the stimulus strength. The mechanism of adaptation in these systems can be 
understood in terms of the dose-response curves of the components KK and K as shown 
in Figure 2-19A and B for Model IVA. In the figure, the activation curve of K* as a 
function of KK* concentration (Figure 2-19A) has a sharp threshold below which 
virtually no activation occurs. Figure 2-19B shows the dose-response curves for KK 
(dashed gray line) and KK* (solid black line) when feedback is present and for KK* 
(dashed black line) when the feedback loop is absent. When exposed to a sufficiently 
high stimulus level, the maximum amplitude of KK* (Figure 2-19B, solid gray line) 
transiently rises over the threshold value (dotted gray line, Figure 2-19A and B) needed 
for activating K and triggers feedback degradation. The systems adapt because the 
negative feedback is sufficient to maintain the steady-state level of KK* below the K* 
activation threshold. This architecture results not only in the adaptation of the signaling 
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species K*, but also of the active upstream kinase KK* (Figure 2-19E inset). An 
ultrasensitive K* response curve is not essential in order to achieve adaptation. However, 
for a system with a graded K* response curve to show good adaptation, the feedback 
must reduce the level of active KK* considerably, which in practice may mean degrading 
or desensitizing virtually all of KK.  
 Figure 2-19C shows the response amplitude (gray curve) and steady state level 
(black curve) for K* as a function of the stimulus strength. For comparison also shown in 
the figure is the maximum response of K* in the absence of feedback (dashed black 
curve). The response duration (black curve) and time to reach the maximum  K* 
amplitude (gray curve) are depicted in Figure 2-19D. The figure clearly illustrates how 
the response’s duration becomes shorter as the dose increases, to eventually become 
dose-independent at high enough doses. Figure 2-20A and B show the respective curves 
for Model IVB. Figure 2-19E and Figure 2-20C show typical time series for Models IVA 
and B, respectively. In both cases adaptation is very good and unlike the case of feedback 
deactivation it is not necessarily lost as the stimulus level increases. 
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Figure 2-19 Model IVA. A) Steady state response curve for K*. Dotted line indicates the activation 
threshold. B) Response curves for KK* in the absence of feedback (black dashed), peak amplitude in the 
presence of feedback (gray), adapted amplitude (black). The dotted line corresponds to the activation 
threshold in A. C) Maximum peak amplitude in the absence (dashed) and in the presence of feedback 
(gray). Adaptation amplitude (black). D) Signal duration (time between half-maxima) (black), and time to 
peak (gray). E) Time courses for K and KK(inset) for square-step stimuli if different strength. (With 
permission from the Biophysical Journal) 
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Figure 2-20 Model IVB. A) Maximum peak amplitude in the absence (dashed) and presence (gray) of 
feedback, and adaptation amplitude (black) as a function of the stimulus dose. B) Signal duration (black) 
and time to peak (gray) as function of the stimulus dose. C) Typical K* response at different doses. (With 
permission from the Biophysical Journal) 
 
 The reason why the response duration initially becomes shorter with increasing 
stimulus to eventually become dose independent, is that since roughly the same amount 
of upstream activator has to be degraded or desensitized, a stronger signal results in a 
faster deactivation of the pathway. At high stimulus levels K* activity saturates and the 
rate of degradation or desensitization becomes signal independent. As a result, in the high 
dose regime, these models generate a strong transient response, with amplitude and 
duration independent of the stimulus strength. This behavior is in stark contrast with the 
one observed for feedback deactivation in which the response length is dose independent 
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at low stimulus levels and increases as stimulus strength grows. The time series for 
Model IVA (Figure 2-19E) illustrate two interesting phenomena associated with the sharp 
K* response curve. The complex decay observed at different doses is caused by the 
interplay between KK* degradation and K* deactivation kinetics. At high doses, elevated 
K* levels cause the rapid degradation of KK* (see inset in Figure 2-19E) without 
producing a significant drop in K*. As KK* activation decays beneath the K* activation 
threshold, K* levels rapidly fall, causing KK* degradation to slow down. At the final 
stage, K* and KK* activation levels slowly decline until reaching steady state. The initial 
and final phases are dominated by KK kinetics, whereas the intermediate stage is 
dominated by K* deactivation kinetics. At lower doses, KK* levels are not sufficient to 
fully activate K*, and the initial phase is missing. The second effect is a delay in the 
onset of signaling observed at low stimulus doses because of the time it takes KK to 
reach K’s activation threshold. This phenomenon is not exclusive to model Model IVA 
and often occurs when elements with ultrasensitive response curves are involved in 
signaling. 
 
Figure 2-21 Effect of intermediate steps on Model IVA and B. A) Intermediate stage between the source 
of and the feedback target. B) Mediated feedback. 
 75 
 
The addition of intermediate steps in Models IVA and B can be accomplished in 
two ways: 1) extra steps can be placed between the upstream activator and the signaling 
species K (Figure 2-21A), or 2) extra steps can be placed in the feedback loop (Figure 
2-21B). Both architectures add new features to the models and increase the likelihood of 
generating oscillations. In the first case, the addition of an extra step again introduces a 
transient memory in the system that delays the downstream effect of the feedback 
desensitization (or degradation) of KK*.  As clearly illustrated in Figure 2-22, this effect 
allows the system to achieve better sensitivity at low doses. This figure compares the 
maximum response for Model IVB and the model shown in Figure 2-21A. The figure 
was produced using similar parameter values for both models with the exception of the 
feedback strength (k5 in (2.20)), because the delay produced by the extra step allows a 
stronger feedback without compromising the ability to produce a strong response. Note 
that this increased sensitivity does not require the signal to be amplified by the pathway.  
 Like in the previous cases (Model III), the introduction of an intermediate step in 
the feedback loop (Figure 2-21B) allows a separation of time scales between signal 
initiation and attenuation. In general, the introduction of intermediate components 
endows these systems with more flexibility and permits the dynamics of species K to 
differ from that of KK, producing different response profiles which has potentially 
interesting biological implications (as discussed later in Chapter 3). 
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Figure 2-22 Intermediate step effect on model IVB. Maximum peak amplitude with (dash) and without 
(solid) intermediary as function of the stimulus dose for the model in Figure 2-21A. Notice how for similar 
parameters the intermediate step increases sensitivity at low doses. (With permission from the Biophysical 
Journal) 
 
For both models recovery is slow, because good adaptation requires slow protein 
production (Model IVA) or slow recovery from the desensitized state (Model IVB).  The 
recovery time can be improved in Model IVA by a proportional increase in both the 
production and degradation rates. However, the time scales for these processes are 
constrained in living cells. Model IVB recovery can be accelerated if the feedback 
desensitization not only acts on KK* but also on the inactive form KK. This additional 
depletion of KK permits a faster KK- to KK turnover allowing for quicker recovery. 
When re-stimulated following the removal of the signal, we observed that significant 
signaling was still possible even before recovery was complete. This effect is strongly 
dose dependent and depends on the amount of activator still available as well as the 
production and re-sensitization rates. However, when compared to the deactivation-based 
systems, the degradation or desensitization of a pathway component resulting from the 
initial challenge severely reduced the ability of systems based in these mechanisms to 
respond to subsequent increases in the stimulus level. 
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2.3.4 Adaptive systems: General remarks 
Signaling systems that adapt to sustained stimuli must meet two requirements. 
The pathway must generate a response of sufficient strength and duration to elicit the 
correct response, while at the same time returning to basal levels upon continued 
exposure to the stimulus. We analyzed different strategies of adaptation that revealed 
several general principles. First, when the signaling molecule is also a direct negative 
regulator of an upstream pathway component, the time scales for signaling and feedback 
inhibition are linked limiting the dynamic properties of the pathway. This intrinsic 
connection is the reason Model II, which relies on feed back deactivation, cannot adapt or 
signal well. The near irreversible nature of feedback mechanisms based on 
desensitization and/or degradation (Models IV A and B) allows strong signaling and good 
adaptation without requiring a strong sustained negative feedback. The removal of the 
signaling species from the signaling pool means that a weak feedback is sufficient for 
adaptation. Even for these models, the addition of a feedback intermediary greatly adds 
flexibility by allowing different temporal dynamics at different levels in the signaling 
cascade. This could have interesting implications for the locations of branching points 
where signaling pathways feed into secondary pathways to elicit a complex cellular 
response. Different dynamics at different points along the pathway could allow for a 
variety of responses depending on where the secondary branches are connected. 
It has been recognized that multiple level signaling cascades can amplify weak 
signals (25, 26, 30, 60), and it has been suggested such cascades provide a mechanism for 
increasing the rate of signal propagation (26, 93). Here we have shown a novel way in 
which intermediate steps in a signaling cascade can improve sensitivity to low stimulus 
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levels. In this mechanism, a long-lived intermediate step can store information about the 
activity level of an upstream component after feedback inhibition has terminated it. The 
result is prolonged and increased activity of any downstream components. An advantage 
of placing the delay downstream of the feedback target is that this architecture allows a 
rapid decrease in the activity of promiscuous upstream elements without a rapid 
attenuation of the response. In contrast, mechanisms that rely on slow intermediary steps 
in the feedback loop to decouple the signal and feedback timescales (e.g. Model I) must 
wait until the feedback acts, for the upstream target activation level to subside. This could 
have adverse effects potentially leading to cross talk if the upstream component is 
involved in multiple pathways. 
Feedback deactivation has the ability to produce responses in which the response 
duration depends on the stimulus strength. In contrast, for sufficiently strong stimulus 
levels mechanisms that rely on desensitization or degradation, the response amplitude and 
duration become independent of dose. This effect is due to the finite amount and/or dose-
independent production rate of the upstream activator that is the target of the feedback. 
Because of this feature, Models IVA and B are well suited for situations in which the 
stimulus strength is irrelevant for the response and/or an all-or-none response is desired.  
An interesting observation is that with the appropriate choice of parameters these models 
can be made into “signal repositories” with signal potency (area under the peak) 
regulated by the amount of activator “burnt” (degraded or desensitized) by the feedback 
in each event. No signal will result once the pool has been depleted, potentially avoiding 
multiple reactions to the same event. 
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Our study suggests that systems that adapt through feedback regulation are 
inherently slow to recover, often resulting in a refractory period much longer than the 
adaptation time. The notable exception is Model III B, which relies on an intermediate 
step delaying the effect of the feedback, to produce a transient response. This model is 
capable of fast recovery because the “slow” pathway component returns to its pre-
stimulus level during the adaptation process. However, fast recovery comes at the price 
of a very limited range of stimulus strengths for which good adaptation is achievable. 
Obviously, slow recovery times may render these models unsuitable for pathways that 
must respond to time-dependent stimuli. Interestingly, the responses observed when the 
models are exposed to stepped increases in the stimulus level demonstrate that in general 
models based on feedback deactivation (Models I-III) do a better job responding to 
subsequent increases in the stimulus level than models based on degradation or 
desensitization (Models IVA and B). However, this effect is strongly dose dependent, and 
for a limited range of doses, any of the systems can generate a response to this type of 
stepped increase in the stimulus level. Interestingly, when the stimulation level increases 
in the adaptation timescale or faster, the results are often complex responses of lower 
amplitude than the response corresponding to the same final stimulus level applied all at 
once, potentially resulting in a sub-optimal cellular response. Furthermore, feedback-
based adapting systems can produce strong responses only for stimuli that increase fast 
relative to the adaptation time scale, with slow rising stimuli becoming “invisible”. This 
phenomenon is observed in the response of neuronal tissue to neurotransmitters in the 
environment and has been know to neurophysiologists (12), who refer to it as 
accommodation. Taken together, these observations mean that adapting systems not only 
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must be tailored to elicit a response from their downstream targets, but also to receive 
particular temporal profiles from upstream activators. This limitation raises the 
interesting possibility that the redundancy present at the upper levels on some signaling 
networks (e.g. yeast’s osmotic stress response) (94) may have evolved to provide 
signaling capabilities at multiple time-scales. It also suggests that the parallel pathways 
found in many signaling systems are designed to deal with different temporal patterns of 
stimulation. 
2.3.5 Adaptive systems and dynamic range 
By regulating the activation or deactivation rates, the deactivation-based adaptive 
systems analyzed above are able to modify the EC50 value of the species that is feedback-
regulated. As a result, the effective dynamic range of that particular species can be 
stretched, potentially increasing the dynamic range of the whole pathway. In some cases, 
this can also have the seemingly puzzling effect of quantitative signaling occurring well 
beyond the point at which the steady-state response curve indicates the species activity 
saturates. Part of the answer to the puzzle is that the signaling event is just a transient and 
the response curve is constantly modulated during the event. A deeper understanding of 
this effect can be gained by looking at the way Model I above measures the stimulus. In 
fact, that system is a reaction rate-meter, because it determines how much stimulus is out 
there by measuring how fast the forward reaction (first term in (2.5)) can go. In other 
words, by gradually increasing the backward rate, the system is actually testing the 
activation rate of K not its amplitude of activation. More precisely, the system is 
measuring the maximum possible forward rate, which coincides with the initial rate 
(because the inactive K concentration is maximal just prior stimulation). When the 
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forward reaction cannot longer cope with the increasing backward rate, the system adapts 
and the time it took for this to happen constitutes the readout. In fact, upon stimulation, 
the forward rate quickly drops because most K has been consumed (activated). Then, as 
X becomes gradually activated, the increased K* turnover provides the forward reaction 
with inactive K at increasing rates thus allowing it to proceed faster, with rates that are 
ultimately limited by the concentration of the stimulus. Figure 2-23 shows a typical 
signaling event triggered by stimulation of Model I with a square step stimulus profile. 
Figure 2-23B shows how the absolute values of forward and backward rates. The quick 
decay of the forward rate is followed by a gradual recovery due to the increased 
availability of K brought about by the increasing backward rate. The backward rate in 
turns increases as more X is activated. At some point in time, the forward rate reaches its 
maximum (close to the initial rate), and cannot cope with the increasing backward rate 
causing the system to adapt. 
 
 
Figure 2-23 Model I measures maximum rates. A) Species K (black) and X (gray) response to a square-
step stimulus. B) Forward (gray) and backward (dash) reaction rates. Note how the system rapidly reaches 
its quasi-equilibrium state and the forward increases back to its initial level. At this point the forward rate 
cannot further increases and the system adapts. 
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2.4  Duration encoding and decoding 
2.4.1 Overview 
As discussed in section 2.2.3, duration encoding requires the propagated signal to 
act transiently.  That is, at least one component of the pathway must return to its pre-
stimulus level on a time-scale significantly shorter than that of the physiological 
response. This transient activity could result from the stimulus itself being transient or 
arise because the pathway contains regulatory elements that convert a sustained input into 
a transient output. The first case is commonly observed in inter-cellular signaling, where 
the duration of pathway activity often is regulated by the slow degradation of an agonist 
(95, 96). The guiding theme of the previous sections has been the second case, that is, 
intra-cellular adaptive systems with the ability to transduce information about the 
amplitude of the input signal into duration of the output signal even in the presence of a 
persistent stimulus.  Figure 2-24 shows schematically how duration encoding works. In 
this example, a fixed agonist concentration quickly activates receptors in the plasma 
membrane. The steady-state level of active receptor (input) causes the activation of a 
signaling module (grey box) that generates a transient activation of the signaling protein 
A. In the ideal case, the output of the encoding module is a signal of constant amplitude 
but dose-dependent duration, such as the one corresponding to A* in Figure 2-24.  At 
each stimulus dose, the amplitude of A* rapidly saturates, but information about the level 
of receptor occupancy is preserved in the duration of the signal. As already demonstrated, 
deactivation-based feedback mechanisms can produce such a transformation. 
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Figure 2-24 Duration encoding. Dose-to-duration encoding. The receptor occupancy level is proportional 
to the ligand concentration. An encoder transforms receptor occupancy into the duration of protein A 
activity. A* activates two downstream proteins, B and C. Because of its slow activation kinetics, B acts as 
an integrator transforming the duration of A activity into the amplitude of B activity. Protein C has fast 
kinetics and therefore its activity level mimics A* and information continues to be transmitted as signal 
duration. 
 
 
Figure 2-24 shows two possible scenarios for how A* activates its downstream 
targets. In the first scenario, species B is slowly activated by A*. This causes the activity 
of B (B*) to increase over the entire period of A’s transient activation. If the kinetics for 
the deactivation of B also are slow, B activity remains elevated for a significant amount 
of time after A* has returned to its basal level. In this case B effectively works as a 
decoder, transforming the duration of A activity into the amplitude of B activity. In other 
words, slow kinetics makes B an integrator capable of measuring for how long the 
upstream signal has been on. In the second scenario depicted in Figure 2-24, species C 
has fast activation and deactivation kinetics. As a result, the C* concentration closely 
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mimics the behavior of A* reaching a quasi-equilibrium level soon after the signal is 
received and returning to pre-stimulation levels once the A activity ceases. In this case, 
quantitative information about the stimulus is preserved even when C* is saturated 
because it is encoded as signal duration. Duration encoding does not restrict the temporal 
nature of the cellular response. For example, positive feedback acting downstream of 
either components B or C can be used to convert transient pathway activation into a 
permanent developmental switch (97), or other downstream modules can convert 
transient signals into responses of various temporal profiles (section 3.2.2). 
2.4.2 Encoders 
As mentioned previously, the focus of this chapter is cases involving sustained 
inputs. Therefore, in order to produce duration-encoded signals it is necessary to consider 
systems capable of adaptation or desensitization such as the ones analyzed in the 
preceding sections. That is systems that respond to a stimulus by generating a transient 
increase in pathway activity to then return to basal levels even if the stimulus persists for 
a long time. Ideally, in order to work as a “dose-duration” transducer, the duration of the 
transient output has to increase with the concentration of the stimulus. This is not a 
general property of adaptive systems, but as demonstrated in a previous section, 
deactivation-based systems have this ability.  
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Figure 2-25 Dose-duration encoders. A) Feed-forward architectures. B) Feedback-based architectures. 
 
Figure 2-25 shows a number of architectures capable of producing the desired 
transformation. The two pathway architectures depicted in Figure 2-25A consist of 
incoherent feed-forward loops (98) in which the upstream stimulus activates both a 
positive and negative regulator of the signaling protein K. For the system to show 
transient activity, negative regulation must occur on a slower time scale than activation of 
K. As shown in the figure, this can be achieved if the negative regulation is mediated by 
an intermediate species X. This species can operate either by inhibiting activation of K by 
KK or by promoting deactivation of K. Figure 2-25B shows two simple pathway 
architectures involving negative feedback loops that can exhibit adaptive behavior. In 
these examples, the signaling molecule activates its own negative regulator. In the first 
case, the negative regulator X increases the deactivation rate of K6 and in the second case 
X decreases K’s activation rate. Both strategies produce qualitatively similar behavior. 
Similar to the case of feed forward regulation, adaptive behavior in these systems 
requires the negative feedback to operate on a slower time scale relative to activation of 
K. The two keys for the dose-duration transformation are that the activation rate of K is 
proportional to the stimulus concentration (KK* concentration in the model under 
consideration) and that the activation of the negative regulator occurs with slow kinetics. 
                                                
6 This model is the same as Model I discussed at length in section 2.3.3.2 
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Figure 2-26 Modes. A) The four operational regimes for Model I. B) Typical responses on each regime. 
 
 
All these systems can potentially operate in the dose regions discussed in section 
2.3.3.2 and summarized again in Figure 2-26. Regime II arises when the stimulus 
strength is sufficient to saturate K activity but the negative regulation is potent enough to 
eventually cause it to subside. This is the regime where the dose-duration transformation 
occurs (Figure 2-26E, center panel). A property of these systems, and in particular this 
regime, is that it produces clearly different outputs for a range of stimulus doses well 
beyond the original (that is without feedback) dynamic range. A downstream module 
capable of decoding these signals would endow the pathway with an overall increased 
dynamic range. In other words, by exploiting the dynamic properties of the system, rather 
than relying on steady-state characteristics, signaling pathways can increase their 
dynamic range.   
When operating in Regime II, the temporal profile of K* resembles a square pulse 
(Figure 2-26C). This is because the dose-response characteristics of the system where 
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taken to be switch-like. It is important however, to study how the dose-duration 
transformation is affected when this assumption is relaxed. We start by observing that the 
steep dose-response curves result from the low values of the Michaelis constants used in 
the reaction rates (k1M, k2M, and k3M in (2.5)), which means that the reaction rates saturate 
quickly. In particular, the small k1M value causes the activation rate of K to be roughly 
independent of the K concentration except at very low levels. The opposite extreme 
occurs when the activation rate operates far from saturation (high k1M limit). In this case 
the system can be described in terms of mass action kinetics. For the system to efficiently 
adapt, some degree of steepness in the response curve is still required. This can be 
achieved by manipulating the parameters involved in the negative regulation. For such 
cases, the system’s response to a sustained stimulus is no longer a square pulse, but 
shows a more gradual decay in time (Figure 2-27). However, the length of time required 
for the signal to decline below a given threshold still depends on the strength of the 
stimulus, and therefore the stimulus concentration can still be encoded as signal duration.  
The scenario discussed above is of particular interest because it relates to a situation in 
which the negative feedback loop acts at the level of the receptor. Figure 2-27 shows a 
schematic diagram of a model in which the ligated receptor activates a negative pathway 
regulator X. The protein X inhibits the pathway by modifying the ligated receptor 
(phosphorylating it in this example) and decreasing its affinity for the ligand (Figure 
2-27A). Eqations (2.21)-(2.23) provide a mathematical description of this model.  
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Figure 2-27 Dyanmic regulation of a receptor affinity. A) An active receptor activates a species X, 
which promotes the ligand release reaction. B). Response curves in the absence (right) and presence of 
maximally activated X (left). C) Typical responses on each of the four operational regimes. 
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The steady-state receptor occupation curves in the presence and absence of the 
negative regulator X and the temporal responses for the four regimes of operation for this 
model are presented in Figure 2-27B and C. Note that that the loss of the square pulse-
like transient output does not prevent duration encoding, because higher ligand levels still 
cause the signal to persist for a longer time. Furthermore, a square-pulse activity profile is 
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easily generated if the pathway contains an intermediate species with sharp dose-response 
characteristics. As shown in Figure 2-28 and described by equation (2.24), species B 
measures for how long the receptor occupancy remains above the activation threshold, 
thereby rectifying and transforming the gradual decrease in the occupancy level into a 
square-pulse response.   
 
 
 
Figure 2-28 Rectification of an upstream signal. A species B, with a sharp dose-response curve can 
measure for how long its input signal remains over its activation threshold (dashed line) and produce a 
square-like response. 
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Because in this example the negative feedback acts on the receptor, an important 
consequence of this pathway architecture is that it allows for “signaling beyond 
saturation”. That is, the system responds in dose-dependent manner to ligand 
concentrations higher than the level that would be required to virtually saturate the 
receptor in the absence of the feedback. In other words, the dissociation constant of the 
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receptor is context dependent and as such can be dynamically modulated and exploited to 
expand the dynamic range of the signaling pathway. 
The mechanisms of duration encoding discussed so far involved activation and 
deactivation processes that are reversible. Feedback or feed-forward degradation and 
desensitization also produce adaptive systems. However, in their simplest incarnations, 
these mechanisms of adaptation tend to function as dose to duration transducer only over 
a narrow band of stimulus concentrations, if at all (see section 2.3.3.5).  For this reason 
we do not further analyze these adaptive systems here, although we want to stress that at 
least in principle and under the right assumptions they work as duration encoders as well. 
There is, however, a special case, in which adaptation by degradation or 
desensitization can produce the dose-duration transformation in a trivial way. This occurs 
when the system directly degrades the stimulus. Duration encoding ensues because higher 
agonist levels require longer periods of time to be degraded. For example, when a 
messenger peptide is released to the intracellular space in the presence of a protease, the 
more peptide that has been released the longer it takes for the protease to degrade it, and 
as a result, the longer the pathway is active. The same concept can be applied to 
intracellular calcium release or hormones in the bloodstream. Selective internalization of 
ligated-receptors can also transform dose information into signal duration (See Chapter 
4). Because the signal strength in the media is determined by measuring the time it takes 
to eliminate the agonist, it is evident that this approach works best when dealing with 
events involving localized transient release of the signaling molecule. The mechanism of 
negative regulation (protease, internalization, etc.) can be constitutively present or 
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feedback regulated. As we show in Chapter 4, this mechanism appears to play a role 
regulating signaling through the pheromone response pathway in yeast. 
2.4.3 General remarks 
While the analysis above focused on minimal models for duration encoding, more 
complex architectures involving multiple levels of regulation would allow a tighter 
control of the input-output properties of the signaling system (99). It is important to 
emphasize that duration encoding, or any other encoding method for that matter, does not 
have to function throughout the whole network. It is likely that multiple information 
processing strategies coexist at different levels (or even under different conditions) in a 
single pathway. These observations raise the question of what advantages duration 
encoding provides over using the amplitude of pathway activity to transmit information. 
One important advantage of duration encoding is that it can potentially increase the 
dynamic range of the signaling pathway. That is, duration encoding increases the range of 
stimulus concentration for which the pathway can respond in a dose-dependent manner. 
Duration encoding may also provide a more robust transmission mechanism than 
amplitude encoding, especially in multilevel networks where accurate quantitative 
information transfer using amplitude encoding would require the response characteristics 
of the individual components to be carefully matched. Duration encoding may also play a 
role preventing spurious activation of pathways that share components. In the next 
chapter we propose a strategy termed “kinetic insulation” for achieving pathway 
specificity by dynamically regulating pathway activity. This mechanism relies solely on 
the temporal profiles of the propagated signals to insure signal fidelity and avoid cross 
talk. This investigation suggests that pathways with shared components are good 
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candidates for duration encoding. The MAPK cascade in the yeast pheromone response is 
an example of such a system because several of the signaling proteins in this system (e.g. 
Ste11 and Ste7) are known to participate in the hyper-osmotic shock (94) and filamentous 
growth (100, 101) pathways (Figure 3-1). As a matter of fact, in Chapter 4 we 
demonstrate that this organism uses duration encoding to relay information down the 
pheromone response pathway. 
The duration-encoding mechanisms presented here not only allow the system to 
overcome pathway components with a narrow dynamic range (e.g. switch-like dose 
response characteristics), but take advantage of them. Operation in Regime II  (Figure 
2-26), where the dose to duration transformation works optimally, requires that the 
activity level of at least one signaling component saturates in response to the stimulus. As 
we demonstrated, in this regime the system continues to respond in a dose-dependent 
manner to stimulus levels above those required to saturate the pathway in the absence of 
feedback or feed forward regulation. The explanation for this apparent paradox lies in the 
dynamic nature of the response curve for the pathway. As the signaling event progresses, 
negative feedback regulation (or feed forward) shifts the EC50 towards higher stimulus 
levels, increasing the dynamic range of a stage of the pathway “on the fly”. This is in 
contrast to the effect of amplification in which a leftward shift of the EC50 (Figure 2-4) 
increases sensitivity at low stimulus levels, often sacrificing dynamic range as a result.  
When the negative feedback operates by allostericaly regulating the receptor 
affinity, the situation is even more interesting because in this case Kd is dynamically 
regulated (Figure 2-27). This has the potential effect of shifting the EC50 of the cellular 
response significantly to the right of the receptor occupancy curve. Depending on the 
 93 
response of the downstream components, this can in principle increase the dynamic range 
of the whole system (the system response curve is not only shifted but also stretched). 
Because of this dynamic property, receptor occupancy curves measured by ligand-
binding assays are potentially time-dependent quantities and need to be interpreted with 
care. Interestingly, Kd values determined in vitro or in reconstituted systems usually 
differ from those obtained in-vivo, and this discrepancy is often attributed to an abnormal 
conformation of the receptor in the artificial environment. The analysis presented here 
suggests that even if the microenvironment of an in-vitro experiment matches cellular 
conditions, the results of ligand binding assays might differ from their counterpart in-vivo 
due to dynamic regulation of the receptor. This could happen, for example, if the receptor 
occupancy curve is determined in a system in which a downstream element of the 
signaling pathway has been disrupted, thereby breaking the negative feedback loop.  
Duration encoding and dynamically encoded signals have been observed in a 
number of systems. For example the intensity of light (number of photons) impinging on 
photoreceptors in rod cells is encoded as the duration of the transducin (G protein) 
mediated activity of the pathway (102). It has been shown that the RGS protein RGS9 
plays a key role in determining the duration of the signal (103). The recent discovery that 
different temporal profiles of IκB kinase (IKK) activity in the NF-kB signaling module 
selectively activate different groups of target genes, further supports the notion that dose-
to-duration encoding can play a significant regulatory role determining cellular responses 
(50, 51, 104). In this case, stimulation of murine embryonic fibroblasts with tumor 
necrosis factor-α produces a short transient peak of IKK activity whereas stimulation 
with polysaccharides results in a slower and more sustained response. This example 
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further illustrates how the temporal dynamics of the activity in a signaling pathway is not 
only important for quantitative information transfer but also in managing specificity.  
Finally we note that depending on the nature of the stimulus, signaling systems 
can alternate between the operating regimes depicted in Figure 2-26. It is remarkable that 
very simple architectures can generate such a variety of responses determined only by the 
strength of the stimulus. The systems described in this section not only function as 
amplitude and duration-encoders, but can also act as biochemical switches that transition 
from transient to sustained outputs depending on the intensity of the stimulus. Such 
switches have been proposed to underlie cell fate decision process in a number of systems 
(44, 78, 79, 101, 105). Given the simplicity and flexibility of the systems considered here, 
it is likely that dose-to-duration encoding plays an important role in signal transduction. 
We predict more instances of dose-to-duration encoding will be discovered as the 
temporal properties of more signaling systems continue to be characterized. 
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Chapter 3 
 
Alternative encodings for specificity control 
3.1 The cross-talk problem 
Intracellular signaling pathways that share components are ubiquitous in nature. 
For example, in yeast the mating and starvation response pathways involve a common 
kinase (Ste7) (6, 106), yet respond to both environmental cues in very distinct and highly 
precise ways. In higher organisms, the situation is even more complex and undesired 
cross-talk underlies many pathological conditions (107-110). Therefore, understanding 
the mechanisms responsible for pathway specificity is a fundamental problem in signal 
transduction. Several solutions to this cross-talk problem have been proposed. Scaffold 
proteins are thought to limit cross-talk by sequestering and enabling activation of 
signaling molecules unique to a given response pathway (28, 111-113). A classic 
example is the yeast scaffold protein Ste5, which is required for mating but not the 
starvation response. Another mechanism to achieve specificity is cross-inhibition, in 
which a downstream component prevents signal propagation through the inactivation of 
an inappropriate pathway. Cross inhibition is also used in the yeast mating response. In 
this case, stimulation with pheromone produces an increased degradation of a 
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transcription factor (Tec1) involved in the starvation genetic program (114, 115). Finally, 
in higher eukaryotes spatial localization of signaling molecules plays a role in pathway 
specificity as observed in the widely studied response of ERK kinase to different growth 
factors (reviewed in (116, 117)) or in cAMP signaling in cardiac myocytes (118). These 
mechanisms play important roles in achieving pathway specificity and therefore have 
been subject to a number of theoretical studies in recent years (27, 106, 119-121).   
Most of the approaches described above do not take advantage of the dynamic 
nature of intracellular signals and relay mostly in steady-state properties to ensure 
specificity. Interestingly, it has been observed that the component pathways of networks 
with shared elements have very different dynamics and often operate on distinct time-
scales. For example, the MAPK Hog1 is activated very quickly and decays with a 
characteristic time of a few minutes during the yeast’s hyper-osmotic shock response (46, 
47). On the other hand, signaling in the mating response operates in a considerably longer 
time scale: MAPK Fus3 is activated over the period of tens of minutes or more (see 
Chapter 4). Furthermore, MAP kinase activity during the filamentous growth response to 
certain starvation conditions is thought to operate on even longer time-scales (79). What 
is interesting in this case, is that the three pathways (HOSR, MR, FG) share components, 
in particular MAP-KKK Ste11 (Figure 3-1).  
The distinct dynamics exhibited by signaling systems led us to ask: could these 
dynamics be used to minimize cross-talk and ensure specificity in the presence of shared 
components. In this section, we describe a mechanism termed “kinetic insulation” which 
takes advantage of the distinct chemical kinetics and network architectures commonly 
present in pathways with shared components to do exactly that. The analysis that follows 
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reveals that temporal dynamics can be exploited by cellular systems to route information 
through a common component. We show that this approach is sufficient to maintain 
specificity and prevent cross talk in a variety of scenarios. In addition, we discuss 
different strategies for encoding information that allows properties of the input stimulus 
(strength, rate of change, and duration) to be transmitted by the pathway and 
subsequently decoded by the cell. 
 
 
 
Figure 3-1 Yeast pathways. A number of pathways share the MAP-KKK Ste11. MAPK Kss1 is activated 
in response to pheromone and during nutrient deficit induced invasive/filamentous growth. More shared 
proteins (Ste12, Dig1/2) can be found downstream in the pathway (not shown). 
 
3.2 Kinetic insulation 
3.2.1 Discriminating transient and slowly varying signals. 
Figure 3-2 shows a schematic diagram of a hypothetical signaling system. The system 
consists of two response pathways, A and B, that share the intermediate component C. 
Signaling through each pathway is initiated when the ligand, SA or SB, binds to the 
appropriate receptor, RA or RB, respectively. The correct response to either stimulus 
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requires activation of the appropriate terminal kinase, KA or KB, without significant 
activation of the other. We demonstrate that when the upstream components of pathway 
A cause C activity to increase slowly, and the upstream components of pathway B cause 
activity to increase transiently, then simple downstream pathway architectures can be 
constructed such that the kinases KA and KB discriminate between these two inputs (see  
Figure 3-2B). We then show how the appropriate input signal to C can occur regardless 
of the temporal profile of the external stimulus. In Figure 3-2B kinase KA responds to a 
slowly increasing signal while remaining in the inactive state if the signal is transient. 
The simplest way to achieve this behavior is if KA has slow activation kinetics relative to 
the timescale of the transient signal. Thus KA acts as a “low-pass” filter ignoring the fast 
transient signal from pathway B. To achieve pathway specificity, KB has to be 
significantly activated only when C receives a fast transient input signal, but remains 
inactive if the input signal varies slowly in time. This is achieved using an adaptive 
system. Adaptive systems generate a transient response, which eventually returns to pre-
stimulus levels, even in the presence of a sustained input signal. This behavior can occur 
through the action of feed-forward or negative feedback loops as discussed in Chapter 2. 
There we demonstrated that in order to generate a large amplitude signal, an adaptive 
system must be excited by an input that increases rapidly with respect to the adaptation 
time scale. Otherwise, as the input signal increases, the system continuously adapts and 
the activity of the terminal kinase remains near its basal level, phenomenon termed 
“accommodation”. If the downstream components of pathway B form an adaptive 
system, then the pathway functions as a “high-pass” filter. That is, pathway B is unable to 
respond to the slowly increasing input signals resulting from the activation of pathway A, 
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but produces a strong response to the fast transient signals from pathway B.  Figure 1B 
shows a schematic diagram of a pathway architecture involving negative feedback that 
produces such a system. In this system the kinase KB phosphorylates and activates a 
phosphatase (P*) that in turn dephosphorylates and deactivates KB (Model I studied in 
Chapter 2). A consequence of this design is that KB activation is also transient. However, 
as we show in the next section, a transient signal can be transformed into a sustained 
signal in a straightforward manner.  
 In general, the common pathway component C can play an active role in 
modulating the temporal response of the two branches. However, for simplicity we 
assumed that C undergoes stimulus-dependent phosphorylation and constitutive 
dephosphorylation. The rates of these two processes must be sufficiently fast so that C is 
able to respond to the transient input signal from pathway B without significant distortion 
of its temporal profile. 
 
 
Figure 3-2 Kinetic insulation. A) Pathways A and B share component C. The terminal kinases KA and 
KB, respond to external cues received by receptors, RA and RB, respectively. B) Slow kinetics prevents 
KA from being activated by a short transient signal. The adaptive nature of KB prevents its activation by a 
slowly varying signal. C) Temporal activation profile of KA and KB when C is exposed to a slowly 
increasing stimulus (inset). D) Temporal activation profile of KA and KB when C is stimulated with a 
square pulse lasting 45 minutes (inset).  
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Equations (3.1)-(3.4) describe the system in mathematical terms. The 
normalization criteria are the same applied in previous models. 
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 To test the ability of the system to discriminate between input signals with different 
temporal profiles, we performed a series of computational experiments in which C was 
activated using either a square pulse or slowly ramped input. The input signals and the 
temporal response of KA and KB are shown in Figure 3-2B and C. As can be seen, KA 
and KB only respond when C is activated with an input signal of the appropriate temporal 
profile. To test the range of input profiles the system can discriminate, we repeated the 
simulations varying the final amplitude and rise time for the ramped input (Figure 3-3A) 
and the signal duration and amplitude for square pulses (Figure 3-3B). The left panel in 
Figure 3-3A shows the activation level of KA reached after eight hours of stimulation 
whereas the right panel shows the maximum peak amplitude recorded for KB during that 
period. The figure clearly illustrates that, except for very low input amplitudes, KA is 
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strongly activated whereas KB is activated only in response to fast rising inputs (bottom 
right region of the right panel). Figure 3-3B shows the maximum activation level reached 
by KA (left panel) and KB (right panel) as a function of the amplitude (horizontal axis) 
and duration (vertical axis) of a square pulse input to the common component. As can be 
seen, KB is strongly activated over a wide range of amplitudes and durations, whereas 
KA shows modest activity for pulses of sufficient duration (~ 2 hrs). 
The results presented above demonstrate that for pathways in which the signal 
must pass through a common element, simple downstream architectures can be used to 
selectively transmit a response based on the temporal profile of the input received by the 
shared component. We term this filtering mechanism “kinetic insulation”. We next 
considered what upstream architectures are required to convert receptor activity into 
appropriate input signals for the common pathway component. In the following section 
we describe mechanisms for encoding stimulus dose information into an appropriate 
temporal response 
 
 
Figure 3-3 System response to various input profiles. (A) Species C is exposed to ramped inputs of 
various rise times and final doses. The gray scale indicates KA’s activity level after eight hours of 
stimulation (left) and maximum activation level of KB (right). (B) Species C is exposed to square pulses of 
different durations and doses. The gray scale represents the maximum activation level of kinase KA (left) 
and kinase KB (right). The gray scale is the same in the four panels with white corresponding to total 
activation and black to no activation.  
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3.2.2 Processing stimulus profiles into appropriate input signals.  
 
          Kinetic insulation requires that the common signaling component receive distinct 
temporal inputs from pathways A and B. However, depending on environmental 
conditions the cell can be presented with a variety of stimulus profiles. Therefore, a 
strategy must be in place to ensure that the appropriate signal is transmitted to the 
common component regardless of the temporal profile of the incoming stimulus. In our 
example, activation of pathway A requires that C receive a slowly increasing signal. 
However, the concentration of stimulus SA can vary slowly or rapidly in time. In the 
latter case pathway A must be able to convert the rapidly changing stimulus level into a 
transmitted signal that slowly increases in time. In the same way, pathway B must be 
capable of transmitting a transient input signal to C in response to arbitrary SB profiles. 
Therefore, below we consider strategies for generating transient and slowly increasing 
signals from three distinct stimulus concentration profiles: a) sustained (a fast rise 
followed by a sustained stimulus), b) square pulse, and c) ramped. Figure 3-4 depicts 
mechanisms that can be used to modulate pathway activity to generate the desired 
temporal profile for the six possible scenarios.  
 
Figure 3-4 Simple architectures designed to modulate the temporal profile of the input stimulus. (A) 
Architectures that transform sustained, transient, and slow increasing inputs into a slowly increasing output 
signal. (B) Architectures that transform the same set of inputs into a transient signal.  
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          Transforming a sustained stimulus into a ramped response is easily achieved by a 
signaling species with slow activation kinetics (Figure 3-4A, left column). The simplest 
way of producing a ramped response from a square pulse stimulus involves two steps, 
designated here as A and AA (Figure 3-4A, middle column). Initially, an upstream 
pathway component AA is rapidly activated by the transient stimulus to form the active 
and relatively stable AA*. The sustained level of AA* then slowly activates the species A 
generating the desired ramped response. The ramped stimulus can be transmitted directly 
as a ramped response. Or, if needed, the addition of an intermediate pathway component 
with slow activation kinetics can be used to further slow down the response rate (Figure 
3-4A, right column).  
         A sustained stimulus is converted into a transient signal by using an adaptive 
system (Figure 3-4B, left column). The production of a transient response from a square 
pulse stimulus is straightforward and achieved by using a signaling species with fast 
activation/de-activation kinetics (Figure 3-4B middle column). Additionally an adaptive 
system can be used to guarantee a particular response duration, or make other output 
properties independent of the stimulus profile. Converting a ramped stimulus profile into 
a fast transient signal requires multiple steps because adaptive systems tend to be 
insensitive to slowly increasing stimulus levels. The simplest architecture able to perform 
this conversion contains a signaling species BB with fast activation and slow deactivation 
kinetics directly upstream of an adaptive system consisting of signaling molecule B 
(Figure 3-4B, right column). Species BB rapidly amplifies the slowly increasing stimulus 
level and passes a relatively sustained signal to B, which in turn is converted into a 
transient output by the adaptive system. The high sensitivity of the upstream component 
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BB makes this architecture very sensitive to noise. Using an ultra-sensitive switch (59) 
for BB helps avoid a spurious response because the system only responds once the 
stimulus level crosses a threshold value. This has the additional effect of introducing a 
delay between the time the stimulus level starts increasing and when the downstream 
transient signal is generated. This delay depends on the rate at which the stimulus is 
increasing and provides a mechanism for modulating the response depending on how fast 
the environmental conditions are changing. The above analysis is not meant to be 
comprehensive, but rather provides the basic building blocks necessary to kinetically 
insulate pathways with common components. 
3.2.3 Preserving specificity through kinetic insulation. 
 As a proof of principle we combined the architectures shown in Figure 3-4 with the 
kinetic insulation mechanism described in Figure 3-2. The resulting model is shown in 
Figure 3-5. For illustrative purposes we designed the model in such a way that both 
branches produce the correct signal profile for each of three stimulus profiles discussed 
above: sustained, square pulse, and ramped. To make pathway A responsive to a transient 
stimulus in addition to sustained and ramped stimuli, it is built from an upstream 
component AA possessing fast activation and slow deactivation kinetics, followed by a 
slow reacting species A (Figure 3-4A center). Pathway B was designed with an upstream 
fast reacting ultra-sensitive species BB followed by an adapting species B (Figure 3-4B 
right). This endows pathway B with the ability to respond to ramped stimulus 
concentrations as well as to sustained and square pulse profiles. The model is described 
by equations (3.5)-(3.10) for the upstream section, and (3.1)-(3.3) for the terminal 
kinases. The equations for KA and KB remain unchanged from the previous model, but 
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the equation for the common species C now has been modified to account for the 
upstream branches. 
 
 
Figure 3-5 A full model for kinetic insulation. Upstream components of pathway A transform sustained, 
transient and slowly increasing SA levels into a slowly increasing output signal that is detectable by kinase 
KA, but unseen by KB. Upstream components of pathway B transform sustained, transient and slowly 
increasing SA levels into a transient output signal that is detectable by kinase KB, but unseen by KA. 
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The three types of stimulus profiles discussed above were used for the simulations 
shown in Figure 3-6. First these profiles were taken as the concentration of SA and used 
to activate the receptor RA (Figure 3-6A – C). The left panels show the responses of the 
intermediate species. As can be seen, all three stimulus profiles quickly activate the 
upstream species AA (AA*, dashed black line) generating a long-lived signal that in turn 
causes the slow activation of the second component A (A*, solid gray line). As a result C 
also is activated slowly (C*, dashed gray line) as required for effective kinetic insulation. 
The right panels show that in all three scenarios, only KA is significantly activated (gray 
lines), whereas KB is activated only very weakly (black line) even when the stimulus is 
very transient.  
Figure 3-6D-F show the response when pathway B is stimulated with the same 
profiles used above. As expected, the fast kinetics of the intermediate species BB (left 
panel, dashed black line) and the adaptive nature of B (left panel, solid gray line) produce 
a transient input signal propagated downstream by C (left panel, dashed gray line). This 
causes significant activation of KB (right panel, black line) with just minimum activation 
of the slowly responding KA (right panel, gray line). The switch-like nature of the 
upstream component BB is evident in Figure 3-6F (left panel) showing the response to a 
slowly rising stimulus concentration. The right panel of Figure 3-6F clearly shows the 
resulting delay in the activation of KB.  
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Figure 3-6 System response to various stimulus. Input and response of pathway A (left two columns) and 
pathway B (right two columns). Panels A, B, and C illustrate the systems response to sustained, transient 
(45 minutes), and ramped stimuli, respectively, applied to pathway A. Temporal profiles for the stimulus 
SA and activity levels of AA, A, and C are shown in the left column. Temporal profiles for KA and KB 
activity are shown in the right column. Panels D, E, and F illustrate the systems response to the same 
sustained, transient, and ramped stimuli respectively, applied to pathway B. Times series for the stimulus 
SB and species BB, B, and C are shown in the left column. Time series for KA and KB activity are shown 
in the right column. Note the delay introduced by ultra-sensitive component BB in (F).   
 
         To test the model further we studied the response when both branches are 
stimulated concurrently. If both stimuli appear simultaneously, the result is a 
superposition of the individual responses with KB activation occurring transiently and 
KA activation levels rising slowly (Figure 3-7A). When the stimuli are not synchronized, 
the response depends on the order in which the branches are excited. When pathway B is 
stimulated first, pathway A remains competent for signaling and specificity is not 
affected. Alternatively, when pathway A is stimulated first, signaling through pathway B 
is possible only if C activation is not saturated. In this particular example, C saturation 
does not occur until a long time after pathway A was stimulated (Figure 3-7B-C). 
Interestingly, this limitation provides an effective cross-inhibition mechanism to prevent 
KB activation during the later stages of response A. However, it is possible to engineer 
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pathway A in such a way that it does not saturate C causing pathway B to remain 
competent for signaling. 
 
 
Figure 3-7 Specificity under simultaneous stimulation. (A) Application of a slowly increasing stimulus 
to pathway A and a square pulse lasting 45 minutes to pathway B. Temporal profiles of the stimuli and the 
shared component C (left panel) and the terminal kinases KA and KB response (right panel). (B) The same 
square pulse is applied to branch B after a four-hour delay. This demonstrates that stimulation of pathway 
B still elicits an appropriate response even when pathway A is active. (C) A similar square pulse is applied 
to branch B after ten hours. In this particular case, saturation of the common component C prevents 
signaling through pathway B.  
3.3 General remarks 
Different environmental stimuli are capable of producing characteristic cellular 
responses. However, most stimuli act through signaling components that are not unique 
to one signaling pathway. Component sharing is particularly prevalent among MAP 
kinase signaling cascades. For example the nutrient-response and pheromone-response 
pathways in yeast require the same MAP kinase kinase (Ste7) and the same MAP kinase 
kinase kinase (Ste11). Yet nutrient starvation and pheromone stimulation produce highly 
distinct and mutually exclusive cellular behaviors (106).  
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Component sharing has certain advantages for the cell, since it reduces the biological cost 
and complexity of assembling multiple signal transduction systems. However the 
prevalence of component sharing raises the fundamental question of how cellular 
pathways preserve signal specificity and avoid inappropriate cross activation. In the past 
signal specificity has been attributed to the scaffolded assembly of signaling proteins, as 
well as to cross-inhibition mechanisms that neutralize the activity of components in 
competing pathways (27, 111, 112, 115, 119, 122). Kinetic insulation is a novel 
mechanism for preserving pathway specificity in which signaling elements downstream 
of the common component are designed to respond only to specific temporal profiles of 
pathway activity. Our model is founded on the observation that signaling cascades exhibit 
distinct dynamical behaviors, including differences in the persistence of activation 
(transient versus sustained signaling) as well as variations in activation and deactivation 
timescales. Indeed it is well known that the dose and duration of an external stimulus can 
profoundly influence the magnitude or nature of the response. These observations led us 
to consider the possibility that cells use information encoded in the temporal profile of 
pathway activity to maintain signal identity. We reasoned that similar to modern 
communication devices that transmit multiple signals through a single channel, a cell 
might use biochemical networks to encode external cues into temporal patterns that can 
be received only by the intended target. Extending the analogy further, we designed 
simple architectures that can function as “filters” and combined them into a system 
capable of maintaining specificity under a wide range of conditions. The above 
computational experiments demonstrate how signal specificity can be achieved without 
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the need for scaffold proteins or cross-inhibition. Furthermore, we showed that kinetic 
insulation allows the activation of one pathway without neutralizing the other provided 
that the shared component is not saturated. This situation is easily achievable because the 
upstream portions of the pathways can be designed in such a way that saturation of the 
common component does not occur. Alternatively, saturation of the shared component by 
the slow pathway A provides an extra layer of control that can be used to prevent an 
undesired response to stimulus B once a response to stimulus A has been initiated.  
MAP kinase signaling pathways are typically comprised of three or more protein 
kinases, acting in sequence. This level of organization has in the past been ascribed to a 
need for signal amplification. The kinetic insulation approach described here not only is 
congruent with the existence of multi-component pathways, but it necessitates such 
complexity. Our results indicate that this common network architecture may serve not 
only to amplify the signal, but also to modulate the temporal profile of pathway activity. 
For instance we show how the inclusion of additional upstream components (AA and BB 
in Figure 3-4) allows the system to respond appropriately to various stimuli profiles.  
The observation above raises the possibility that cells can exploit the temporal 
modulation of a signal as it travels through the pathway to encode relevant information 
about the stimulus. This is especially important when the specific properties of the 
external cue, such as dose and duration, determine the magnitude or nature of the 
response. In these cases, this information must be encoded and preserved as the signal 
travels through the pathway. For example, yeast undergoes two developmental fates in 
response to pheromone. Low levels of pheromone lead to filamentous growth, whereas 
high concentrations produce a mating response (52). Interestingly, the different 
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modulation schemes studied above (Figure 3-4) also have important implications on how 
information about the stimulus profile is encoded. This suggests that information 
processing and signals specificity are two closely related issues. For example, 
information about a stimulus can be encoded as activation duration, activation level, or 
activation rate depending on the system’s kinetic requirements. In the case of pathway A, 
which requires slow increasing signals in order to produce a specific response, the 
activation rate is the only option. In pathway B, a transient signal is generated and 
therefore information about the stimulus is most efficiently encoded as duration, although 
amplitude encoding is also possible. The nature of the stimulus does not dictate the 
encoding strategy, as exemplified by the case of a sustained input generating a transient 
signal in pathway B.  
In Chapter 2, we demonstrated that an adaptive system based on negative 
feedback could function as a signal transducer converting stimulus dose into response 
duration. We showed also that this mechanism allows information about the stimulus 
level to be transmitted even after a pathway component, such as the receptor, has been 
saturated. In this system, the ability to detect saturating stimulus concentrations results 
from the delay between receptor activation and the time needed for a negative feedback 
loop to become sufficiently activated to counteract the receptor activation rate. Another 
interesting case occurs when an ultrasensitive component responds in a switch-like 
manner to a slowly increasing stimulus thus creating a delay. This delay is determined by 
the rate of change of the stimulus. A pathway functioning in this way can be combined 
with another parallel pathway in a feed-forward fashion to produce signals of amplitude 
or duration proportional to the rate of increase of the stimulus concentration. In general 
 112 
the relevant information can be transformed from one encoding scheme into another as 
the signal is modulated by successive stages of the pathway. For example, in Figure 3-4A 
(center) the duration of a transient stimulus is encoded in the activation level of AA, 
which is then converted into activation rate of A.  
As mentioned above, the addition of upstream components (AA and BB in Figure 
3-4) allows the system to respond appropriately to various stimuli profiles. However, it 
also tends to hinder the systems ability to encode information about the temporal 
characteristics of the stimulus. This is obviously undesirable when the detailed nature of 
the stimulus is important, and suggests that signaling pathways are likely tuned for a 
specific subset of stimulation profiles. Therefore multi-branched signaling pathways 
might result from the cells need to respond to different temporal profiles of the same 
stimulus. For example, one environmental cue that can occur over a wide range of time 
scales is osmotic stress. It is intriguing that the osmotic response of many simple 
eukaryotes consists of multiple branched pathways (57, 123, 124). This pathway 
architecture has been interpreted as providing either a backup system or a mechanism for 
sensing a wide range of osmotic conditions. The recent discovery that the Sho1 branch of 
the osmotic response of yeast is a rapidly adapting system (47) opens the possibility that 
the other pathway branches are necessary to allow the cell to respond to slow changes in 
osmolarity. Thus multi-component signaling architectures provide enormous flexibility in 
transmitting detailed information about an incoming stimulus. In contrast, pathways 
leading to all-or-none responses would need only to relay qualitative information about 
the presence or absence of a stimulus, in which case a much simpler architecture would 
suffice. 
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         Finally, a kinetic approach to specificity has some interesting advantages. First, it is 
robust. Cross-talk is avoided not just by virtue of a specific interaction, but by the 
inherent kinetics of the signaling species involved combined with network level features 
of the upstream segments of the cascade. Additionally, kinetic insulation might reduce 
the biological cost and complexity of the system as compared to pathways that rely on 
protein scaffolds or cross-inhibition. Given the prevalence of multi-component signaling 
cascades and the use of shared signaling components, it seems reasonable to speculate 
that the kinetic insulation mechanism described here applies to a broad array on 
intracellular signaling systems. 
Chapter 4  
 
Dynamic regulation of signals in yeast 
4.1 Overview of the mating process 
The yeasts Saccharomyces cereviseae (from now on yeast) is a unicellular 
eukaryote that can live stably either as a diploid or as a haploid. In the haploid state, yeast 
exist in two varieties usually referred to as a and α cells. Under the right conditions, an a 
and an α cell can mate to produce a diploid7. The mating response is triggered by the 
presence in the media of a pheromone of the opposite kind. These short peptides, 
denominated a-factor and α factor, bind to specific receptors on the membrane of α and 
a-cells respectively, initiating the cascade of signals that lead to mating. Yeast cells are 
not motile, therefore they can only mate with nearby neighbors. In order to do so, the 
cells must determine the location of the potential mating partner, and grow a projection 
(termed a shmoo) in the proper direction. For a successful mating to happen, the 
projections must reach the mating partner and the cells must fuse. The morphological 
change is just one aspect of a very complex response that includes growth arrest and 
                                                
7 When environmental resources are scarce, diploid cells form spores. When the conditions improve, these 
spores hatch and produce new generations of haploid cells. 
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changes in the expression of more than 400 genes (125). This response is induced by the 
activation of a number of messenger proteins and transcription factors usually grouped in 
what is called the yeast pheromone or mating pathway.  
The mating pathway is activated when pheromone binds to a specific membrane 
receptor (Ste2 for α-factor and Ste3 for a–factor), thereby activating it. The active 
receptor promotes the GDP/GTP exchange in the α subunit of its cognate G-protein. This 
protein is actually a hetero-trimer, formed by an α  (Gpa1), a β (Ste4), and a γ (Ste18) 
subunit. The GTP-bound form of the Gα cannot bind efficiently to the other subunits and, 
upon pathway activation the complex dissociates. The free Gβγ complex remains 
attached to the plasma membrane from where it recruits the scaffold protein Ste5, placing 
it in the proximity of the kinase Ste20. These proteins in turn recruit and activate a 
hierarchy of Mitogen Activated Protein Kinases (MAP kinases) formed by Ste11 
(MAPKKK), Ste7 (MAPKK), Fus3 (MAPK) and Kss1 (MAPK). The MAP kinases Fus3 
and Kss1 interact with two regulatory proteins (Dig1/2, also known as Rst1/2) in a 
process that results in the phosphorylation of the transcription factors Ste12 and Tec1. 
Tec1 does not play a role in the mating response and is quickly degraded8 following 
stimulation with pheromone. Homo-dimeric Ste12, is then able to bind to Pheromone 
Response Elements (PRE’s) and modify the expression of the early genes involved in the 
mating process.  
Historically, the pheromone pathway denomination has been used to refer to events 
that are activated by the Gβγ complex. However, recent experiments have shown that the 
                                                
8 Tec1 degradation prevents activation of Filamentous Response Elements (FRE’s) and is thought to be an 
important specificity control feature. 
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α subunit may be playing a role activating the MAP kinases from the endosome 
membrane (126), and Intense efforts are underway to unveil the relative importance of 
this new branch.  Because the relative contribution of this branch has not been 
characterized yet, we focus on the Gβγ branch. 
 
 
 
 
Figure 4-1 The pheromone pathway (see text). 
 
4.2 A MAPK code 
As briefly mentioned in the Introduction, the developmental response initiated by 
yeast in response to pheromone depends critically on the concentration (52, 53) (Figure 
2-1). In the presence of very low levels or no pheromone, cells continue to grow and 
divide normally. At intermediate levels, the cells become elongated and are capable of 
chemotropic growth when presented with a pheromone gradient.  High levels of 
pheromone produce a bona fide mating response, involving growth arrest and the 
emergence of the characteristic mating projections. It is clear that for this system to 
produce the proper response, quantitative information about the pheromone dose has to 
 117 
be propagated down the mating pathway. Recent data generated in collaboration with 
Henrik Dohlman’s lab suggest that the mating response pathway is using duration 
encoding (see Chapter 2) to relay information about the concentration of pheromone in 
the medium and establish which developmental program is followed. 
Figure 4-2 shows time course data for dual-phosphorylated (active) Fus3 and Kss1 
in response to different doses of pheromone. The data were obtained from a population of 
a cells exposed to the indicated pheromone concentration. At different intervals, aliquots 
where taken from the culture, the cells were lysed, and the amount of phosphorylated 
Fus3 and Kss1 determined using an immuno-fluorescence assay with a specific antibody. 
The protocol is well established and the details are described in reference (79). 
 
 
Figure 4-2 MAPK phosphorylation profile. Kinases Fus3 (right) and Kss1 (left) phosphorylation levels 
at the indicated times after pheromone induction. Experiments were repeated three times and the error bars 
represent the observed variability. Data provided by Dr. Nan Hao. 
 
The transition from chemotropic growth to mating occurs between 3 and 10 µM, 
where there is a large increase in Fus3 activity. Note the qualitative similarity between 
the experimental results and the graphs in Figure 2-24 (compare pp-Fus3 to B* and pp-
Kss1 to C*). The roughly dose-independent rate (slope) for Fus3 phosphorylation 
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suggests that its activation rate is saturated. This could happen if the level of upstream 
kinase activity is independent of the pheromone dose, whereas the duration of this 
activity is dose-dependent. Kss1 on the other hand, shows fast kinetics. Note that for high 
pheromone concentrations (10 µM), Kss1 seems to undergo two stages of 
phosphorylation with a second increase in phosphorylation starting around 30 minutes 
after the initial inoculation. If we ignore the second peak of Kss1 activity for the time 
being, then by virtue of its fast kinetics, Kss1 phosphorylation is providing a glimpse of 
the upstream signal dynamics. Furthermore, it is clear from the data that for the doses 
assayed, Kss1 operates in Regimes I and II (and perhaps III) depicted in Figure 2-26. 
These observations, combined with the very good correlation between the duration of the 
Kss1 and Fus3 signals (defined as the time at which phosphorylation begins to decrease), 
suggest that Fus3 and Kss1 phosphorylation are driven by a duration-encoded upstream 
signal (input).  
To test this possibility we started by considering a simplified scenario in which 
Fus3 and Kss1 phosphorylation and dephosphorylation can be described in terms of 
Michaelis-Menten kinetics. Equations (4.1) and (4.2) define the evolution of the 
phosphorylated form of Fus and Kss1 respectively. In both cases, the dual 
phosphorylation is assumed to happen in a single step and the concentration of the 
species is held constant and normalized to 1. 
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Figure 4-3 MAPK input. A) A square-like input signal fed to equations (4.1) and (4.2) produces 
phosphorylation profiles for Fus3 (right) and Kss1 (left) consistent with experimental observations. Curves 
for ppFus3 are normalized respect to this species maximum value. Curves for ppKss1 are normalized to this 
species maximum concentration ignoring the second peak. Error bars represent the variability observed on 
three repetitions. 
 
In this simplified scenario we sought to establish a single input profile capable of 
reproducing the experimental results for both Kss1 and Fus3. Specifically, we looked for 
a signal profile s(t) that when used as input to (4.1) generates the Fus3 profile and when 
applied to (4.2) generates the Kss1 profile. The analysis produced the input signal and 
MAP kinases profiles shown in Figure 4-3A and B respectively. 
The input signal was obtained by manually fitting the experimental data. The 
simplicity of the approach and the small number of parameters made more sophisticated 
optimization methods unnecessary. Because the experiment only provides the 
phosphorylation levels relative to each other, the ratio of phosphorylated to total protein 
is a free parameter. For the Kss1 case, we assumed that the concentration right after the 
first peak corresponds to saturation (all Kss1 present has been phosphorylated), with the 
assumption that the second peak arises from Kss1 being released from a second cellular 
pool. In the case of Fus3, the optimum correspondence was achieved when the maximum 
phosphorylated fraction (10uM and 1h) was half or less. Higher fractions significantly 
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affected the quasi-linear slope due to depletion of the unphosphorylated form. If the 
second peak of Kss1 phosphorylation is ignored, the coincidence between the simulated 
time-series and the actual experimental data is remarkable. This result suggests that the 
upstream signal driving Kss1 and Fus3 phosphorylation has a square pulse-like shape 
(Figure 4-3A), with higher concentrations being translated as longer duration. The model 
also suggests that at low concentrations, the input signal is operating in the amplitude-
encoded region (region I, Figure 2-26) whereas for higher concentrations it moves to the 
duration-encoded region (region II).  
The nature of the second Kss1 phosphorylation peak at high doses of pheromone 
can be attributed to several factors. A particularly attractive candidate is the pre-existence 
of more than one pool of Kss1 in the cells. As a matter of fact, Kss1 is known to form 
stable complexes with the transcription factor Ste12 and the regulatory proteins Dig1 and 
Dig2 (also known as Rst1 and Rst2). Furthermore, these complexes are regulated in 
response to pheromone and are thought to play an important role eliciting the signal (127-
130). In particular, it has been postulated that MAP kinase dependent phosphorylation of 
Ste12, the Dig proteins or Kss1, causes the dissociation of the complex (127), presumably 
liberating Kss1 that could become a target for double-phosphorylation. An alternative 
source of fresh Kss1 can also be related to Kss1 moving from the nucleus to the 
cytoplasm as the signaling event progresses (131). To test the plausibility of these 
mechanisms as the source of the second peak, we replaced (4.2) with a simple model 
containing a complex between Kss1 and an unspecified protein D. Phosphorylation of 
Kss1 in the complex destabilizes it (131), causing it to break apart. When free, Kss1 can 
be phosphorylated directly by the upstream species represented by signal s. When in a 
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complex, phosphorylation of Kss1 is mediated by a species C, which is activated by the 
phosphorylated form of Kss1. In this model, Kss1 and C are part of a positive feedback 
loop: the signal s promotes free Kss1 phosphorylation, which in turns activate C, which 
phosphorylates the Kss1 in the complex (DKss1), destabilizing it and releasing more 
phosphorylated Kss1. The model is described by equations (4.3)-(4.7). 
 
 
 
d[Fus3*]
dt
=
k
1
! s ! (1" [Fus3*])
k
1M
+ (1" [Fus3*])
"
k
2
![Fus3*]
k
2 M
+ [Fus3*]
     (4.3) 
 
 
 
d[Kss1*]
dt
=
k
3
! s ! (K
TOT
" [Kss1*]" [DKss1]" [DKss1*])
k
3M
+ (K
TOT
" [Kss1*]" [DKss1]" [DKss1*])
"
k
4
![Kss1*]
k
4 M
+ [Kss1*]
+ k
5
![DKss1*]
    (4.4) 
 
 
d[DKss1]
dt
= k
6
! (K
TOT
" [Kss1*]" [DKss1]" [DKss1*]) ! (D
TOT
" [DKss1]" [DKss1*])
"k
7
![DKss1]"
k
8
![C*][DKss1]
k
8 M
+ [DKss1]
+
k
9
![DKss1*]
k
9 M
+ [DKss1*]
 
(4.5) 
 
 
 
d[DKss1*]
dt
=
k
8
![C*][DKss1]
k
8 M
+ [DKss1]
"
k
9
![DKss1*]
k
9 M
+ [DKss1*]
" k
5
![DKss1*]    (4.6) 
 
 
 
d[C*]
dt
=
k
10
![Kss1*] ! (C
TOT
" [C*])
k
10 M
+ (C
TOT
" [C*])
"
k
11
![C*]
k
11M
+ [C*]
     (4.7) 
 
 
 122 
 
Figure 4-4 Effect of a secondary Kss1 pool. A square-like input signal (A) applied to a model with a 
secondary pool of Kss1 reproduces Fus3 (B) and Kss1(C) phosphorylation data well. D) Dynamics of the 
pp-Kss1 (purple), Kss1 (blue), D-Kss1 (orange), and C* (gray) for each pheromone dose.  
 
 
As the figure shows, there is good agreement between the model and the 
experimental observations. The model parameters were hand tuned. A simulated 
annealing optimization method was assayed but did not produce significantly better 
results. The total concentration of Kss1 was chosen to reflect the physiological levels 
(~5500 molecules/cell) as reported in (132), whereas the concentration of D (2000 
molecules/cell) was chosen considering the physiological amounts of the possible 
inhibitory partners Dig1 (~1400 molecules/cell), Dig2 (1300 molecules/cell), Ste12 (1900 
molecules/cell). The balance between the available amounts of D and Kss1 is important 
because it determines how much free Kss1 is available for phosphorylation before the 
complex is broken-down. Interestingly, the natural choice based on the concentrations of 
the Dig’s and Ste12, produces good agreement between the model and the experiment. 
This exercise demonstrates that the two-pool hypothesis can indeed explain the second 
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Kss1 phosphorylation wave. However, the model does not explicitly identify species D or 
C, and therefore the nature of the second pool and its regulatory mechanisms is still 
ambiguous an open to further investigation. In this respect, the analysis of the model can 
provide some guidance and hint at some properties the candidate mechanisms must have. 
Figure 4-4 shows the simulated time evolution of phospho-Kss1 (purple), free Kss1 (light 
blue), Kss1-D complex (orange), and active C (gray), in response to the same pheromone 
concentrations used in the experiments described before. The plots clearly show that the 
slow kinetics of species C activation introduce a delay that prevents the phosphorylation 
of Kss1 in the complex until after the upstream signal has been active for a while. Note 
that phosphorylation and release of Kss1 from the complex occurs only after a significant 
amount of C has been activated. In a way, species C resembles the activity profiles of 
Fus3 (compare with previous figure) and that suggest an alternative architecture in which 
Fus3 is responsible (most likely through an intermediary) for destabilizing the second 
pool of Kss1. In fact, Ste12 and Dig proteins have been shown to be substrates for Fus3 
(130, 133-135). This model uses species C to create a delay and species D to sequester 
Kss1 in a second pool that is not immediately accessible for phosphorylation. It must be 
stressed that spatial sequestration of a fraction of Kss1 in the nucleus (131) could achieve 
similar results. In fact, since Ste12 and the Dig are nuclear proteins, and Fus3 is know to 
shuttle to the nucleus (136), it is likely that these two mechanisms both play a role 
generating the second Kss1 phosphorylation peak in response to high pheromone doses. 
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4.3 Encoding mechanisms 
4.3.1 Overview 
The analysis in the previous section provides evidence that yeast cells are using 
duration encoding, at least in the stage of the pathway upstream of Kss1 and Fus3. The 
first natural question is what is the mechanism responsible for encoding pheromone dose 
into signal duration. Unfortunately, the pheromone response pathway is more complex 
than the sketch in Figure 4-1 mainly due to a number of feedback reactions and the 
presence of the protease Bar1. However, there is a key fact that any mechanism has to 
account for, which greatly restricts potential mechanisms. This fact is that our 
experiments reveal a dose-dependent response to concentrations of pheromone up to 
10uM, whereas the dissociation constant for the α-factor receptor has been determined to 
be anywhere between 4 and 15 nM (56, 137-140). This means that this pathway is 
responding in a dose dependent manner for concentrations that are virtually saturating the 
receptor. This should not come as a surprise, especially when the findings described in 
the previous sections are taken into account. Signaling beyond saturation is a hallmark of 
some of the dose-duration encoding strategies involving feedback regulation of the 
receptor affinity. Stimulus degradation, an alternative mechanism briefly discussed in 
section 2.4.2, can also explain this observation. In this case, dose is converted into signal 
duration by a system that measures how long it takes for the amount of agonist present in 
the media to be degraded. Regardless of the specific details, the observation of signaling 
beyond saturation indicates the mechanisms responsible for dose to duration 
transformation operates at the head of the pathway, and possibly on the ligand itself. The 
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following sections explore possible mechanisms for duration encoding using the know 
biochemistry of the pathway. The goal is to present a number of plausible scenarios and 
indicate the requirements for each of them to work as encoders. In most cases, the 
necessary assumptions constitute a basis for predictions that can be validated 
experimentally. 
4.3.2 Protease Bar1 
The EC50 for the MAP kinases response is displaced considerably to the right of 
the receptor dissociation constant. This could indicate that the receptor affinity is being 
dynamically modulated or that the local concentration of pheromone seen by the cells is 
less than what was added. This last scenario could materialize if pheromone is quickly 
degraded after being added to the cell culture. This could be due to the presence of 
protease Bar1, which is secreted constitutively by yeast cells but also has been reported to 
be upregulated in the response to pheromone. The protease Bar1 has been shown to 
degrade pheromone but little is know about its potency. The observed dose-dependency 
however, would require different initial concentrations of pheromone to be quickly 
degraded to different final concentrations. Since there is no active pheromone addition 
after the initial inoculation, an equilibrium cannot be sustained making this possibility 
unlikely. A more plausible scenario is one in which pheromone is slowly degraded by 
Bar1. Because the pheromone amount in the growth media is fixed, the higher the initial 
concentration, the longer it would presumably take the protease to degrade it. Such a 
process could certainly account for the EC50 shift as well as for the dose-duration 
transformation. Support for this mechanism comes from experiments looking at FUS1 
induction. This gene is specific for the pheromone response and experiments using the 
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Lac-Z assay (55) in a BAR1 deletion background show dose response results consistent 
with a receptor Kd value of ~10nM (56). 
The most efficient way to determine the effect of protease Bar1 is to repeat the 
dose-response experiments in cells on which the gene encoding this protein has been 
deleted. This mutant exists and has been extensively characterized. Figure 4-5B (dots) 
shows the temporal profiles for Fus3 and Kss1 double phosphorylation in response to 
different concentrations of mating pheromone. 
 
  
 
Figure 4-5 Effect of BAR1 gene deletion. (A) Proposed input signal. Kinases Fus3 (B) and Ksss1 (C) 
experimentally determined phosphorylation dynamics (dots), and the results of applying the input signal in 
(A) to equations (4.1) and (4.2) (solid lines). Both profiles are normalized respect to its maximum value. 
Experimental data provided by Dr. Nan Hao. Error bars reflect the variability observed in three repetitions. 
 
 
 
The experimental data shows that phosphorylation of these two species becomes 
saturated for pheromone concentrations over 10nM, much less that 30 uM observed in the 
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strain containing the BAR1 gene. This is consistent with a receptor Kd of around 5nM. 
Interestingly, the phosphorylation profiles of Fus3 and Kss1 in a BAR1Δ strain still point 
to duration encoding taking place, so once again, we sought for a common signal that 
could reproduce these new data when feed to equations (4.1) and (4.2). The resulting 
input signal is shown in Figure 4-5A. The fitting was again performed manually. This 
time, the parameters for Kss1 and Fus3 were fixed to the same values determined in the 
previous experiment and only the input signal’s profile and the maximum Fus3 
phosphorylated fraction were adjusted. The optimal value for this last parameter was very 
close to the one used to fit the wild-type data (~0.5). Considering these constrains, the 
quality of the fit is even more remarkable. The shape of the input signals resemble the 
profiles we would expect from the encoding mechanisms analyzed before for the case of 
a large k1M (e.g. with a relatively graded dose response curve, compare with Figure 2-27), 
although the resolution of the data makes the assignment of regions ambiguous. A 
difference observed in this case is that the signals do not seem to adapt all the way back 
to basal levels. A small residual activity is necessary to account for the non-zero 
phosphorylation of the MAP kinases at a later stage. It is important to notice that this 
could also be the case with the wild-type experiments, but they may not last long enough 
to see the effect clearly.  
The above experiments show that Bar1 is a good encoding candidate for the dose-
duration transformation observed in the wild type yeast strain. Slow pheromone 
degradation can produce a square like pulse downstream in the cascade in the presence of 
an intermediate stage with a sharp dose-response curve. Such a mechanism was discussed 
in section 2.4.2 in the framework of encoders based on receptor affinity regulation 
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(Figure 2-28). The same approach can be used to rectify any slow decaying signal, 
regardless of the cause of decay. Even in the absence of this intermediate stage, it is 
possible for high concentrations of pheromone to saturate the protease capping the 
degradation rate and producing a signal resembling the predicted input in Figure 4-3. The 
results of a model making use of this mechanism are presented in section 4.3.5. 
From the experiments we cannot tell whether the Bar1 effect is dependent on the 
upregulation of the BAR1 gene as part of the response. Protease Bar1 is released 
constitutively and it is quite possible that the amount of it already in the media before 
induction with pheromone is enough to cause the effect. This could be experimentally 
investigated by thoroughly washing and re-suspending the cells in fresh media before 
adding pheromone. Finally, this model makes a key prediction: the dose-duration 
encoding is dependent on the cell density, for more cells in the same volume would result 
in higher protease levels. This effect should be clearer when regulation occurs mainly 
because of the protease being constitutively released. Absence of a density-dependence 
may indicate that the concentration of extra-cellular Bar1 may be subject to a homeostatic 
control mechanism, that is, cells are able to sense and maintain a constant concentration 
of extracellular Bar1.  
4.3.3 Modulation of the receptor affinity 
Even though the case for Bar1-driven pheromone degradation is compelling, the 
possibility that the change in the Fus3 and Kss1 phosphorylation profiles is caused by an 
unexpected effect of the BAR1 gene deletion, rather than pheromone degradation, deserve 
to be considered. This is more so when we consider the physiological context in which 
mating takes place. In a natural setting, a pathway that is regulated by Bar1 would make 
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mating effectively a community decision because all the cells in the colony produce the 
protease. Furthermore, since pheromone is continuously re-supplied by cells of the 
opposite type, it is hard to foresee how the observed encoding could be achieved in a 
reliable way.  
These considerations prompted us to consider an alternative mechanism based in 
the feedback regulation of the receptor affinity similar to the one discussed in section 
2.4.2 (see Figure 2-27 and Figure 2-28). This mechanism can account for the 
displacement in the EC50 to the micro-molar range and at the same time produce a 
duration encoded signal that can be rectified to generate the proposed input signal profile 
for Fus3 and Kss1. The proposed model assumes that the receptor is chemically modified 
in a signal-dependent fashion (e.g. phosphorylated) to a form with a lower affinity for 
pheromone. For simplicity we model the pheromone release and the reaction reversing 
the receptor modification as a single process, although it can be modeled in the necessary 
number of steps without affecting the results. The model is described by equations (4.8)-
(4.13). 
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, where RTOTAL = [R] + [RL] + [RL*],  Fus3TOTAL = [ppFus3] + [Fus3],  Kss1TOTAL =  
[ppKss1] + [Kss1], and MKTOTAL =  [MK*] + [MK].  
Figure 4-6 shows a diagram of the model and the dynamics expected for each 
component. In order to focus on the encoding mechanism, the model does not include the 
second Kss1 pool responsible for the second wave of phosphorylation. The good 
agreement between the model and the experimental observation demonstrates that this 
mechanism can produce the dose-duration transformation and explain the Fus3 and Kss1 
phosphorylation dynamics.  
 
 
Figure 4-6 Receptor affinity modulation. A) Upon ligand binding, the pheromone receptor activates 
species X, which phosphorylates the receptor causing a conformational change that accelerates pheromone 
release. A cascade consisting on species MK, Fus3 and Kss1 is activated. B) Dynamics corresponding to 
the occupied receptor [RL] (top-right), active MK (top-left), Fus3 (bottom-right), and Kss1 (bottom-left). 
Curves are normalized respect to each species maximum concentration value, except for Kss1 in which the 
secondary peak has been ignored. Experimental data is shown for comparison. 
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A key question is what is the identity of species X? That is, what interaction is 
capable of modulating the receptor affinity for pheromone? The top candidate is the α 
subunit of the G protein (Gpa1). It has been shown in vitro that the dissociation rate of 
pheromone from the receptor changes in a GTP dependent manner (140). This effect has 
also been observed in mammalian receptors (141). This allows us to speculate that 
dissociation of the G-protein from the receptor may lead to a conformational change 
weakening the bonds with the pheromone molecule. The caveat is that this effect has 
been observed at high PH values (PH=8) and therefore the physiological relevance of this 
finding is still unclear. The existence of organelles with differing PH levels inside the 
cells raises the interesting possibility that regulation is achieved through interplay of 
receptor trafficking and affinity modulation. If this were the main encoding mechanism, 
then the experiments with the BAR1 deletion strain would indicate that Bar1 might be 
playing more than a simple proteolytic role. In a pure affinity based scenario we expect 
signal duration to be independent of cell density. However, Bar1’s effect on pheromone 
is clearly established and therefore we estimate that a combination of the two proposed 
mechanism is the most likely scenario. In this case, it is reasonable to expect cell density 
or pre-washing to have some effect, especially at low pheromone dose. In any case, 
experiments at different does and with fresh media will provide valuables clues regarding 
the relative importance of pheromone degradation and affinity modulation in the 
encoding process. 
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4.3.4 Intrinsic dose-duration encoding 
4.3.4.1 A Bar1 independent encoder 
Close examination of the MAP kinase phosphorylation profiles and the shape of 
the input signals in Figure 4-5 reveals that higher pheromone doses produce longer 
lasting signals, and therefore, quantitative information is still duration-encoded in the 
absence of Bar1. This means that there must be also a second, Bar1-independent 
mechanism generating a dose-duration transformation in the protease-deleted strain. At 
the moment of this writing, there is no evidence for the presence of another proteases 
capable of degrading pheromone. Furthermore, Jenness and Spatrick report no loss of 
pheromone activity under conditions similar to the ones used for our experiments (~107 
cells/ml) during an incubation period of 3 hours (142). These authors report a slow decay 
(t1/2~80 minutes) at ten times the cell density used in our experiments and they attribute 
this effect to internalization of pheromone bound to the receptor (discussed in the next 
section). This information is important because it allows us to rule out the effect of a less 
potent protease that could potentially account for the Bar1-independent encoding 
observed in the deletion strand. Therefore, it is important to analyze what intrinsic 
mechanisms, that is, not dependent on pheromone degradation, could mediate this 
additional encoding.   
4.3.4.2 Receptor internalization 
Both, a and α receptors are constitutively internalized. During vegetative growth, 
constant production balances internalization and a constant number of approximately 
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10,000 receptors is maintained on the cellular surface (56, 137). The dynamics of the 
internalization process has been only partially characterized mainly because of the efforts 
of Duane Jenness, using radiolabeled pheromone in the 80’s. Thanks to these experiments 
we know that upon pheromone exposure, receptors disappear from the membrane on time 
scales of tens of minutes. This effect has been attributed to increased internalization of 
both, occupied and unoccupied receptors (142). After a period of time, receptors re-
appear on the cell membrane due to upregulation of the Ste2 (or Ste3) gene as part of the 
mating response. This typically occurs between 90 and 120 minutes after induction (142, 
143). Receptor internalization can modulate the pheromone response pathway activity in 
two ways. The first one is through the elimination of pheromone from the media as the 
receptors drag it with them during internalization, in a variation of the protease-driven 
degradation theme observed in the wild type strain. The other one is through the 
reduction in the absolute number of active receptors as the signaling event progresses.  
The first mechanism is easier to analyze in terms of existing data. Jenness and 
Spatrick used radio-labeled pheromone to determine the number of receptors on the cell 
membrane at different times after exposure to pheromone (142). In the presence of 
Cycloheximide (a chemical that rapidly blocks the synthesis of proteins), their data 
allows us to estimate a constitutive internalization rate of approximately 30 
receptors/min9 (the uncertainty in this value cannot be determined from the data as 
published). This rate remained constant for 100 minutes. This value is consistent with the 
half-life value of 232 minutes obtained in Henrik Dohlman’s lab. In the presence of 
pheromone, the internalization rate can be estimated by fitting Jenness and Spatrick data 
                                                
9 An initial load of 10,000 receptors was assumed to calibrate the cpm (counts per minute) data provided by 
the authors. 
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with an exponential decay. The half-life value obtained this way is 16 minutes. These 
observations allow us to write the following very simplistic model for receptor 
internalization: 
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The half-life of the receptor in the absence of pheromone (232 minutes) can be 
combined with the number of receptors at steady state (RSS=k1/k2) to obtain values for k1 
(k1=43 rec/min) and k2 (k2n=4.3x10-3 1/min). In the presence of pheromone, the half-life 
drops and k2 increases (k2p=6.25x10-2 1/min). Assuming k1 does not change during the 
initial phase of the signaling event (t<1h), this equation can be solved to obtain the 
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This equation allows us to calculate the number of receptors that are internalized 
as a function of time by integrating the second term in (4.14) (k2p x R(t)): 
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Knowing the number of cells in the culture, and assuming 10,000 receptors per 
cell, this equation can be used to estimate how fast pheromone is internalized (and 
presumably destroyed) in our experiments. These experiments were performed at an 
optical density (600 nm) of 1.0, which it is estimated to represent a concentration of 
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2x107 cells/ml (144). Figure 4-7A shows the dynamics of receptor internalization 
obtained from (4.15), and the number of internalized receptors from equation (4.16). 
Figure 4-7B shows the estimated effect of the internalization in the concentrations of 
pheromone used in the BAR1 deletion experiments. These curves where calculated by 
assuming that each internalized receptor takes a pheromone molecule with it. However, at 
these concentrations the receptors are partially occupied, and when this is taken into 
consideration (assuming a conservative dissociation constant of 4nM) we obtain the 
curves depicted in Figure 4-7C.  
 
 
 
Figure 4-7 Effect of receptor internalization. A) Number of receptors on the cell surface (black) and 
number of receptors internalized in response to pheromone (gray). B) Effect on pheromone concentration if 
each internalized receptor takes a molecule of pheromone. C) Effect on the pheromone concentration if 
only the fraction of occupied receptors at each concentration carries a pheromone molecule. Cell density is 
2x107 cells/ml.  
 
As the figures clearly demonstrate, receptor internalization only affects the lowest 
concentrations of pheromone. This effect becomes negligible when the occupancy 
fraction is taken into account. The reason why this approach fails to produce a significant 
decay in the pheromone levels is because the initial number of receptors is too low 
compared with the number of pheromone molecules. Further internalization is limited by 
the rate at which receptor is replenished and because of this, increasing the rate of 
pheromone-induced internalization has little effect. However, as mentioned before, the 
rate of receptor production increases during the response so it is important to consider a 
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more realistic model in which k1 changes with time. To analyze the impact of an 
increasing production rate we numerically solved equation (4.14) for the arbitrary k1 
profile shown in Figure 4-8A. In the absence of detailed experimental information, this 
profile corresponds to a best-case scenario in which the rate of receptor production 
increases more than 10-fold during a period starting 20 minutes after pheromone 
exposure (reasonable time for gene upregulation to occur) and ending an hour into the 
response. Figure 4-8B shows the number of receptors on the cell surface recovering after 
an hour of exposure, consistent with experimental observations. Figure 4-8C and D 
illustrate the effect on the concentration of pheromone when the occupancy fraction is 
ignored or taken into account respectively. From the figure, we can see that if we assume 
each internalized receptor takes a pheromone molecule with it, then there is a significant 
increase in the rate at which pheromone is internalized when compared with the case with 
fixed production rate. However, when the occupancy fraction at the different 
concentrations is taken into account, the effect again becomes negligible in the time-scale 
relevant for signaling.  
When the occupancy fraction is taken into account, changes in pheromone 
concentration are too small to account for the observed MAP kinase phosphorylation 
response. The internalization and production rates must be significantly higher than the 
experimentally derived ones to achieve a sizable effect. An interesting observation is that 
the number of cells in the culture has a significant effect on the pheromone internalization 
rate. The effect is illustrated in Figure 4-9 in which a cell density of 5x107 (OD600=1.57) 
was used. This high cellular density is well outside the normal inter-experiment 
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variability, however, this example shows that variations in cell density have measurable 
experimental effects that could be used to test the models. 
 
 
Figure 4-8 Effect of receptor upregulation. A) Temporal profile of the kinetic constant describing recptor 
producion (see text). B) Number of receptors on the surface (black) and number of receptors internalized 
(gray) after pheromone induction. C) Effect on pheromone concentration if each internalized receptor takes 
a molecule of pheromone. D) Effect on the pheromone concentration if only the fraction of occupied 
receptors at each concentration carries a pheromone molecule. Cell density is 2x107 cells/ml.  
 
 
Figure 4-9 Effect of cell density. Effect of receptor internalization on pheromone concentration for the 
cases of Figure 4-8 when the cell density is 5x107 cells/ml (OD600~1.57). 
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Taken together, the results discussed above make pheromone internalization an 
unlikely candidate for the dose-duration encoding mechanism in the absence of protease 
Bar1. This conclusion depends heavily on the currently available parameter estimates. 
We should point out however, that a change in one order of magnitude in the parameters 
could render this into a viable scenario. Also, receptors are not internalized as single 
units, but aggregate near actin patches and internalized in endocytic vesicles (145), which 
could potentially result in increased pheromone uptake. Because of these caveats, at this 
point we cannot definitively rule out this mechanism until the experimental data on the 
cell-density dependence becomes available.  
Receptor depletion from the plasma membrane can also regulate signaling 
because of the reduction in the absolute number of active receptors. In other words, when 
exposed to the same pheromone concentration, pathway activity will be more intense 
when there are more receptors to activate it. In this scenario, signaling activity rapidly 
increases in response to pheromone driven by the occupied receptors. As the receptors get 
internalized, this driving force slows down and pathway activity decays. For this effect to 
account for the Bar1-independent dose-duration encoding, the internalization of the 
receptors has to take longer for higher pheromone doses and occur rapidly when the dose 
is low. This requirement seems inconsistent with the role of pheromone as a promoter for 
internalization. However, there are a number of possibilities that could lead to slower 
internalization at high doses that are worth considering. For example, preferential 
internalization of unoccupied receptors, signal-mediated negative regulation of the 
internalization process, signal-driven receptor recycling, all can delay internalization in a 
dose dependent manner. At the writing of this thesis there is no evidence of preferential 
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internalization of either the occupied or unoccupied receptor. Experimental data show 
that both species are internalized with similar rates (142). It is worth stressing however, 
that there has not been independent verification of these data to our knowledge. Equally, 
there is no evidence of signaling slowing down the internalization process. In fact, 
Jenness and Spatrick show data supporting that the initial internalization rate increases 
with pheromone concentration. Furthermore, there is evidence that pheromone induced 
internalization of the α factor receptor does not require signaling through the Gβγ branch 
of the pathway (146). This situation contrasts with the case for the a factor receptor Ste3 
(67). Also, even though signal-dependent recycling has been demonstrated for the a 
factor receptor (147) no evidence supporting recycling has been published for the α 
factor receptor Ste2. Again, it is important to stress that the only experiment measuring 
the dose dependence of the internalization process was the one using radiolabeled 
pheromone published by Jenness and Spatrick. To the best of our knowledge, no 
independent confirmation has been published. In summary, the current data does not 
support any of these mechanisms. However, given the lack of independent validation, we 
cannot rule out the possibility that new, more precise observations may change this 
conclusion.  
Finally, receptor endocytosis poses a number of interesting questions. Chief 
among them is how can internalization be independent of the presence of a bound ligand 
and at the same time be independent of signaling through the G-protein branch? In other 
words, what prompts the unoccupied receptor internalization? One answer can be that 
receptors are clumped together and unoccupied receptors are internalized in a collateral 
manner. An alternative explanation is that there is a so far unrecognized alternative 
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signaling pathway activated during the pheromone response. Interestingly, the increased 
receptor internalization observed in response to pheromone is phosphorylation-dependent 
(146). The standard interpretation is that either the detachment of the active G-protein or 
a structural change in the occupied receptor allows hyper-phosphorylation to happen. 
Unfortunately, no experimental data supporting these explanations have been published 
and therefore the nature of the biochemical processes driving internalization remains 
unclear. More advanced techniques are available nowadays and an experimental revision 
of the internalization dynamics as a function of pheromone concentration would provide 
more conclusive evidence to rule out (or rule in) receptor internalization as the Bar1-
independent encoding mechanism. 
4.3.4.3 Regulated receptor affinity 
The proposed input curves responsible for generating the MAPK activity profile 
(Figure 4-5) resemble the dynamics produced by an encoder based on the regulation of 
receptor affinity via a negative feedback such the one considered in section 2.4.2 (Figure 
2-27). To test how well such a mechanism can reproduce the data, we built a simple 
model based on an hypothetical protein X, that when activated attaches to the receptor 
and reduces its affinity for pheromone. This model is similar the one considered in 
section 4.3.3, except that in the present case there is no need for the intermediate species 
MK to rectify the input profile and therefore, for simplicity, this component has been 
eliminated. Figure 4-10C shows a fit of the model described by equations (4.17)-(4.21) to 
the BAR1 deletion strain data. 
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Figure 4-10 Receptor affinity modulation in a BAR1 deleted strain. A) Upon ligand binding, the 
pheromone receptor activates species X, which phosphorylates the receptor causing a conformational 
change that accelerates pheromone release. For simplicity, the active receptor is used to activate Fus3 and 
Kss1. B) Response curves for the receptor without (right), and with full X activation (left). C) Dynamics 
corresponding to the occupied receptor [RL] (right), Fus3 (center), and Kss1 (left). Curves are normalized 
respect to each species maximum concentration level. The error bars reflect the variability observed in 
three experiments. 
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Figure 4-10B depicts the effect of the negative regulator X on the receptor 
affinity. The curve on the left is the occupancy curve in the absence of X activity, 
whereas the curve to the right corresponds to [X*]=1. From the figures, it is evident that 
the model captures the qualitative behavior of the system but fails to reproduce the data 
adequately. The cause of the poor correspondence is that, as written, the model allows 
minimal flexibility to set the slope for the receptor response curve. The shape of this 
curve plays an important role determining the relative amplitude of the responses to 
different pheromone doses and the lack of flexibility significantly hurts the fit. Notice 
that in order to reproduce the experimental data, the initial receptor dissociation constant 
has been set to ~1.5 nM, which is low compared to the accepted experimental values (4-
15 nM). However, the fact that the model captures the qualitative behavior (longer 
signals at higher doses) is not a small feat and the reason of the suboptimal fit could be 
related to its simplicity. In fact, the low Kd value points to the need for a downstream 
stage capable of amplifying the signal. Such a stage would add flexibility and allow the 
pathway to further modulate the signal before reaching the kinases Fus3 and Kss1. Many 
candidates can do this, including the G-protein subunits, the kinases Ste11 or Ste7, and 
the action of the protein Ste5. Any or all of these components can provide extra layers of 
modulation that could lead to the precise Fus3 and Kss1 dynamics observed in the 
experiments. 
As mentioned in section 4.3.3, there are several candidates for species X. The 
most attractive is the G protein because existing data demonstrate that its state affects the 
receptor affinity in-vitro (140).  As discussed before, receptor phosphorylation or 
interaction with other species (most notably Sst2) could also play a role. Until more is 
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know about the kinetics of these species, little else can be said about the likelihood of this 
encoding mechanism other that it has the potential, at least in qualitative terms, to 
account for dose-duration encoding. 
4.3.4.4 Internal encoding 
The mechanisms discussed above work at the head of the pathway. This was 
necessary to explain the wild-type response because of the observed dextral shift in the 
EC50. The BAR1 deleted strain does not display this behavior. On the contrary, the dose-
dependent response is limited to within the dynamic range of the receptor. Experiments 
determining FUS1 gene induction in the absence of Bar1, show a dose-response that in 
most cases10 overlaps with the receptor occupancy curve (56). There is no need in this 
case to restrict the encoding mechanism to the cell surface, and therefore a few other 
possibilities must be explored. To do this, we built a model postulating a hypothetical 
adaptive system similar to Model I (2.3.3.2) operating upstream of Fus3 and Kss1.  
Figure 4-11 shows a diagram of the model and the fit to the BAR1 deletion strain MAP 
kinase phosphorylation data. The model is described by equations (4.22)-(4.26). 
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10 Some authors report a dextral shift in the EC50 even in the BAR1 deleted strain (151) 
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Figure 4-11 Internal feedback. A) Active receptors activate species M, which together with P is part of a 
negative feedback based adaptive system. M Activates kinases Fus3 and Kss1. B) Temporal profiles of 
active M, Fus3, and Kss1. Data obtained from a BAR1 deleted strain is shown for comparison. 
 
 
As the figure clearly demonstrates, a deactivation-based feedback mechanism can 
reproduce the experimental observations remarkably well. Based on the findings of 
Chapter 2, we expect a feed-forward deactivation-based mechanism to work as well. 
Again, the fraction of Fus3 and Kss1 that is being phosphorylated relative to the total 
amount in the cell is unknown. For this fit, we found that a maximum phosphorylated 
fraction of 0.5 or less for Fus3 produced good results. For Kss1 we assumed that all the 
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available protein is phosphorylated at 10nM. The natural question now is what is the 
precise nature of the adaptive system. More specifically, what is the identity of species M 
and P. 
There are several negative regulatory mechanisms described for the yeast 
pheromone response pathway. Perhaps, the best characterized one is the regulation of the 
G-protein activity by the RGS (Regulator of G Protein Signaling) protein Sst2. This 
protein catalyzes the hydrolysis of GTP bound to Gpa1 (the G-alpha subunit), 
accelerating its conversion to GDP at least a hundred fold (148, 149). The GDP-bound 
form of Gpa1 is then free to bind to the other subunits and presumably terminate pathway 
activity. Sst2 is constitutively present but also the SST2 gene is upregulated as part of the 
response (45, 150).  
In order for Sst2 to act as the negative regulator P, its activity has to be regulated 
in a signal-dependent way. Gene upregulation is a slow process and it cannot explain the 
quick signal decay at low pheromone doses. Although Sst2 can be phosphorylated, the 
enzymatic activity is not affected by this modification (151). There is some evidence 
however, that signal-dependent phosphorylation may stabilize the protein against 
degradation (45). This effect could provide a suitable regulated mechanism thanks to 
which Sst2 concentration increases rapidly, not because of stimulated production but 
because of reduced turnover. A different possibility is that Sst2 activity is regulated by 
the spatial relocation known to occur upon pheromone induction. Recent experiments 
demonstrated that Sst2 binds to the C terminal of Ste2 (the pheromone receptor) through 
a DEP domain (152). These experiments show that Sst2 activity is severely impaired in 
mutants that cannot bind the receptor and that phosphorylation of the receptor C-terminal 
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portion prevents binding. Taken together, these observations provide an elegant 
mechanism of Sst2 activity regulation: Sst2 is constitutively present, but it does not 
become active until pheromone binds to the receptor. To prevent constitutive activity we 
need to assume that either binding occurs only to occupied receptors, or that in the 
absence of pheromone, binding is prevented by the presence of the G-protein bound to 
the receptor (153). In this scenario, the regulatory role of receptor phosphorylation as 
well as its internalization remains unclear and must be addressed experimentally. 
Deletion of Sst2 causes otherwise wild type cells to become hypersensitive to 
pheromone and brings the EC50 in line with the receptor occupancy curve. This indicates 
that there must be significant amplification going on downstream of the receptor, since 
lower pheromone doses are able to elicit a full response. Also, the pheromone response 
pathway is constitutively active in cells carrying this mutation. However, these cells are 
large and resemble the characteristic mating phenotype. Because of this, some 
researchers propose that the observed basal activity is due to pheromone released by the 
small number of cells that changed mating type (142) rather than faulty regulation due to 
the lack of Sst2. In any case, Sst2 is playing an important negative role, as evidenced by 
the increased sensitivity of the deletion strains. Interaction with the receptor and 
phosphorylation provide two mechanisms capable of regulating Sst2 activity in a signal-
dependent manner. Based on these observations, a scenario in which the G-protein plays 
the role of M and Sst2 plays P is indeed plausible and can be tested by observing the G 
protein association and dissociation dynamics. 
There are at least six other negative regulatory mechanisms known to operate in 
this pathway: i) induced degradation of Ste7 (MAPKK) (154, 155), ii) degradation of 
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Ste11 (MAPKKK) (92), iii) feedback hyper-phosphorylation of Ste5 (156), iv) hyper-
phosphorylation of Ste711, v) induction of phosphatase Msg5 (157-159), and vi) spatial 
reorganization of the MAP kinases. Very little is known about the dynamics and strength 
of any of these processes and therefore little can be said about the plausibility of any of 
them playing a role in the dose-duration transformation occurring in the absence of Bar1. 
However, some predictions can be made regarding what is needed to happen for these 
processes to produce the observed encoding.  
The discussion in section 2.3.3.5 suggests that if induced protein degradation (e.g. 
Ste11 or Ste7) were to produce a duration encoded signal, then the process has to proceed 
in a heterologous manner. That is, the degradation machinery has to preferentially target 
the inactive protein because otherwise, degradation would halt the system faster as the 
pheromone dose increases. Successful duration encoding necessitates a degradation 
process that happens faster at lower doses but slows down at higher doses. Therefore, if 
experiments demonstrate that degradation of Ste11 or Ste7 is responsible for the 
encoding, we can predict that either degradation is heterologous or that there has to be an 
associated process slowing down degradation at high pheromone doses. This could 
happen for example, through RNA stabilization or gene induction. 
The protein Ste5 is a complicated entity because it has a number of functions, not 
all of them understood. On the one hand, after being recruited to the plasma membrane, 
presumably by free Gβγ subunit, it functions as a scaffold bringing the components of the 
MAP kinase cascade together (160-162). This re-localization to the membrane is part of a 
more complex behavior that includes shuttling in and out the nucleus, although the reason 
                                                
11 Yildirim et al. Submitted for publication. 
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for this shuttling is still unclear (163). On the other hand, Ste5 is subject to regulation by 
phosphorylation (156, 162) by kinase Fus3. It has been recently shown that hyper-
phosphorylation of Ste5 has a negative effect on Fus3 phosphorylation, thereby providing 
a negative feedback loop that could be used as part of a duration encoder. Kinase Kss1 
phosphorylation, on the other hand, does not require Ste5. Another recent investigation 
shows that a mutation that inhibits Fus3 docking to Ste5 (Ste5ND) has a significant effect 
on Fus3 dynamics12, dramatically accelerating its phosphorylation in response to 
pheromone stimulation. Taken together, these experiments show that Ste5 functions both 
as a positive (Fus3 phosphorylation does not occur in its absence) and a negative 
regulator (Fus3 phosphorylation is slowed down). These observations suggest that Ste5 
could be playing the role of species M with Fus3 acting as negative regulator as well as 
messenger molecule. This resembles Model II discussed in detail in section 2.3.3.3. Our 
findings demonstrated that this kind of architecture produces poor adaptation unless an 
intermediary compound separates the positive and negative regulation time-scales or 
delay the effect of the feedback. Therefore, if feedback regulation of Ste5 by Fus3 is 
responsible for the encoding we expect the existence of an intermediary. 
The case in which regulation occurs through hyper-phosphorylation of Ste7 is 
closely related to the case of regulation by feedback phosphorylation of Ste5. It has very 
recently been shown that Fus3 hyper-phosphorylates Ste7, rendering it incompetent to 
phosphorylate Kss113. No effect has been reported on Fus3, so this mechanism for Kss1 
regulation would require an additional module to control Fus3. Because our findings 
suggest that both Fus3 and Kss1 respond to a common upstream signal, this scenario is 
                                                
12 Nan Hao, personal communication. 
13 Hao, Yildirim, Dohlman, Elston, submitted for publication. 
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unlikely. It is possible for regulation of Ste7 by Fus3 to partially affect the dynamics of 
Kss1, but it is not likely to be the main driver. 
The gene encoding phosphatase Msg5 is induced in response to pheromone. This 
phosphatase is thought to be a mayor regulator of MAP kinase activity (31, 157-159). 
Msg5 operates in conjunction with phosphatases Ptp2 and Ptp3. Production of a 
phosphatase can produce a model such as the one described above, with Msg5 playing 
the role of P. The caveat with this scenario is that protein production takes too long 
(typically on the order of an hour) to explain the quick decay observed at low doses. If 
upregulation of the MSG5 gene were to cause the encoding, then it must happen on a 
faster time scale. It is worth mentioning that Msg5 (and the other proteases) do regulate 
Fus3 and Kss1 phosphorylation in the sense that it is their enzymatic activity what de-
phosphorylates the kinases after the upstream activity subsides. 
Finally, there is a last scenario that is worth mentioning. After pheromone 
induction, a complex ballet takes place and all the proteins discussed above are 
redistributed between the cell membrane, the cytoplasm, and the nucleus. Each different 
environment has its  own biochemistry (for example, the phosphatase Ptp2 resides almost 
exclusively in the nucleus) and it is possible for the encoding to occur when a signaling 
species moves to a different location and get exposed to a local negative regulator as a 
result. This process would not require the activity of the negative regulator itself being 
regulated. The effects of the cell spatial extension on signal regulation is something that 
has only very recently begun to be appreciated and more research is needed before a 
meaningful prediction of its effect on quantitative signal encoding can be made. 
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This section discussed some mechanisms that could account for the dose-duration 
transformation observed in cells lacking the protease Bar1. In particular, all the 
mechanisms analyzed are endogenous and do not relay on the degradation or 
internalization of pheromone. A key experiment that can distinguish whether encoding in 
the absence of Bar1 is of endogenous origin is the measurement of the cell-density effect. 
If the pheromone internalization or degradation is the main encoding mechanism, 
variation in the cell density should produce measurable differences in the MAP kinases 
phosphorylation profiles. The negative result, that is if the cell density has no effect, 
would provide strong support for an endogenous encoder.   
4.3.5 Putting it all together 
In the previous section we discussed several possible scenarios that can explain 
the dose-duration encoding observed both in wild type and BAR1 deletion strains. The 
question now is can these mechanisms work together and explain both sets of 
experimental data simultaneously? The answer is in fact positive and as a proof of 
concept here we present a combined model that can account for the two sets of 
experiments. In this model (Figure 4-12), the encoding observed in the wild-type strain is 
caused by the slow degradation of pheromone discussed in section 4.3.2 whereas an 
adaptive endogenous encoder (Section 4.3.4.4) was used to reproduce the effect observed 
in the BAR1 deleted strain. The model is described by equations (4.27)-(4.35). 
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The model includes the mechanisms already discussed with the only difference 
that intermediary species C, responsible for phosphorylating the Kss1-D complex is now 
activated by active M. The same equations and parameters were used to model the wild 
type cells and the BAR1 mutant, except that k60 (pheromone degradation) was set to zero 
in the last case. The model does not include upregulation of the BAR1 gene and therefore 
a fixed amount is assumed present at the beginning of the experiment14.  
The parameters for the data fitting where estimated using a Monte Carlo 
algorithm. As Figure 4-12 B and C show, the composite model reproduces the wild type 
and BAR1 deletion data well, although some deviations occur, especially at low doses. 
This is not surprising given that the model does not contain any amplification step or 
other regulatory elements that may serve to fine-tune the response. As with previous 
models, the fraction of phosphorylated vs. unphosphorylated kinase cannot be determined 
from the experiment and therefore it was adjusted in order to get a good fit. This model 
does not consider the effects of receptor internalization due the current lack of knowledge 
about the process. This omission can also be in part responsible for the deviations. It is 
important to stress that this is not the only possible model consistent with the 
experimental data. The experimental signatures discussed before can be used to validate 
the model, especially the effect of the cell density on the signals.  
 
                                                
14 The model is run to steady state in the absence of pheromone and then a fixed amount is added. 
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Figure 4-12 A complete model for MAPK activity. A) Active receptors activate species M, which is part 
of an adaptive system together with P. M activates Fus3, Kss1, and a putative species C. Kss1 exists 
partially as a complex with species D. This complex is phosphorylated by active C and separates as a result, 
causing the second phosphorylation peak observed for Kss1. Pheromone is degraded by Bar1 constitutively 
present in the media. B) Simulated (solid lines) and observed (dots) dynamics of active M, Fus3, and Kss1 
in a wild type strain. C) Simulated (solid lines) and observed (dots) dynamics of active M, Fus3, and Kss1 
in a strain lacking the BAR1 gene. Concentrations in the BAR1 deletion strain are relative to the WT ones. 
Data provided by Dr. Nan Hao.  
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4.4 General remarks 
4.4.1 Information encoding in the pheromone response pathway 
 
In the pages above, evidence was presented supporting the use of duration 
encoding in the yeast pheromone response pathway.  The models discussed were mostly 
based on known, albeit partially characterized, biochemical processes. The effect of 
removing the BAR1 gene on the encoded signal suggests this protease plays a prominent 
role. As we demonstrated, the most obvious mechanism by which this can happen is the 
Bar1 mediated degradation of pheromone. However, a deletion mutant cannot by itself 
rule out the possibility that Bar1 is affecting signaling in some unexpected way and that 
the encoding is actually happening at the receptor level. This last scenario is compelling 
because it would mean that regulation occurs at the individual cell level. A Bar1-driven 
encoding, on the other hand, would mean that the pathway activity is regulated by the 
community. There is no reason however, why both mechanisms cannot coexist. For 
example we can envision a scenario in which signaling at low dose is regulated by 
pheromone degradation (at 0.1 and 0.3 nM curves in Figure 4-3) and a slower feedback 
drives adaptation at higher pheromone levels for which degradation would take too long. 
This hybrid scenario is attractive because it could be expanded to explain the dose-
duration encoding observed in the BAR1 deletion strain.  
If the protease Bar1 turns out to be the main encoding mechanism, a hypothesis 
that can be tested by analyzing the effect of cell-density on the signals, then this would 
require some reconsideration of how the mating process occurs in natural settings. One 
possibility is that the release of Bar1 is regulated in order to maintain a low background 
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pheromone concentration. The pathway then would get activated only in response to an 
episodic release of pheromone by a close-by partner. Such a strategy would prevent cells 
from responding to pheromone cues originating from cells that are too far away for 
mating.  
An open question is what is the role of receptor internalization? This process is 
still not well understood. Current literature indicates that the receptor internalization is a 
homologous process (both occupied and unoccupied receptors are equally internalized) 
(142) and in the case of the α-factor receptor Ste2, the process is independent of 
signaling through the G-protein (146). This contrasts with the case for the a-factor 
receptor (Ste3), which undergoes signal dependent internalization (67). Another puzzling 
difference is that internalized Ste3 is partially recycled (147), process that has not been 
observed for the α-factor receptor. Elucidating the dynamics of this process is of crucial 
importance to understand signaling in this pathway. Signal-dependent recycling could 
result in the time for receptors elimination being proportional to the pheromone dose 
(dose-dependent recycling is equivalent to a dose-dependent increase in production), 
producing yet another encoding mechanism candidate. The nature of this process has 
important implications for the signals generated in response to low doses of pheromone. 
As the simple calculations above show, pheromone internalized together with receptors 
could produce results akin to pheromone degradation by protease Bar1. With the current 
estimates for the parameter values, this is unlikely. However, an increase in the rate of 
receptor production and degradation of an order of magnitude would result in this process 
having a sizable effect, especially at low doses. It is interesting to point out that receptors 
are internalized in vesicles that form in the plasma membrane, and therefore it is possible 
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for the ratio of internalized pheromone to internalized receptors to be larger than unity. In 
this scenario, pheromone internalization could play a role in the duration encoding 
observed in the absence of protease Bar1. An interesting idea is that that once 
internalized, the receptors keep signaling for a while, and as more receptors are produced 
and subsequently internalized the pool of active receptors grows larger than the initial 
count. This could potentially provide and alternative explanation for the second peak of 
Kss1 phosphorylation observed in the experiments15 
However, the experimental data currently available points to the existence of an 
endogenous encoder, for which there are several candidates. The G-protein cycle is the 
best characterized process among the ones discussed in the previous section and it has all 
the elements necessary to produce duration encoding. Among the other mechanisms, 
feedback regulation of Ste5 or other pathway components by Fus3 or Kss1 is the most 
compelling because there is experimental evidence demonstrating increased Kss1 signals 
in cells lacking Fus3 (79, 164). A possibility that cannot be ruled out is that Fus3 acts 
indirectly as the negative regulator of Kss1 on top of one of the processes described 
above. Clearly, more detailed experiments in strains containing mutant versions of the 
FUS3 gene are necessary to investigate this possibility.  
One interesting observation is that because of its slow kinetics and almost linear 
rate of phosphorylation, Fus3 seems to be acting as an integrator; timing for how long the 
upstream signal has been on. This information is being decoded back to Fus3 
phosphorylation level and hence its activity. Furthermore, the combination of fast and 
slow kinetics exhibited by the two MAP kinases has the potential to form a feed-forward 
                                                
15 This idea was proposed by Meng Jin in the Elston Lab. 
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adaptive system. In fact, it has been demonstrated that pheromone induced degradation of 
the transcriptional activator Ste12 requires Fus3, but not Kss1 (165). This system is 
similar to the one depicted in Figure 2-25A and may play a critical role in ensuring 
proper timing of the transcriptional programs required for chemotropic growth and 
mating. 
Even though the models presented here do not identify the specific actors playing 
the key regulatory roles in this pathway, they considerably narrow down the possibilities. 
By providing a rational explanation of how the pathway processes information, our 
analysis has shown the features that should be present in the regulatory schema. This 
information provides a useful framework for the design of the future experiments that 
will lead to the elucidation of the design principles behind the pheromone response 
pathway. 
4.4.2 Dynamic control of specificity in yeast? 
 The yeast pheromone response pathway does not exist in isolation. As described 
previously, this pathway is part of a complex network than includes the hyper-osmotic 
shock response pathway and also the pathway responsible for the filamentous growth 
(also referred to as invasive growth) observed under certain starvation conditions (164). 
All three pathways share component Ste11, and the MAP kinase Kss1 in the case of the 
mating and filamentous growth pathway (Figure 3-1). It is intriguing that the terminal 
kinases in the three pathways have very different dynamics. More specifically, Hog1, the 
kinase activated by the osmotic shock pathway is quickly activated and reaches its peak 
activity level within minutes to then quickly decay to pre-stimulation levels (46-48). 
Kinases Kss1 and Fus3 activities, on the other hand, are also transient but as shown 
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above, operate on slower time scales, especially Fus3. Finally, sustained Kss1 activity 
seems to be necessary for invasive growth (79). These observations suggest that, as 
already proposed by Sabbagh et al. for the mating and filamentous growth responses, 
specificity in this network is maintained through the careful regulation of each pathway 
dynamics. We can speculate that the quick shut down of Hog1 activity in response to 
hyper-osmotic conditions may be in place to prevent the activation of the other kinases. 
Supports this the substantial cross talk observed in cells lacking Hog1 (166), which is 
consistent with the role played by Hog1 in the quick feedback deactivation of the 
pathway (47). The protein Ste50, a partner of Ste11, has also been shown to play an 
important role preventing cross-talk among these pathways (167, 168) and recent 
evidence indicates that this protein may be subject to regulation by Hog116. Additionally, 
FUS3 mutants have been identified that are impervious to Hog1-mediated repression and 
cause growth arrest (a component of the mating response) when exposed to osmotic 
stress (169).  Interestingly, this network appear to contain a branch with an adaptive 
system (Hog1) that relays information in the form of short pulses, a branch with slow 
activation kinetics (Fus3) leading to mating, and a branch that depend on sustained 
signaling (Kss1) to produce filamentous growth. Such a network fits neatly the kinetic 
insulation paradigm discussed in Chapter 3 with the addition of a transient-to-sustained 
switch that segregates the mating and the filamentous growth responses.
                                                
16 Nan Hao. Personal communication. 
Chapter 5 
 
Significance and perspectives 
5.1 Dynamics of intracellular signals 
The preceding chapters explored important aspects of signaling networks, with 
dynamic regulation and its effects as the driving theme. Signals are not simple events that 
prompt multistable systems to change from one steady state to another. As the yeast 
pathways demonstrate, signals can be complex transient events that must balance 
dynamic range, reliability, and speed. The key finding is that a host of new effects, some 
very counterintuitive, become possible when signals are studied as the dynamic events 
they are. These dynamics provide cells with enormous flexibility to overcome limitations 
imposed by components with narrow dynamic range or maintain specificity even in the 
face of shared pathway components. Therefore, in order to understand intracellular 
signaling networks and signals we must look beyond the steady states and tackle the 
much more difficult problem of understanding the transient responses as well.  
In Chapter 2 we studied the multiple aspects that make adaptive systems suitable 
for signaling. Unlike their counterparts engineered for control, a significant overshot is a 
necessary ingredient for these biological signal modulators. There are a number of 
 160 
reasons why a cell would want to convert a sustained input into a transient signal. On the 
one hand, the sustained activation of a pathway consumes more energy than a transient 
activation. Also, sustained activity may result in the undesirable activation of other 
pathways, especially in the face of shared components, which by definition have to be 
promiscuous. As we shown in Chapter 3, by modulating the pathway activity, cells can 
control information flow in a very precise fashion. That chapter shows that pathway 
specificity may not come from built-in specificity in the interactions between the pathway 
proteins, but may come from their activation patterns instead. Therefore, when looking 
for the sources of specificity in given pathway, the search has to include the dynamics of 
the components.  
We show that different adapting network architectures have different properties, 
advantages, and drawbacks. Some adapt better than others. Some recover faster than 
others. Some are capable of reacting to multiple challenges in a short period of time while 
others a less suited for this kind of application. These observations suggest new ways of 
experimentally investigate pathway architectures by characterizing their dynamics. They 
also could provide answers to questions such as why evolution settled on different 
network architectures for different systems. In fact, the enormous advantage associated 
with the use of dynamic signals suggests that the need to control and modulate these 
dynamics is probably a mayor evolutionary drive. These observations could also shed 
light on why pathways branch where they do. Consider the case of the model used to 
illustrate the kinetic insulation mechanism (Figure 3-5). In that example it makes sense 
for the pathway to branch at the level of kinase C only if the goal is to select which 
branch to activate based in profile of the upstream signal. Now, if for example, the 
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response to signal B requires the activation of some cellular system that necessitates a 
long, persistent signal, then it would make sense to introduce a branch at the level of 
protein BB. On the other hand, if this secondary system needs to be activated transiently, 
then branching at the level of protein B would be more adequate. The corollary is that 
much can be learned about how a network works by studying the location and dynamics 
of the branching points. Conversely, this could also explain the evolution of these 
interconnected signaling pathways. Systems that need to be activated transiently probably 
are connected at levels where the pathway activity is transient and systems that require a 
longer excitation period are probably connected to branches that show sustained activity. 
Based on the results discussed above, it is safe to speculate that for signaling pathways, 
function, architecture, and dynamics are all interconnected and it is unlikely that they can 
be understood in isolation.  
From the discussion above is should be clear that signaling pathways not only 
transfer but also process information. Understanding a pathway is synonymous to 
understanding the path information follows from the receptors to the cellular targets 
responsible for eliciting the different biochemical processes that constitute the 
physiological response. This information is often quantitative and in Chapter 2, different 
information encoding strategies were analyzed. Special emphasis was put on duration 
encoding because of the evidence presented in Chapter 4 supporting this as the strategy of 
choice in the yeast pheromone response pathway. This pathway has been studied for 
more than 30 years and is considered by many as the prototypical MAPK cascade. Yet 
until now, it was not known how information about the pheromone level was being 
encoded. This work answers that question and provides useful guidance for researchers 
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working to identify the main regulatory mechanisms in the pathway. In Chapter 4 we 
show that pheromone concentration is encoded as duration, at least upstream of the MAP 
kinases Fus3 and Kss1. Protein Fus3 then acts an integrator, decoding this temporal 
information into concentration. This time, concentration of phosphorylated Fus3. We also 
showed a number of possible mechanisms that can perform the encoding, and our 
experimental results indicate that even thought protease-driven pheromone degradation 
plays an important role, there must be another, Bar1-independent, encoding mechanism at 
play. More importantly, we suggested a number of key experiments that narrow down the 
field of possibilities. Confirmation of the degradation of pheromone by the protease Bar1 
as the main encoding mechanism would represent an important advance. Such an 
outcome would imply that the decision between mating and chemotropic growth is based 
on the state of the colony, effectively making the pheromone response pathway into a 
more complex mating-quorum sensing mechanism. Important questions remain to be 
answered in this system. Chief among them is the role of receptor internalization. This 
process cannot be ruled out as the encoding mechanism, and as discussed before, this 
would set some requirements that could be tested experimentally. In a pathway that relays 
on external components outside of its control (Bar1) to turn off the signal, receptor 
internalization could provide reassurance that the pathway will in fact be turned off. 
Internalization may set the higher limit for signal duration.  
The pheromone pathway is a prototype for many signaling networks across species. 
It is interesting to speculate about the possibility that the encoding observed here could be 
a more general feature shared by other systems. The plausibility of this will depend on 
the specifics of the encoding mechanisms, but the possibility of duration-encoding being 
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a general modus operandi for some family of GPCR/G proteins is intriguing. Such a 
discovery would be a significant contribution towards the understanding of the basic 
design principles behind signaling pathways. A thorough understanding of this 
phenomenon could also immediately translate into new therapeutic approaches. Most 
drugs in the market today approach disease from a steady-state perspective, for example, 
by completely inhibiting a kinase or blocking a receptor. Undesirable side effects are a 
common consequence of this approach. The findings in this work suggest that when the 
dynamics of a pathway are important, it should be possible to restore it to proper function 
modulating the kinetics of the relevant reactions. Knowing the logic behind the pathway 
operation in quantitative terms could provide guidance for the design of therapies with 
minimal side effects. 
Our findings also raise interesting issues about the properties of the components 
downstream of a duration-encoded pathway, in particular, how is the encoded 
information used. Pheromone concentration is encoded as duration somewhere upstream 
of Fus3 and Kss1. Kinase Kss1 preserves this encoding while kinase Fus3 decodes it 
back to activity level. It was suggested that this combination is ideally suited to produce 
an adaptive system downstream of these kinases. However, the question remains of how 
is this code is interpreted and acted upon by the pathway targets. One clue may come 
from the discoveries made in the cell cycle control system. The progression through the 
stages of the cell cycle is driven by the slow production of a regulatory protein (14), 
which as it crosses a threshold level, causes a bi-stable system to switch to a new steady 
state. In a way, Fus3 recapitulates the cell cycle-control system. The pathway is taking a 
stimulus that was added all at once (a square step), and producing a slow raising species 
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(phospo-Fus3). Evidence of bistability in the pheromone response has been recently 
presented (53), providing further support for this intriguing possibility.  
In this work we unveiled the semantics of the MAPK stage of the pheromone 
pathway, a MAPK code. We analyzed this code from a theoretical standpoint and 
illustrated how cells could use it advantageously to transfer quantitative information. A 
thorough analysis of a variety of mechanisms provided us with a general picture of how 
this system may work and what networks architectures we should expect to find. As a 
result of this analysis we generated models and made testable predictions. Even though 
the precise nature of the encoder has not been determined, these predictions will serve as 
a guide for further research in the field. Knowledge of the code allows us to ask 
meaningful questions, and more importantly understand the answers.  
5.2 Future directions 
The findings of this work illustrate that studying pathway dynamics provides great 
insight into the organization and design rationale of intracellular signaling networks. This 
work answered a number of questions but also raised new ones, some very specific and 
others of a more general nature. The most obvious examples of the first kind are related 
to the yeast pheromone pathway. The evidence presented for duration encoding as a 
MAPK code provides a new framework for the study of this system in terms of which 
new questions can be asked and answers interpreted. The following are some important 
questions and how we think they could be addressed: 
• What is the precise nature of the encoding mechanism?  
Experimental observations suggest that protease Bar1 may be the key 
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player, but other possibilities cannot be ruled out. As discussed in Chapter 4, there 
are a number of key experiments that may strengthen the case for Bar1 or rule it 
out. Of particular importance is the determination of MAPK phosphorylation 
dynamics at different cell densities and in fresh media. A result showing signals 
being independent of the cell density would support a scenario in which encoding 
is due to a mechanism other than Bar1-mediated pheromone degradation. Such a 
result would also indicate that Bar1 is affecting the pathway in a novel way, and 
would justify a search for potential interaction partners. Additionally, much could 
be learned from a careful quantitative characterization of Bar1 potency. 
Interestingly, this issue has been investigated only in relative terms, which makes 
it difficult to gauge Bar1 effect on the concentration of pheromone. We can 
expect that a more definitive answer to the question of what is generating the 
encoding will arise as biosensors or specific antibodies become available for 
elements upstream in the pathway. A promising approach is the use of 
fluorescence resonance energy transfer (FRET) between the subunits of the G 
protein to monitor the dynamics at the head of the pathway. This technique was 
already applied (56) to this system but not enough observations were made. Our 
findings suggest that refocusing these experiments to determine the dynamics of 
G protein activity in response to different doses of mating pheromone could 
provide important information about the role of the G protein cycle. 
• How is the MAPK code decoded by the pathway downstream effectors? 
We showed that Fus3 acts as an integrator, converting signal duration into 
phosphorylation levels. On the other hand, Kss1 phosphorylation remains 
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duration-encoded. Investigating the dynamics of the targets downstream of the 
MAPK (Ste12, Tec1, Far1) should provide some initial clues. Some data on Ste12 
is already available (165) and shows a transient response. Considering that slow 
Fus3 and fast Kss1 kinetics are ideally suited to form a feed-forward based 
adaptive system, it would be instructive to test how the dynamics is affected in 
mutants lacking one or the other MAPK. Ultimately, the question that needs to be 
answered is how gene expression is regulated by the pathway, and what is the role 
being played by duration encoding. 
• What role does receptor internalization play? 
Receptors are internalized on a time-scale similar to the one for signaling. 
Therefore, it is important to understand what regulatory role (if any) this process 
plays. It has been suggested previously in the text that internalization may serve 
as a way to limit the duration of a signal under environmental conditions with a 
continuous supply of pheromone. This raises the question of how duration 
encoding operates in such a scenario. A number of mutant strains defective in 
internalization are already available, and investigating signal dynamics on them 
can provide the answers. However, these mutants must be characterized, 
especially respect of the effects of the mutations on the receptor/Sst2 interaction 
(152), before interpreting the observations. Related to this question are the 
puzzling differences between Ste2 (α-factor receptor) and Ste3 (a-factor receptor) 
in terms of internalization. Most of the experiments from where this knowledge 
comes from have not been independently reproduced or validated. It would be 
valuable to apply modern optical technology to characterize the internalization 
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and recycling of both proteins. In particular, we should seek to establish beyond 
doubt whether internalization is homologous and if its dynamics are dose-
dependent. Another related question is what prompts unbound Ste2 
internalization. If this process is signal-independent, as it is though to be, how do 
the unoccupied receptors know that something is going on? 
• What is the physiological relevance of the MAPK code? 
When in their natural environment, cells are exposed to variable 
concentrations of pheromone, which they do not control. The concentration of 
pheromone is affected by environmental conditions as well as by the protease 
secreted by other cells in the colony. This raises the question of how is this code 
used under such conditions. This can be investigated by measuring MAPK or 
other pathway proteins activity in microfluidic chambers. However, for optimal 
results, this would require the use of biosensors not currently available. Gene 
expression reporters, on the other hand, are easier to build and many are already 
available. Understanding the process by which the genetic machinery reads the 
duration code could permit to infer signal activity based on gene expression 
reporters. This in turns would allow investigating the pathway in a more natural 
setting.  
These are just a few of the questions inspired by this work. An extensive list can be 
made with further questions such as: Why does the cell use duration encoding? Is yeast 
using Kinetic insulation? Is the combination of Bar1 and pheromone being used as a 
population control mechanism?  
The existence of the MAPK code described in Chapter 4 also raises a number of more 
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general questions. The possibility of dose-duration encoding being a widespread strategy 
can be investigated by characterizing the dynamics of other signaling pathways, 
especially those mediated by GPCR’s and MAPK cascades. It is interesting to speculate 
that, just like as similar signaling modules are found in a variety of systems, perhaps their 
dynamics are carried over between systems and are modular as well. Comparing 
evolutionary related pathways in terms of signaling dynamics and location of branching 
points would reveal how new pathways were built into existing networks and provide 
important clues about how signal specificity is maintained. Examples of preserved 
interactions abound, so it is possible that the signals dynamics and the associated 
encoding strategies might be preserved as well. Looking at changes in the dynamics as 
species diverge can provide significant insight about how a pathway operates, and allow 
us to peek into the design principles behind signaling networks in general. 
The ultimate function of a signaling network is to reliably process and propagate 
information. To understand a pathway we must understand these processes, and as this 
work shows, in order to understand these processes we must understand the underlying 
dynamics. By revealing the existence of a MAPK code, we have provided a new 
framework for studying signaling in yeast pheromone response pathway, a prototypical 
organism. Kinetic insulation may further guide this research by placing this pathway in 
the context of a more ample signaling network. Understanding the mechanisms that 
control information processing and propagation in this organism could be a first step 
towards the application of a dynamics-based approach to the study of signaling pathways.  
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Appendix: 
This appendix contains the parameters used to generate the figures presented in this work.  
Figure 2-5: Equation (2.3) was used for the receptor and equation (2.4) has been used for A, B, and C. In 
all cases [P]=1.  
1st column: (R) kd=1 (A) k1=50, k1M=5, k2=2, k2M=5 (B) k1=50, k1M=5, k2=2, k2M=5 (C) k1=50, k1M= 5, 
k2=2, k2M=5.  
2nd column: (R) kd=1 (A) k1=2, k1M=5, k2=2, k2M=5 (B) k1=2, k1M=5, k2=2, k2M=5 (C) k1=2, k1M= 5, k2=2, 
k2M=5.  
3rd column: (R) kd=1 (A) k1=2, k1M=5, k2=2, k2M=5 (B) k1=20, k1M=5, k2=2, k2M=5 (C) k1=2, k1M= 5, k2=2, 
k2M=5.  
 
Figure 2-6: Equation (2.3) was used for the receptor and equation (2.4) has been used for A, B, and C. In 
all cases [P]=1.  
1st column: (R) kd=1 (A) k1=2, k1M=5, k2=2, k2M=5 (B) k1=6, k1M=0.05, k2=2, k2M=0.05 (C) k1=2, k1M= 5, 
k2=2, k2M=5.  
2nd column: (R) kd=1 (A) k1=2, k1M=5, k2=2, k2M=5 (B) k1=40, k1M=5, k2=2, k2M=5 (C) k1=6, k1M= 0.05, 
k2=2, k2M=0.05.  
3rd column: (R) kd=1 (A) k1=4, k1M=0.1, k2=2, k2M=0.1 (B) k1=4, k1M=0.1, k2=2, k2M=0.1 (C) k1=4, k1M= 
0.1, k2=2, k2M=0.1.  
 
Figure 2-10: Equations (2.5) and (2.6) with [P]=1. 
k1=3, k1M=0.05, k2=0.005, k2M=0.01, k3=0.25, k3M=0.01, k4=0.0001, k4M=1, k5=2 10-6, k5M=1. 
 
Figure 2-11: Equations (2.5) and (2.6) with [P]=1. 
k1=1, k1M=5 10-3, k2=3 10-4, k2M=10-2, k3=2.5 10-1, k3M=2 10-3, k4=1x10-3, k4M=5 10-1, k5=10-5, k5M=1. 
 
Figure 2-14: Equations (2.7) and (2.8) with [P]=1. 
k1=2 10-1, k1M=1, k2=10-6, k2M=5 10-1, k3=1.5 10-2, k3M=10-2, k4=6 10-4, k4M=10-2, k5 =3.2 10-2, k5M=10-3 
 
Figure 2-16: Equations (2.9)-(2.11). 
k1=10-1, k1M=1.5 10-1, k2=3 10-3, k2M=1, k3=4.8 10-4, k3M=1, k4=5 10-6, k4M=1, k5=3 10-2, k5M=2 10-3, 
k6=10, k6M=0.1, k7=1, k7M=1 10-1 
 
Figure 2-17: Equations (2.12)-(2.14). 
k1=5 10-1, k1M=1.5, k2=10-6, k2M=8 10-2, k3=1.5 10-1, k3M=6 10-1, k4=3 10-3, k4M=6 10-1, k5=8 10-2, k5M=3 
10-3, k6=10-2, k6M=1, k7=5 10-3, k7M=1 
 
Figure 2-19: Equations (2.15)-(2.17). 
k1=510-2, k1M=1, k2=10-3, k2M=10-2, k3=7.5 10-1, k3M=5 10-2, k4=1.9 10-1, k4M=5 10-3, k0=7.5 10-5, k5=7.5 
10-5, k6=7.5 10-5, k6' =9.6 10-3 
 
Figure 2-20: Equations (2.17)-(2.20). 
k1=6 10-1, k1M=5 10-1, k2=2x10-2, k2M=10-1, k3=10-2, k3M=5 10-2, k4=4 10-3, k4M=10-1, k5=4 10-3, k5M=1, 
k6=2 10-5 
 
Figure 2-22: Equations (2.18)-(2.20) where used for KK. Equation (2.17) was used to model the evolution 
of K* with [KI*] as the upstream input and for the evolution of KI* with KK* as the upstream input. 
k1=6 10-1, k1M=5x10-1, k2=2 10-2, k2M=10-1, k5=8 10-3, k5M=1, k6=2 10-5 
For K*: k3=10-2, k3M=5 10-2, k4=4 10-3, k4M=10-1 For KI*: k3=2.5 10-3, k3M=10-2, k4=10-5, k4M=10-2 
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Figure 2-21 and Figure 2-26: Same as Figure 2-10. 
 
Figure 2-27: Equations (2.21)-(2.23) 
k1=1, k2=10-2, k3=80, k4=10-4, k4m=10-1, k5=5 10-6, k5M=1, k0=10, k0M=10-1 
 
Figure 2-28: Equation (2.24) was used in conjunction with (2.21)-(2.23) as before. 
k6=10, k6M=10-2, k7=4, k7M=10-2 
 
Figure 3-2 and Figure 3-3: Equations (3.1)-(3.4). 
k1=0.5, k1M=10, v2= 0.25, k2M=10, k3=0.5, k3M=10, k4=2 10-4, k4M=1, v5=2.5 10-6, k5M=1, k6=2.5 10-2, 
k6M=0.01, v7=3 10-4, k7M=0.01, k8=0.25, k8M=2 10-3, k9=1.5 10-4, k9M=0.5, v10=5 10-5, k10M=0.5 
 
Figure 3-5, Figure 3-6, and Figure 3-7: Equations (3.5)-(3.10) and (3.1)-(3.3) as before. 
k20=20, k20M=10
-2, v21=1, k21M=10
-2, k22=10
-1, k22M=10
-1, v23=3 10
-4, k23M=10
-2, k24=0.25, k24M=2 10
-3,  
k25=1e-3, k25M=1, v26=10
-5, k26M=1, k30=5 10
-3, k30M=1, v31=2 10
-5, k31M=0.25, k32=10
-4, k32M=1, v33=10
-5, 
k33M=1 
 
Figure 4-3: Equations (4.1) and (4.2) 
k1=5.53 10-4, k1M=3.75 10-2, k2=3.25 10-4, k2M=3 10-1, k3=2.55 10-2, k3M=1, k4=2.5 10-3, k4M=2 
Input signal: S (time < tpulse) and signal= S e-(time-tpulse)/λ  (time > tpulse). The signal parameters for each 
concentration were: S=0.2,0.25,0.75,0.75,0.75, tpulse= 4’, 4’, 6’, 22’, 55’, and λ=(50, 50, 250, 300, 300) x 
3600 min. 
 
Figure 4-4: Equations (4.3)-(4.7) 
FTOT=8500, KTOT=5500, DTOT=2000, CTOT=8000 
k1=4.14, k1M=319, k2=2.76, k2M=2550, k3=105, k3M=5500, k4=13.75, k4M=11000, k5=0.01, k6=4 10
-8, k7=10
-
5, k8=1.4 10
-3, k8M=100, k9=2, k9M=100, k10=10
-3, k10M=50, k11=30, k11M=50 
 
Figure 4-5: Equations (4.1) and (4.2) with the same parameters but modified input signals. 
Input signal: S (time < tpulse) and signal= (S-S0) e-(time-tpulse)/λ + S0 (time > tpulse). The signal parameters for 
each concentration were: S=0.15, 0.22, 0.35, 0.45, 0.65, tpulse=1’, 1’, 2’, 3’, 3’, and λ=(100, 100, 500, 650, 
8000) x 3600 min. S0 = 0.0075; 
 
Figure 4-6: Equations (4.8)-(4.13). 
k1=3.8 10
-2, k2=4.7 10
-3, k3=33, k4=1.7 10
-5, k4M=8.8 10
-3, k5=4 10
-7, k5M=0.23, k0=16, k0M=7.7 10
-3, k10=5.2 
10-4, k10M=3.4 10
-2, k20=7.1 10
-4, k20M=1.41, k30=3.4 10
-3, k30M=9.6 10
-2, k40=8 10
-4, k40M=0.5, k8=5.7, k8M=5 
10-3, k9=0.6, k9M=0.11 
 
Figure 4-7, Figure 4-8, and Figure 4-9: Equations (4.14)-(4.16). The concentrations of pheromone used 
are indicated in the figure and we assumed 10000 rec/cell. Cell density is indicated in the text. k1=43 
rec/min, k2p=6.25 10
-2 1/min, k2n=4.3 10
-3 1/min, kd=4nM. The k1 profile in Figure 4-9 was: k1(t)= [k1 (t < 
tstart), k1 (1 + trate (t - tstart)) (t > tstart & t < tend, k1 (1 + trate (tend - tstart)) (t > tend)] with tstart = 20’, 
tend = 60’, trate = ¼  
   
Figure 4-10: Equations (4.17)-(4.21). 
k1=7.5 10-3, k2=10-2, k3=500, k4=2 10-4, k4M=10-2, k5=4 10-7, k5M=10-2, k0=8.5 10-2, k0M=10-3, k6=2.8 10-4, 
k6M=3.75 10-2, k7=1.6 10-4, k7M=0.3, k8=1.27 10-1, k8M=1, k9=10-2, k9M=0.5 
 
Figure 4-11: Equations (4.22)-(4.26) 
k1=2 106, k2=10-2, k10=67, k10M=0.88, k11=1.4 104, k11M=0.4, k12=1.2 105, k12M=1.6 10-3, k6=301 10-5, k6M=7 
10-2, k7=8.9 10-7, k7M=0.15, k8=9 10-2, k8M=4.8, k9=2 10-3, k9M=1.1, k4=1.6 10-3, k4M=2.5 10-2, k5=1.7 10-5, 
k5M=4 10-2 
 
 
Figure 4-12: Equations (4.27)-(4.35): 
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k1=2 106, k2=10-2, k60=7.86 10-13, k60M=3.4 10-8, k10=12.2, k10M=9 10-3, k11=1.63 104, k11M=2.9, k12=6.15 
104, k12M=2.1 10-2, k70=1.85 10-3, k70M=0.1, k71=1.1 10-6, k71M=0.18, k20=2.55 10-4, k20M=0.43, k30=4.6 10-5, 
k30M=5.3 10-2, k3=97.4, k3M=1.88 104, k4=1.84, k4M=1.48 103, k6=7 10-9, k7=3.3 10-6, k8=1.64, k8M=3.55, 
k9=9.6 10-2, k9M=103, k13=6.4 10-2, k40=3.8 10-3, k40M=6.4 10-4, k50=3.5 10-3, k50M=3.4 10-3 
 
 
The ODE systems describing the models were solved using the software Mathematica ® 
(Wolfram Research, Champagne, Il).
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